Any feedback?
Information on EC 3.1.3.2 - acid phosphatase
for references in articles please use BRENDA:EC3.1.3.2Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
3.1.3.2 acid phosphataseIUBMB Comments
Wide specificity. Also catalyses transphosphorylations.
Specify your search results
Word Map
- 3.1.3.2
- osteoclast
- lysosomal
- resorption
- marrow
-
cytochemical
- rankl
-
osteoclastogenesis
- cathepsin
-
multinucleated
- collagen
- osteoporosis
- granule
- beta-glucuronidase
- osteocalcin
- lymphocyte
- monocyte
-
prostate-specific
- osteoprotegerin
-
histochemistry
- periodontal
- metastases
- phosphorus
- phagocytic
- alveolar
-
trabecular
-
seminal
-
rankl-induced
- parathyroid
-
ovariectomized
- tibia
- femur
-
cytochemistry
-
lumbar
- osteolysis
- nfatc1
-
resorb
- tooth
- calcitonin
- m-csf
-
dentin
- calvaria
-
bone-specific
-
orthodontic
-
telopeptide
-
postmenopausal
-
histomorphometric
-
micro-ct
-
micro-computed
- medicine
- synthesis
- molecular biology
- phytase
- diagnostics
-
n-acetyl-beta-d-glucosaminidase
- biotechnology
- agriculture
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
Synonyms
acid phosphatase, tartrate-resistant acid phosphatase, prostatic acid phosphatase, tracp, acpase, uteroferrin, tracp 5b, phosphatidic acid phosphatase, tracp5b, pp2a phosphatase, 
more
top
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
acid monophosphatase
-
-
-
-
acid nucleoside diphosphate phosphatase
-
-
-
-
Acid phosphatase PII
-
-
-
-
acid phosphohydrolase
-
-
-
-
acid phosphomoesterase
-
-
-
-
acid phosphomonoester hydrolase
-
-
-
-
ACP1
-
-
-
-
AcPase
-
-
-
-
Adipocyte acid phosphatase, isozyme alpha
-
-
-
-
Adipocyte acid phosphatase, isozyme beta
-
-
-
-
APase
-
-
-
-
APASE6
-
-
-
-
glycerophosphatase
-
-
-
-
HPAP
-
-
-
-
LAP
-
-
-
-
Low molecular weight phosphotyrosine protein phosphatase
-
-
-
-
Minor phosphate-irrepressible acid phosphatase
-
-
-
-
NSAP
-
-
-
-
P56
-
-
-
-
P60
-
-
-
-
PAP
-
-
-
-
pH 2.5 acid phosphatase
-
-
-
-
pH 6-optimum acid phosphatase
-
-
-
-
phosphomonoesterase
-
-
-
-
Stationary-phase survival protein surE
-
-
-
-
Tartrate-resistant acid ATPase
-
-
-
-
TR-AP
-
-
-
-
TrATPase
-
-
-
-
uteroferrin
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PATHWAY SOURCE
PATHWAYS
BRENDA
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
phosphate-monoester phosphohydrolase (acid optimum)
Wide specificity. Also catalyses transphosphorylations.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CAS REGISTRY NUMBER
COMMENTARY
9001-77-8
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
6,8 difluoro-4-methylumbelliferyl phosphate + H2O
6,8 difluoro-4-methylumbelliferol + phosphate
-
-
-
?
Ac-RK(pS)AGKPKN + H2O
?
synthetic phosphorylated oligopeptide
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
Phosphotyrosine-protein-phosphatases and human reproduction: an association between low molecular weight acid phosphatase (ACP1) and spontaneous abortion.
Achondroplasia
FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification.
acid phosphatase deficiency
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
acid phosphatase deficiency
Isolation and characterization of acid phosphatase mutants in Schizosaccharomycespombe.
acid phosphatase deficiency
Liver-specific lysosomal acid phosphatase deficiency (Apl) on mouse chromosome 17.
acid phosphatase deficiency
Lysosomal Acid Phosphatase Deficiency: Liver Specific Variant in the Mouse.
acid phosphatase deficiency
Lysosomal tartrate sensitive acid phosphatase deficiency in cells which contain lysosomal "high uptake forms".
acid phosphatase deficiency
Spatial and Temporal Expression of Lysosomal Acid Phosphatase 2 (ACP2) Reveals Dynamic Patterning of the Mouse Cerebellar Cortex.
acid phosphatase deficiency
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.
acid phosphatase deficiency
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus.
Acidosis
Automated determination of blood metabolic acidosis, total acid phosphatase, angiotensin converting enzyme, fructosamine and urinary oxalate and citrate on the ABX Pentra 400.
Acne Vulgaris
Purification and partial characterization of an acid phosphatase (EC 3.1.3.2) produced by Propionibacterium acnes.
Acquired Immunodeficiency Syndrome
Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.
Acquired Immunodeficiency Syndrome
[In vivo neutralization of physiological cervicovaginal acidity by sperm nitrogen bases]
Acute Kidney Injury
[The dynamics of postmortem cellular changes. Ultrastructural-histochemical research]
Adenocarcinoma
'Endometrial' adenocarcinoma of the prostatic urethra arising in a villous polyp. A light microscopic and immunoperoxidase study.
Adenocarcinoma
A case report of a high serum acid phosphatase level in metastatic prostatic adenocarcinoma.
Adenocarcinoma
Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases.
Adenocarcinoma
Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Adenocarcinoma
Atypical ductal adenocarcinoma of the prostate with endometrioid immunohistological features.
Adenocarcinoma
Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Adenocarcinoma
Carcinosarcoma of the prostate in combination with adenocarcinoma of the prostate and adenocarcinoma of the seminal vesicles. A case report with immunocytochemical analysis and review of the literature.
Adenocarcinoma
Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
Adenocarcinoma
Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8.
Adenocarcinoma
Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Adenocarcinoma
Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Adenocarcinoma
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Adenocarcinoma
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
Adenocarcinoma
Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and Borderline High Prostate-Specific Antigen: A Pilot Study.
Adenocarcinoma
Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.
Adenocarcinoma
Discordance between concentrations of prostate-specific antigen and acid phosphatase in serum of patients with adenocarcinoma of the prostate.
Adenocarcinoma
Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma.
Adenocarcinoma
DNA and protein content as cellular biochemical parameters. A discussion with two examples: acid phosphatase and cathepsin D in rat liver and hepatoma and acid phosphatase in human breast normal tissue and adenocarcinoma.
Adenocarcinoma
Effect of hormone therapy on immune response in patients with prostatic cancer.
Adenocarcinoma
Effect of hormone treatment on prostatic acid phosphatase in a serially transplantable human prostatic adenocarcinoma (PC-82).
Adenocarcinoma
Elevated prostatic acid phosphatase: a prognostic factor for stage C adenocarcinoma of the prostate.
Adenocarcinoma
Enzymorphology of adenocarcinoma of the endometrium; beta-glucuronidase, acid phosphatase, reduced diphosphopyridine nucleotide (DPNH) diaphorase, and alpha-naphthyl esterase.
Adenocarcinoma
Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Adenocarcinoma
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Adenocarcinoma
Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer.
Adenocarcinoma
Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
Adenocarcinoma
Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma.
Adenocarcinoma
Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
Adenocarcinoma
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Adenocarcinoma
Identification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP.
Adenocarcinoma
Immunocytochemical demonstration of prostatic acid phosphatase: different secretion kinetics between normal, hyperplastic and neoplastic prostates.
Adenocarcinoma
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Adenocarcinoma
Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
Adenocarcinoma
Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores.
Adenocarcinoma
Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Adenocarcinoma
Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma.
Adenocarcinoma
Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
Adenocarcinoma
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinoma.
Adenocarcinoma
Metastatic Adenocarcinoma of the Prostate to the Brain Initially Suspected as Meningioma by Magnetic Resonance Imaging.
Adenocarcinoma
Metastatic prostatic carcinoma to testis: histological features mimicking lymphoma.
Adenocarcinoma
Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity.
Adenocarcinoma
MULTIMODAL IMAGING AND HISTOLOGIC CORRELATION OF ISOLATED METASTASIS OF PROSTATE ADENOCARCINOMA TO THE CHOROID.
Adenocarcinoma
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Adenocarcinoma
Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
Adenocarcinoma
Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
Adenocarcinoma
Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study.
Adenocarcinoma
Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Adenocarcinoma
Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
Adenocarcinoma
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Adenocarcinoma
Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
Adenocarcinoma
Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.
Adenocarcinoma
Prostate specific antigen and prostate specific acid phosphatase in adenocarcinoma of Skene's paraurethral glands and ducts.
Adenocarcinoma
Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
Adenocarcinoma
Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease.
Adenocarcinoma
Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
Adenocarcinoma
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma.
Adenocarcinoma
Prostatic acid phosphatase as measured with two radioimmunoassay kits in the detection of prostatic adenocarcinoma.
Adenocarcinoma
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Adenocarcinoma
Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies.
Adenocarcinoma
Prostatic adenocarcinoma metastatic to the breasts: report of a case with diagnosis by fine needle aspiration biopsy.
Adenocarcinoma
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Adenocarcinoma
Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Adenocarcinoma
R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
Adenocarcinoma
Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.
Adenocarcinoma
Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.
Adenocarcinoma
Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
Adenocarcinoma
Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases.
Adenocarcinoma
Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.
Adenocarcinoma
Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases.
Adenocarcinoma
The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.
Adenocarcinoma
The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
Adenocarcinoma
The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
Adenocarcinoma
The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma.
Adenocarcinoma
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinoma.
Adenocarcinoma
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Adenocarcinoma
The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
Adenocarcinoma
The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
Adenocarcinoma
The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy.
Adenocarcinoma
The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
Adenocarcinoma
The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
Adenocarcinoma
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.
Adenocarcinoma
Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycle.
Adenocarcinoma
Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma.
Adenocarcinoma
Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.
Adenocarcinoma
[A primary adenocarcinoma of the seminal vesicles. Case report of a rare malignancy]
Adenocarcinoma
[An immunohistological study of metastatic adenocarcinoma of the lymph node: is it useful in diagnosing a primary tumor?]
Adenocarcinoma
[Clinical analysis and treatment of carcinoma of the prostate with bone metastasis]
Adenocarcinoma
[Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors]
Adenocarcinoma
[Diagnostic, clinical and therapeutic aspects of primary transitional cell carcinoma of the prostate]
Adenocarcinoma
[Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)]
Adenocarcinoma
[Relation of serum levels of acid phosphatase in the femoral vein and the inferior vena cava in adenocarcinoma of the prostate]
Adenocarcinoma
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
Adenocarcinoma
[Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]
Adenocarcinoma of Lung
Lipin-1 determines lung cancer cell survival and chemotherapy sensitivity by regulation of endoplasmic reticulum homeostasis and autophagy.
Adenocarcinoma of Lung
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.
Adenocarcinoma, Bronchiolo-Alveolar
[Enzyme cytochemistry and morphometric study of the effects of macrophages on A549 pulmonary alveolar cell carcinoma cell line]
Adenocarcinoma, Clear Cell
Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Adenocarcinoma, Clear Cell
Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Adenocarcinoma, Clear Cell
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Adenocarcinoma, Clear Cell
Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
Adenocarcinoma, Mucinous
Ultrastructural cytochemistry of human gastric cancer: electron microscopic observations of five organellae marker enzymes.
Adenocarcinoma, Papillary
Papillary adenocarcinomas of the prostate. An immunohistochemical study.
Adenoma
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Adenoma
Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Adenoma
Enzyme activities in biopsy specimens from large-bowel mucosa in colorectal adenomas and carcinomas.
Adenoma
Nephrogenic adenomas of the urethra involving the prostate gland: a report of two cases of a lesion that may be confused with prostatic adenocarcinoma.
Adenoma
[Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma]
Adenoma
[Enzymatic activity of adenosine triphosphatase and acid phosphatase in adenoma of the tongue]
Adenoma
[Immunochemical properties of acid phosphatase of the human prostate gland and its adenoma]
Adenoma
[The significance of acid phosphatase activity in the cytologic diagnosis of thyroid malignancy (author's transl)]
Adenoma
[Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase]
Adenoma, Pleomorphic
Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.
Adenomatoid Tumor
Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Adrenal Insufficiency
Effect of thyroidectomy and adrenalectomy on the physiochemical status of rat testes.
Adrenocortical Adenoma
Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
Adrenocortical Adenoma
Enzyme histocytochemical studies in human adrenocortical adenomas. [I]. Primary aldosteronism.
Agranulocytosis
Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations.
Alveolar Bone Loss
Effectiveness of the diode laser in the treatment of ligature-induced periodontitis in rats: a histopathological, histometric, and immunohistochemical study.
Alveolar Bone Loss
Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement.
Alveolar Bone Loss
Novel antioxidative nanotherapeutics in a rat periodontitis model: Reactive oxygen species scavenging by redox injectable gel suppresses alveolar bone resorption.
Alveolar Bone Loss
Osteopenic effects of high-fat diet-induced obesity on mechanically induced alveolar bone remodeling.
Alveolar Bone Loss
Periodontal ligament-associated protein-1 gets involved in experimental periodontitis.
Alveolar Bone Loss
Protective effect of hinokitiol against periodontal bone loss in ligature-induced experimental periodontitis in mice.
Alzheimer Disease
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
Alzheimer Disease
Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia.
Alzheimer Disease
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Amebiasis
Structure-Function Relationship Study of a Secretory Amoebic Phosphatase: A Computational-Experimental Approach.
Amelogenesis Imperfecta
Defects in the acid phosphatase ACPT cause recessive hypoplastic amelogenesis imperfecta.
Amelogenesis Imperfecta
Recessive Mutations in ACPT, Encoding Testicular Acid Phosphatase, Cause Hypoplastic Amelogenesis Imperfecta.
Anaphylaxis
Morphochemical investigations of the liver and biochemical studies of the blood of guinea pigs in anaphylactic shock.
Anemia
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Anemia
The activity of certain hydrolases of rat erythrocytes in experimental magnesium deficiency.
Anemia
[Activity of selected neutrophil enzymes of patients maintained on hemodialysis and treated with erythropoietin (rHu EPO)]
Anemia
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
Anemia, Hemolytic
Development of the embryonic chick phagocytic system: intraembryonic erythrophagocytosis induced by phenylhydrazine.
Anemia, Pernicious
Cytochemical detection of erythroblastic enzymes in acquired dyserythropoiesis.
Anemia, Sickle Cell
Predictors of osteoclast activity in patients with sickle cell disease.
Anemia, Sickle Cell
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Anemia, Sickle Cell
Tissue damage in sickle cell disease as assessed by serum acid phosphatase.
Angina, Unstable
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
Ankylosis
Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
Appendicitis
Experimental model of acute appendicitis in the rabbit with determination of leucine amino peptidase (LAP) and acid phosphatase (acid-P) activities in portal blood samples.
Arteritis
Polymyalgia rheumatica and giant cell arteritis--rational diagnosis and treatment predicated and disordered prostaglandin metabolism.
Arthritis
Adenosine A2A Receptor Mediates Inhibition of Synovitis and Osteoclastogenesis after Electroacupuncture in Rats with Collagen-Induced Arthritis.
Arthritis
Cherubism mice also deficient in c-Fos exhibit inflammatory bone destruction executed by macrophages that express MMP14 despite the absence of TRAP+ osteoclasts.
Arthritis
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
Arthritis
Induction of autoimmune arthritis after direct injection of bone marrow cells from arthritis-prone SKG/Jcl mice into bone cavity of normal mice.
Arthritis
Metabolomics analysis of the therapeutic effects of Qiwei Tongbi oral liquid on rheumatoid arthritis in rats.
Arthritis
Osseous tissue reaction around hydroxyapatite block implanted into proximal metaphysis of tibia of rat with collagen-induced arthritis.
Arthritis
Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840.
Arthritis
Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/?-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.
Arthritis
[Identification of mesenchymal stem cells derived from rheumatoid arthritis synovial fluid and their regulatory effect on osteoblast formation.]
Arthritis, Experimental
Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis.
Arthritis, Experimental
Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis.
Arthritis, Experimental
Changes in location and number of tartrate-resistant acid phosphatase (TRAP)-positive cells during the development of type II collagen-induced arthritis in DBA/1J mice.
Arthritis, Experimental
Evaluation of protective efficacy of Spirulina platensis against collagen-induced arthritis in rats.
Arthritis, Experimental
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
Arthritis, Experimental
Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/?-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.
Arthritis, Experimental
[Behavior of serum acid phosphatase in adjuvant arthritis of the rat]
Arthritis, Gouty
[Relation of serum Dickkopf-1 with bone destruction in patients with gouty arthritis].
Arthritis, Psoriatic
In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Arthritis, Rheumatoid
Appearance of specific acid phosphatase isozymes in the synovial fluid of patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients.
Arthritis, Rheumatoid
Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Arthritis, Rheumatoid
Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Arthritis, Rheumatoid
Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
Arthritis, Rheumatoid
In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Arthritis, Rheumatoid
Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
Arthritis, Rheumatoid
KLF2 (kruppel like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Arthritis, Rheumatoid
Lymphocyte subpopulations in rheumatoid arthritis. An immunological, enzyme histochemical and morphological study.
Arthritis, Rheumatoid
Predictive value of synovial fluid analysis in rheumatoid arthritis. A 7.5-year follow-up study.
Arthritis, Rheumatoid
Prognostic significance of synovial fluid analysis in rheumatoid arthritis.
Arthritis, Rheumatoid
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Arthritis, Rheumatoid
Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
Arthritis, Rheumatoid
Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage.
Arthritis, Rheumatoid
Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Arthritis, Rheumatoid
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Arthritis, Rheumatoid
[Biomarker of bone and cartilage destruction in rheumatoid arthritis].
Arthritis, Rheumatoid
[Morphologic analysis of synovial effusion in rheumatoid arthritis. I. Light microscopy--cytology, histochemistry and semi-thin sections]
Arthritis, Rheumatoid
[Relation between serum enzymes and articular radionuclide tests in the diagnosis of osteoarthrosis and rheumatoid arthritis]
Arthritis, Rheumatoid
[Study of lysosomal enzymes in human synovial membrane and fluid from rheumatoid and non-rheumatoid patients]
Arthritis, Rheumatoid
[Technetium[(99)Tc] methylenediphosphonate inhibits osteoclast formation from PBMCs in patients with rheumatoid arthritis.]
Arthritis, Rheumatoid
[The chronobiological aspects of lysosomal enzyme activity in the synovial fluid and of remission in rheumatoid inflammation]
Arthritis, Rheumatoid
[The cytochemical characteristics of neutrophilic leukocytes in the peripheral blood and synovial fluid of patients with rheumatoid arthritis in the course of treatment]
Arthritis, Rheumatoid
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
Arthritis, Rheumatoid
[The effect of intra-articular treatment with corticosteroids, polyvinylpyrrolidone and dimethyl sulfoxide on the composition of the synovial fluid in patients with rheumatoid arthritis]
Ascorbic Acid Deficiency
Dietary vitamin C deficiency depressed the gill physical barriers and immune barriers referring to Nrf2, apoptosis, MLCK, NF-?B and TOR signaling in grass carp (Ctenopharyngodon idella) under infection of Flavobacterium columnare.
Ascorbic Acid Deficiency
Dietary vitamin C deficiency depresses the growth, head kidney and spleen immunity and structural integrity by regulating NF-?B, TOR, Nrf2, apoptosis and MLCK signaling in young grass carp (Ctenopharyngodon idella).
Ascorbic Acid Deficiency
Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat.
Asthma
Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate.
Asthma
Immunobiochemical evaluation of bronchoalveolar lavage (BAL) in atopic bronchial asthma, chronic bronchitis and bronchiectasis.
Asthma
[Effect of non-specific sensitization with bacterial vaccine on acid phosphatase release from peripheral blood leukocytes in bronchial asthma]
Asthma
[Effect of specific desensitization on acid phosphatase release from peripheral blood leukocytes in allergic (atopic) bronchial asthma]
Asthma
[Immunoglobulin level and the activity of the lysosomal acid phosphatase in infectious-allergic bronchial asthma]
Asthma
[In vitro Intal effect on the activity of beta-glucuronidase and acid phosphatase of leukocytes in patients with asthma]
Asthma
[The influence of climatic treatment on the levels of complement and some lysosomal enzymes in serum of patients with asthma bronchiale (author's transl)]
Astrocytoma
An acid phosphatase in the plasma membranes of human astrocytoma showing marked specificity toward phosphotyrosine protein.
Astrocytoma
Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain.
Ataxia
Cerebellar Expression of the Neurotrophin Receptor p75 in Naked-Ataxia Mutant Mouse.
Atherosclerosis
ACP1 Genetic Polymorphism and Coronary Artery Disease: An Association Study.
Atherosclerosis
Early atherogenesis in the White Carneau pigeon. III. Lipid accumulation in nascent foam cells.
Atherosclerosis
Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5.
Atherosclerosis
[Subpopulations of lymphocytes and monocytes/macrophages at the early stages of human aorta atherosclerosis]
Autoimmune Diseases
Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase.
Avitaminosis
[Study of enzymatic activity in avitaminosis B1 in the pigeon. II. Acid phosphatase.]
Bacterial Infections
Fishmeal replacement by rice protein concentrate with xylooligosaccharides supplement benefits the growth performance, antioxidant capability and immune responses against Aeromonas hydrophila in blunt snout bream (Megalobrama amblycephala).
Bacterial Infections
YAP in epithelium senses gut barrier loss to deploy defenses against pathogens.
beta-Thalassemia
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.
Blast Crisis
Cytochemical studies in the blastic transformation of chronic granulocytic leukaemia.
Blast Crisis
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Blast Crisis
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.
Blast Crisis
Ultrastructural study of chronic myeloid leukemia in blast crisis using myeloperoxidase and acid phosphatase reactions.
Blister
Acid hydrolases in blister fluid. I. Characterization and quantification of acid phosphatase.
Blister
Acid phosphatase localization in neurons of Bulla gouldiana (Gastropoda: Opisthobranchia.
Blister
Neurotoxic action of permethrin in Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae) female ticks. Morphological and cytochemical evaluation of the central nervous system.
Blister
Programmed cell death in the larval salivary glands of Apis mellifera (Hymenoptera, Apidae).
Bone Diseases
Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Bone Diseases
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Bone Diseases
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
Bone Diseases
Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease.
Bone Diseases
Diagnostic Significance of Serum Alkaline and Acid Phosphatase Values in Relation to Bone Disease.
Bone Diseases
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Bone Diseases
Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales.
Bone Diseases
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Bone Diseases
Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
Bone Diseases
Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Bone Diseases
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Bone Diseases
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Bone Diseases
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Bone Diseases
[The influence and clinical significance of proteasome inhibitor on serum bone metabolite markers in patients with myeloma bone disease].
Bone Diseases, Developmental
Exceptional thermal stability of therapeutical enzymes entrapped in alumina sol-gel matrices.
Bone Diseases, Developmental
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.
Bone Diseases, Metabolic
A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
Bone Diseases, Metabolic
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Bone Diseases, Metabolic
Assessing the Effectiveness of Panchatikta Ghrita, a Classical Ayurvedic Formulation as Add-on Therapy to Vitamin D3 and Calcium Supplements in Patients with Osteopenia: A Randomized, Open-Labeled, Comparative, Controlled Clinical Study.
Bone Diseases, Metabolic
Bone mineral density in pediatric patients with idiopathic hypercalciuria.
Bone Diseases, Metabolic
Clinical usefulness of serum tartrate-resistant fluoride-sensitive acid phosphatase activity in evaluating bone turnover.
Bone Diseases, Metabolic
Condylar Degradation from Decreased Occlusal Loading following Masticatory Muscle Atrophy.
Bone Diseases, Metabolic
Correlation between alkaline and acid phosphatase activities and age-related osteopenia in murine vertebrae.
Bone Diseases, Metabolic
Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Bone Diseases, Metabolic
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
Bone Diseases, Metabolic
Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Bone Diseases, Metabolic
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Bone Diseases, Metabolic
Tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of osteoclast activity in the early phase after cementless total hip replacement.
Bone Diseases, Metabolic
[Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)]
Bone Diseases, Metabolic
[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease]
Bone Diseases, Metabolic
[Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia]
Bone Resorption
"iNOS-Derived Nitric Oxide Stimulates Osteoclast Activity and Alveolar Bone Loss in Ligature-Induced Periodontitis in Rats"
Bone Resorption
(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
Bone Resorption
1,25-Dihydroxy vitamin D3 treatment attenuates osteopenia, and improves bone muscle quality in Goto-Kakizaki type 2 diabetes model rats.
Bone Resorption
16 T high static magnetic field inhibits receptor activator of nuclear factor kappa-? ligand-induced osteoclast differentiation by regulating iron metabolism in Raw264.7 cells.
Bone Resorption
17 beta-estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats.
Bone Resorption
2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
Bone Resorption
4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model.
Bone Resorption
A 300??m Organotypic Bone Slice Culture Model for Temporal Investigation of Endochondral Osteogenesis.
Bone Resorption
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.
Bone Resorption
A dried blood spot-based method to measure levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), a marker of bone resorption.
Bone Resorption
A High-Fat Diet Decreases Bone Mass in Growing Mice with Systemic Chronic Inflammation Induced by Low-Dose, Slow-Release Lipopolysaccharide Pellets.
Bone Resorption
A new cytokine-dependent monoblastic cell line with t(9;11)(p22;q23) differentiates to macrophages with macrophage colony-stimulating factor (M-CSF) and to osteoclast-like cells with M-CSF and interleukin-4.
Bone Resorption
A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Bone Resorption
A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
Bone Resorption
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma.
Bone Resorption
A serum metabolomics-based profile in low bone mineral density postmenopausal women.
Bone Resorption
Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and ?-arrestin recruitment than teriparatide.
Bone Resorption
Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro.
Bone Resorption
Abnormal bone architecture in mice expressing MyD88 in cells of the osteoclast lineage.
Bone Resorption
Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax.
Bone Resorption
ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Bone Resorption
Activin A Expressed in Rheumatoid Synovial Cells Downregulates TNF?-Induced CXCL10 Expression and Osteoclastogenesis.
Bone Resorption
Acute effects of bisphosphonates on new and traditional markers of bone resorption.
Bone Resorption
Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.
Bone Resorption
Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.
Bone Resorption
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Bone Resorption
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.
Bone Resorption
Alterations in osteoclast morphology following long-term 17beta-estradiol administration in the mouse.
Bone Resorption
Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
Bone Resorption
Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-?B and mitogen-activated protein kinase activity in receptor activator of nuclear factor-?B-induced RAW264.7 cells.
Bone Resorption
Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Bone Resorption
An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model.
Bone Resorption
Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis.
Bone Resorption
Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
Bone Resorption
Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian Decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7.
Bone Resorption
Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin.
Bone Resorption
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.
Bone Resorption
Asiatic Acid Attenuates Bone Loss by Regulating Osteoclastic Differentiation.
Bone Resorption
Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9.
Bone Resorption
Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.
Bone Resorption
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Bone Resorption
Atorvastatin promotes bone formation in aged apoE-/- mice through the Sirt1-Runx2 axis.
Bone Resorption
AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats.
Bone Resorption
BADGE, a synthetic antagonist for PPAR?, prevents steroid-related osteonecrosis in a rabbit model.
Bone Resorption
Beneficial effects of hyperoside on bone metabolism in ovariectomized mice.
Bone Resorption
Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment.
Bone Resorption
Biochemical markers of bone metabolism and prediction of fracture in elderly women.
Bone Resorption
Biochemical markers of bone turnover are influenced by recently sustained fracture.
Bone Resorption
Biochemical markers of bone turnover for the clinical investigation of osteoporosis.
Bone Resorption
Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.
Bone Resorption
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Bone Resorption
Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts.
Bone Resorption
Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.
Bone Resorption
Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.
Bone Resorption
Bone composition and metabolism after hyperbaric oxygenation in rats with 1-hydroxyethylidene-1,1-bisphosphonate-induced rickets.
Bone Resorption
Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.
Bone Resorption
Bone formation and resorption markers as diagnostic tools for bone metastases evaluation.
Bone Resorption
Bone formation by marrow osteogenic cells (MBA-15) is not accompanied by osteoclastogenesis and generation of hematopoietic supportive microenvironment.
Bone Resorption
Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.
Bone Resorption
Bone mass protective potential mediated by bovine milk basic protein requires normal calcium homeostasis in mice.
Bone Resorption
Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.
Bone Resorption
Bone metabolism and daily physical activity in women undergoing hemodialysis.
Bone Resorption
Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate.
Bone Resorption
Bone Metabolism in the Healing Process of Lumbar Interbody Fusion-Temporal changes of bone turnover markers.
Bone Resorption
Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
Bone Resorption
Bone resorption associated with uncoupling of osteoclastic and osteoblastic activities in adult T cell leukemia with hypercalcemia: case report.
Bone Resorption
Bone resorption in chronic otitis media. A light-microscopical and histochemical investigation of acid phosphatase activity.
Bone Resorption
Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Bone Resorption
Briarane-type diterpenoids suppress osteoclastogenisis by regulation of Nrf2 and MAPK/NF-kB signaling pathway.
Bone Resorption
BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Bone Resorption
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
Bone Resorption
Cadmium induces the differentiation of duck embryonic bone marrow cells into osteoclasts in vitro.
Bone Resorption
Calcitonin inhibits the increase in bone acid phosphatase activity by high dose of zinc in rats.
Bone Resorption
CaMKII(?) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway.
Bone Resorption
Cannabinoid receptor 2 agonist prevents local and systemic inflammatory bone destruction in rheumatoid arthritis.
Bone Resorption
Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages.
Bone Resorption
Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study.
Bone Resorption
Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption.
Bone Resorption
Characterization of monoclonal antibodies specific to human tartrate-resistant acid phosphatase.
Bone Resorption
Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
Bone Resorption
Chitooligosaccharides prevent osteopenia by promoting bone formation and suppressing bone resorption in ovariectomised rats: possible involvement of COX-2.
Bone Resorption
Chloroquine ameliorates bone loss induced by d-galactose in male rats via inhibition of ERK associated osteoclastogenesis and antioxidant effect.
Bone Resorption
Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
Bone Resorption
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Bone Resorption
Circulating sclerostin is not suppressed following a single bout of exercise in young men.
Bone Resorption
Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Bone Resorption
Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.
Bone Resorption
Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.
Bone Resorption
Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
Bone Resorption
Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Bone Resorption
Cloning and characterization of the 5'-flanking region of the mouse tartrate-resistant acid phosphatase gene.
Bone Resorption
Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone.
Bone Resorption
Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
Bone Resorption
Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Bone Resorption
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.
Bone Resorption
Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Bone Resorption
Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis.
Bone Resorption
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Bone Resorption
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis.
Bone Resorption
Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption.
Bone Resorption
Consumption of Vitamin D-and Calcium-Fortified Soft White Cheese Lowers the Biochemical Marker of Bone Resorption TRAP 5b in Postmenopausal Women at Moderate Risk of Osteoporosis Fracture.
Bone Resorption
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
Bone Resorption
Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients?
Bone Resorption
Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts.
Bone Resorption
Crocin attenuates methylglyoxal-induced osteoclast dysfunction by regulating glyoxalase, oxidative stress, and mitochondrial function.
Bone Resorption
Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone.
Bone Resorption
Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.
Bone Resorption
Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease.
Bone Resorption
Decitabine Inhibits Bone Resorption in Periodontitis by Upregulating Anti-Inflammatory Cytokines and Suppressing Osteoclastogenesis.
Bone Resorption
Decreased bone mineralization in children with phenylketonuria under treatment.
Bone Resorption
Decreasing the Ratio of Dietary Linoleic to ?-Linolenic Acid from 10 to 4 by Changing Only the Former Does Not Prevent Adiposity or Bone Deterioration in Obese Mice.
Bone Resorption
Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function.
Bone Resorption
Detection of alkaline and acid phosphatases around titanium implants: a light microscopical and histochemical study in rabbits.
Bone Resorption
Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
Bone Resorption
Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
Bone Resorption
Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.
Bone Resorption
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Bone Resorption
Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.
Bone Resorption
Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum.
Bone Resorption
Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD).
Bone Resorption
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Bone Resorption
Diamagnetic Levitation Promotes Osteoclast Differentiation From RAW264.7 Cells.
Bone Resorption
Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats.
Bone Resorption
Dietary xylitol protects against the imbalance in bone metabolism during the early phase of collagen type II-induced arthritis in dark agouti rats.
Bone Resorption
Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones.
Bone Resorption
Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease.
Bone Resorption
Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Bone Resorption
Disruption of the Man-6-P Targeting Pathway in Mice Impairs Osteoclast Secretory Lysosome Biogenesis.
Bone Resorption
Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor".
Bone Resorption
Does combined gastrectomy and ovariectomy induce greater osteopenia in young female rats than gastrectomy alone?
Bone Resorption
Dose-response assessment of chemically-modified curcumin in experimental periodontitis.
Bone Resorption
Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.
Bone Resorption
Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism.
Bone Resorption
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Bone Resorption
Edgeworthia papyrifera Regulates Osteoblast and Osteoclast Differentiation In Vitro and Exhibits Anti-osteoporosis Activity in Animal Models of Osteoporosis.
Bone Resorption
Effect of age on some blood variables relating to bone metabolism in women.
Bone Resorption
Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double-blind clinical trial.
Bone Resorption
Effect of bergenin on RANKL-induced osteoclast differentiation in the presence of methylglyoxal.
Bone Resorption
Effect of escitalopram and carbidopa on bone markers in Wistar rats: a preliminary experimental study.
Bone Resorption
Effect of high-density lipoprotein on lipopolysaccharide-induced alveolar bone resorption in rats.
Bone Resorption
Effect of Korean oriental medicine extract on bone mass as compared with alendronate in ovariectomized rats.
Bone Resorption
Effect of local bone marrow stromal cell administration on ligature-induced periodontitis in mice.
Bone Resorption
Effect of vitamin A on bone resorption: evidence for direct stimulation of isolated chicken osteoclasts by retinol and retinoic acid.
Bone Resorption
Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute.
Bone Resorption
Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption.
Bone Resorption
Effects of aging on bone mineral content and bone biomarkers in female cynomolgus monkeys.
Bone Resorption
Effects of an Oleaginous Calcitriol on Changes in Plasma Calcitriol, Calcium and Bone Metabolic Markers in Dairy Cows.
Bone Resorption
Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Bone Resorption
Effects of Ca2+/calmodulin?dependent protein kinase pathway inhibitor KN93 on osteoclastogenesis.
Bone Resorption
Effects of cadmium on bone microstructure and serum tartrate-resistant acid phosphatase 5b in male rats.
Bone Resorption
Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats.
Bone Resorption
Effects of cortisol secreted via a 12-h infusion of adrenocorticotropic hormone on mineral homeostasis and bone metabolism in ovariectomized cows.
Bone Resorption
Effects of Lemon Beverage Containing Citric Acid with Calcium Supplementation on Bone Metabolism and Mineral Density in Postmenopausal Women: Double-Blind 11-Month Intervention Study.
Bone Resorption
Effects of magnesium coating on bone-implant interfaces with and without polyether-ether-ketone particle interference: A rabbit model based on porous Ti6Al4V implants.
Bone Resorption
Effects of Melandrium firmum Rohrbach on RANKL?induced osteoclast differentiation and OVX rats.
Bone Resorption
Effects of moderate intensity static magnetic fields on osteoclastic differentiation in mouse bone marrow cells.
Bone Resorption
Effects of nicotine on bone during orthodontic tooth movement in male rats. Histological and immunohistochemical study.
Bone Resorption
Effects of paprika carotenoid supplementation on bone turnover in postmenopausal women: a randomized, double-blind, placebo-controlled, parallel-group comparison study.
Bone Resorption
Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
Bone Resorption
Effects of pulsed electromagnetic fields on the mRNA expression of RANK and CAII in ovariectomized rat osteoclast-like cell.
Bone Resorption
Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines.
Bone Resorption
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Bone Resorption
Effects of Suppression of Follicle Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal Women.
Bone Resorption
Effects of the (1-34) fragment of synthetic parathyroid hormone-related protein on tartrate-resistant acid phosphatase and alkaline phosphatase and alkaline phosphatase activities, and on osteocalcin synthesis, in cultured fetal rat calvaria.
Bone Resorption
Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-?1/Smads pathway in GIOP rats.
Bone Resorption
Efficacy of vitamin D plus calcium with/without alendronate on bone metabolism in immunologic thrombocytopenic purpura patients with steroid treatment: Nine-month results of a randomized, double-blinded, controlled trial.
Bone Resorption
Elevated HbA1c Is Associated with Altered Cortical and Trabecular Microarchitecture in Girls with Type 1 Diabetes.
Bone Resorption
Endocytosis of tartrate-resistant Acid phosphatase by osteoblast-like cells is followed by inactivation of the enzyme.
Bone Resorption
Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
Bone Resorption
Enzyme histochemical characteristics of osteoblasts and mononucleated osteoclasts in a teleost fish with acellular bone (Oreochromis niloticus, Cichlidae)
Bone Resorption
Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.
Bone Resorption
Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts.
Bone Resorption
Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPAR? and APC.
Bone Resorption
Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
Bone Resorption
Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism.
Bone Resorption
Evaluation of bone turnover markers and serum minerals variations for predicting fracture healing versus non-union processes in adult sheep as a model for orthopedic research.
Bone Resorption
Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales.
Bone Resorption
Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
Bone Resorption
Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Bone Resorption
Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Bone Resorption
Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model.
Bone Resorption
Exosomes from TNF-?-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss.
Bone Resorption
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.
Bone Resorption
Expression of osteoclastogenic and anti-osteoclastogenic cytokines differs in mouse gingiva injected with lipopolysaccharide, peptidoglycan, or both.
Bone Resorption
Extracellular matrix-mediated tissue remodeling following axial movement of teeth.
Bone Resorption
Facilitation of bone resorption activities in synovial lavage fluid patients with mandibular condyle fractures.
Bone Resorption
Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.
Bone Resorption
Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques.
Bone Resorption
FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
Bone Resorption
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function.
Bone Resorption
Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.
Bone Resorption
Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone.
Bone Resorption
Generation and characterization of putative monoclonal and polyclonal antibodies against tartrate-resistant acid phosphatase.
Bone Resorption
Ginsenoside Rg3 Attenuates Aluminum-Induced Osteoporosis Through Regulation of Oxidative Stress and Bone Metabolism in Rats.
Bone Resorption
Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-?B and Akt pathways.
Bone Resorption
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
Bone Resorption
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
Bone Resorption
High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: relevance as a marker of bone resorption in jaundiced patients.
Bone Resorption
High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.
Bone Resorption
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Bone Resorption
High vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model.
Bone Resorption
HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro.
Bone Resorption
Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone.
Bone Resorption
Hormone replacement therapy and osteoporosis: bone enzymes and nutrient imbalances.
Bone Resorption
Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.
Bone Resorption
Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
Bone Resorption
Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomised Double-Blind, Placebo Controlled Trial.
Bone Resorption
Icariin ameliorates dexamethasone?induced bone deterioration in an experimental mouse model via activation of microRNA?186 inhibition of cathepsin K.
Bone Resorption
Identification of a non-purple tartrate-resistant acid phosphatase: an evolutionary link to Ser/Thr protein phosphatases?
Bone Resorption
Identification of rat osteoclasts in bone smears with quantification of acid phosphatase activity in vitamin D deficiency.
Bone Resorption
IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
Bone Resorption
IL-4 inhibits TNF-?-mediated osteoclast formation by inhibition of RANKL expression in TNF-?-activated stromal cells and direct inhibition of TNF-?-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Bone Resorption
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
Bone Resorption
Imbalance of osteoprotegerin/receptor activator of nuclear factor-?B ligand and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome.
Bone Resorption
In vitro bone resorption is dependent on physiological concentrations of zinc.
Bone Resorption
In vivo randomized trial of three marketed milk preparations enriched with calcium and vitamins (D and K) on bone mass and bone turnover markers from biological fluids in premenopausal Caucasian women.
Bone Resorption
Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss.
Bone Resorption
Increase in osteoclastogenesis in an obese Otsuka Long-Evans Tokushima fatty rat model.
Bone Resorption
Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
Bone Resorption
Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.
Bone Resorption
Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes.
Bone Resorption
Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor.
Bone Resorption
Increased Serum 25(OH)D3 Levels in Post-Menopausal Japanese Women with Osteoporosis after 3-Year Bisphosphonate Treatment.
Bone Resorption
Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies.
Bone Resorption
Induction of osteopenia during experimental tooth movement in the rat: alveolar bone remodelling and the mechanostat theory.
Bone Resorption
Influence of oestrogen deficiency and excessive mechanical stress on condylar head of mandible.
Bone Resorption
Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro.
Bone Resorption
Influence of weight reduction on muscle performance and bone mass, structure and metabolism in obese premenopausal women.
Bone Resorption
Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.
Bone Resorption
Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis.
Bone Resorption
Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation.
Bone Resorption
Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
Bone Resorption
Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis.
Bone Resorption
Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.
Bone Resorption
Interferon ? protects against avascular osteonecrosis through interleukin 6 inhibition and silent information regulator transcript-1 upregulation.
Bone Resorption
Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide.
Bone Resorption
Interleukin-35 Inhibits TNF-?-Induced Osteoclastogenesis and Promotes Apoptosis via Shifting the Activation From TNF Receptor-Associated Death Domain (TRADD)-TRAF2 to TRADD-Fas-Associated Death Domain by JAK1/STAT1.
Bone Resorption
Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase.
Bone Resorption
Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Bone Resorption
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Bone Resorption
Intramuscular bone induction by the simultaneous administration of recombinant human bone morphogenetic protein 2 and bisphosphonate for autobone graft.
Bone Resorption
Intravenous 1alpha, 25[OH]2 vitamin D3 (calcitriol) pulse therapy for bone lesions in a murine model of chronic cadmium toxicosis.
Bone Resorption
Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients.
Bone Resorption
Involvement of the mitogen?activated protein kinase signaling pathway in osteoprotegerin?induced inhibition of osteoclast differentiation and maturation.
Bone Resorption
Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation.
Bone Resorption
Isorhamnetin 3-O-neohesperidoside promotes the resorption of crown-covered bone during tooth eruption by osteoclastogenesis.
Bone Resorption
Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices.
Bone Resorption
Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
Bone Resorption
Knockout of TRPV6 Causes Osteopenia in Mice by Increasing Osteoclastic Differentiation and Activity.
Bone Resorption
Kudzu (Pueraria lobata) vine ethanol extracts improve ovariectomy-induced bone loss in female mice.
Bone Resorption
Lactobacillus Fermentum ZS40 prevents secondary osteoporosis in Wistar Rat.
Bone Resorption
Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-?b and Nfatc1 Activities.
Bone Resorption
LDC000067 suppresses RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced osteolysis in vivo.
Bone Resorption
Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob/ob mice.
Bone Resorption
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
Bone Resorption
LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45.
Bone Resorption
Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Bone Resorption
Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice.
Bone Resorption
Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans.
Bone Resorption
Low-1 level mechanical vibration improves bone microstructure, tissue mechanical properties and porous titanium implant osseointegration by promoting anabolic response in type 1 diabetic rabbits.
Bone Resorption
Low?molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
Bone Resorption
Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling.
Bone Resorption
Lysosomal cysteine and aspartic proteinases, acid phosphatase, and an endogenous cysteine proteinase inhibitor, cystatin-beta, in rat osteoclasts.
Bone Resorption
Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Bone Resorption
Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab.
Bone Resorption
Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Bone Resorption
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
Bone Resorption
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
Bone Resorption
MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Bone Resorption
Mesoporous bioactive glasses equipped with stimuli-responsive molecular gates for the controlled delivery of levofloxacin against bacteria.
Bone Resorption
MicroRNA MiR-130b promotes wear particle-induced osteolysis via down regulating frizzled-related protein (FRZB).
Bone Resorption
MicroRNA-130b Promotes Wear Particle-Induced Osteolysis via Downregulating Frizzled-Related Protein (FRZB).
Bone Resorption
MiR-1-3p regulates the differentiation of mesenchymal stem cells to prevent osteoporosis by targeting secreted frizzled-related protein 1.
Bone Resorption
miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway.
Bone Resorption
Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Bone Resorption
Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
Bone Resorption
Morphological changes in periodontal mechanoreceptors of mouse maxillary incisors after the experimental induction of anterior crossbite: a light and electron microscopic observation using immunohistochemistry for PGP 9.5.
Bone Resorption
Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.
Bone Resorption
Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
Bone Resorption
Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines.
Bone Resorption
N-Acetyl Cysteine Treatment Restores Early Phase Fracture Healing in Ethanol-Fed Rats.
Bone Resorption
N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis.
Bone Resorption
N-terminal telopeptides of type I collagen and bone mineral density for early diagnosis of nonunion: An experimental study in rabbits.
Bone Resorption
Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2: possible prognostic implications.
Bone Resorption
Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
Bone Resorption
New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women.
Bone Resorption
Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.
Bone Resorption
Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.
Bone Resorption
Noncanonical G-protein-dependent modulation of osteoclast differentiation and bone resorption mediated by Pasteurella multocida toxin.
Bone Resorption
Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo.
Bone Resorption
Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species.
Bone Resorption
Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
Bone Resorption
Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
Bone Resorption
OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell.
Bone Resorption
Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Bone Resorption
Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
Bone Resorption
Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Bone Resorption
Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number.
Bone Resorption
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Bone Resorption
Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Bone Resorption
Osteoclastic differentiation by mononuclear phagocytes containing biomaterial particles.
Bone Resorption
Osteogenic activity of yellow flag iris (Iris pseudacorus) extract modulating differentiation of osteoblasts and osteoclasts.
Bone Resorption
Osteogenic effect of Drynariae rhizoma extracts and Naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model.
Bone Resorption
Osteoprotective Activity and Metabolite Fingerprint via UPLC/MS and GC/MS of Lepidium sativum in Ovariectomized Rats.
Bone Resorption
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Bone Resorption
Ostericum koreanum Reduces LPS-Induced Bone Loss Through Inhibition of Osteoclastogenesis.
Bone Resorption
p53 positively regulates osteoprotegerin-mediated inhibition of osteoclastogenesis by downregulating TSC2-induced autophagy in vitro.
Bone Resorption
Paeoniflorin Inhibits Receptor Activator for Nuclear Factor ?B (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo.
Bone Resorption
Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.
Bone Resorption
Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
Bone Resorption
Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNF? therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular bone score.
Bone Resorption
Parathyroid hormone related peptide (1-34) and 1,25-dihydroxyvitamin D, have no additive effects on bone tartrate resistant acid phosphatase activity in fetal rat calvaria cultures.
Bone Resorption
Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis.
Bone Resorption
Periodontal ligament cells in adolescents and adults: Genetic level responses to orthodontic forces.
Bone Resorption
Phorbol myristate acetate stimulates osteoclast formation in 1 alpha,25-dihydroxyvitamin D3-primed mouse embryonic calvarial cells by a prostaglandin-dependent mechanism.
Bone Resorption
Pit Assay to Measure the Bone Resorptive Activity of Bone Marrow-derived Osteoclasts.
Bone Resorption
Plasma fluctuation in estradiol-17? and bone resorption markers around parturition in dairy cows.
Bone Resorption
Plasma tartrate resistant acid phosphatase: a marker for osteoclastic bone resorption.
Bone Resorption
Plectin stabilizes microtubules during osteoclastic bone resorption by acting as a scaffold for Src and Pyk2.
Bone Resorption
Polyethylene and methyl methacrylate particle-stimulated inflammatory tissue and macrophages up-regulate bone resorption in a murine neonatal calvaria in vitro organ system.
Bone Resorption
Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts.
Bone Resorption
Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3.
Bone Resorption
Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Bone Resorption
Potential of electrical impedance spectroscopy to differentiate between healthy and osteopenic bone.
Bone Resorption
PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo.
Bone Resorption
Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
Bone Resorption
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.
Bone Resorption
Preventive Effects of Chrysanthemum coronarium L. Extract on Bone Metabolism In Vitro and In Vivo.
Bone Resorption
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice.
Bone Resorption
Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor Cells.
Bone Resorption
Prognostic significance of ACP5 expression in patients with lung adenocarcinoma.
Bone Resorption
Programmed core-shell electrospun nanofibers to sequentially regulate osteogenesis-osteoclastogenesis balance for promoting immediate implant osseointegration.
Bone Resorption
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Bone Resorption
Protective action of aqueous black tea (Camellia sinensis) extract (BTE) against ovariectomy-induced oxidative stress of mononuclear cells and its associated progression of bone loss.
Bone Resorption
Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats.
Bone Resorption
Protocatechuic acid attenuates anterior cruciate ligament transection-induced osteoarthritis by suppressing osteoclastogenesis.
Bone Resorption
Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Bone Resorption
Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
Bone Resorption
Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
Bone Resorption
Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
Bone Resorption
Pulsed electromagnetic fields partially preserve bone mass, microarchitecture, and strength by promoting bone formation in hindlimb-suspended rats.
Bone Resorption
Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
Bone Resorption
Purified Pasteurella multocida protein toxin reduces acid phosphatase-positive osteoclasts in the ventral nasal concha of gnotobiotic pigs.
Bone Resorption
Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells.
Bone Resorption
Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
Bone Resorption
Quantification of osteoclastic resorption of the bovine otic capsule in vitro by an enzyme-linked immunosorbent assay.
Bone Resorption
Quantification of tartrate resistant acid phosphatase distribution in mouse tibiae using image analysis.
Bone Resorption
Quercitrin Nanocoated Implant Surfaces Reduce Osteoclast Activity In Vitro and In Vivo.
Bone Resorption
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Bone Resorption
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
Bone Resorption
Rapid new bone tissue remodeling during distraction osteogenesis is associated with apoptosis.
Bone Resorption
Recombinant VSV G proteins reveal a novel raft-dependent endocytic pathway in resorbing osteoclasts.
Bone Resorption
Recommendations for dietary level of micro-minerals and vitamin D3 to Atlantic salmon (Salmo salar) parr and post-smolt when fed low fish meal diets.
Bone Resorption
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Bone Resorption
Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
Bone Resorption
Relationship between sex hormone fluctuations and biomarkers of bone resorption in bovine plasma during the oestrous cycle.
Bone Resorption
Relationship between tartrate-resistant acid phosphatase 5b and stress fractures in female athletes.
Bone Resorption
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Bone Resorption
Relevance of Caspase-1 and Nlrp3 Inflammasome on Inflammatory Bone Resorption in A Murine Model of Periodontitis.
Bone Resorption
Relevance of parathyroid hormone (PTH), vitamin 25(OH)D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases.
Bone Resorption
Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
Bone Resorption
Restoration of Parathyroid Function After Change of Phosphate Binder From Calcium Carbonate to Lanthanum Carbonate in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone.
Bone Resorption
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
Bone Resorption
Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.
Bone Resorption
Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Bone Resorption
Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Bone Resorption
Role of food fortification with vitamin D and calcium in the bone remodeling process in postmenopausal women: a systematic review of randomized controlled trials.
Bone Resorption
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
Bone Resorption
Running exercise for short duration increases bone mineral density of loaded long bones in young growing rats.
Bone Resorption
Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.
Bone Resorption
Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF??B signaling pathway.
Bone Resorption
Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Bone Resorption
Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-?B and MAPK signaling pathway.
Bone Resorption
Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior.
Bone Resorption
Segregated localization of immunocompetent cells and osteoclasts in the periodontal ligament of the rat molar.
Bone Resorption
Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase.
Bone Resorption
Serum calcium concentration is maintained when bone resorption is suppressed by osteoprotegerin in young growing male rats.
Bone Resorption
Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus.
Bone Resorption
Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
Bone Resorption
Serum N-terminal telopeptide of type I collagen as an early marker of fracture nonunion in rabbits.
Bone Resorption
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Bone Resorption
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Bone Resorption
Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
Bone Resorption
Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Bone Resorption
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
Bone Resorption
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
Bone Resorption
Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-?B and MAPK Signaling Pathways.
Bone Resorption
Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats.
Bone Resorption
Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
Bone Resorption
siRNA Knock-Down of RANK Signaling to Control Osteoclast-Mediated Bone Resorption.
Bone Resorption
Smoking cessation increases levels of osteocalcin and uncarboxylated osteocalcin in human sera.
Bone Resorption
Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase.
Bone Resorption
Specificity and clinical performance of two commercial TRACP 5b immunoassays.
Bone Resorption
Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.
Bone Resorption
Stimulation of a Gs-like G protein in the osteoclast inhibits bone resorption but enhances tartrate-resistant acid phosphatase secretion.
Bone Resorption
Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
Bone Resorption
Strontium ranelate decreases receptor activator of nuclear factor-?B ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.
Bone Resorption
Suppression of alveolar bone resorption by salubrinal in a mouse model of periodontal disease.
Bone Resorption
Suppressive effect of syndecan ectodomains and N-desulfated heparins on osteoclastogenesis via direct binding to macrophage-colony stimulating factor.
Bone Resorption
Suppressive effects of an apoptotic mimicry prepared from jumbo-flying squid-skin phospholipids on the osteoclastogenesis in receptor activator of nuclear factor kappa B ligand/macrophage colony-stimulating factor-induced RAW 264.7 cells.
Bone Resorption
Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation.
Bone Resorption
Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
Bone Resorption
Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein.
Bone Resorption
Tartrate Resistant Acid Phosphatase Assisted Degradation of Single-Wall Carbon Nanotubes (SWCNTs).
Bone Resorption
Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
Bone Resorption
Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma.
Bone Resorption
Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Bone Resorption
Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Bone Resorption
Tartrate-resistant Acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Bone Resorption
Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Bone Resorption
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Bone Resorption
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Bone Resorption
Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear ?B ligand.
Bone Resorption
Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Bone Resorption
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Bone Resorption
Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Bone Resorption
Tartrate-resistant acid phosphatase activity and glutathione levels are modulated during hFOB 1.19 osteoblastic differentiation.
Bone Resorption
Tartrate-resistant acid phosphatase in mononuclear and multinuclear cells during the bone resorption of tooth eruption.
Bone Resorption
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Bone Resorption
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Bone Resorption
Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry.
Bone Resorption
Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis.
Bone Resorption
TGF?1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.
Bone Resorption
The Antiosteoporosis Effects of Zhuanggu Guanjie Pill In Vitro and In Vivo.
Bone Resorption
The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.
Bone Resorption
The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease.
Bone Resorption
The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
Bone Resorption
The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Bone Resorption
The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B.
Bone Resorption
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
Bone Resorption
The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up Study.
Bone Resorption
The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
Bone Resorption
The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
Bone Resorption
The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.
Bone Resorption
The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption.
Bone Resorption
The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study.
Bone Resorption
The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation.
Bone Resorption
The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro.
Bone Resorption
The in vivo effects of a fraction from Dioscorea spongiosa on glucocorticoid-induced osteoporosis.
Bone Resorption
The influence of adrenergic blockade in rats with apical periodontitis under chronic stress conditions.
Bone Resorption
The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes.
Bone Resorption
The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats.
Bone Resorption
The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro.
Bone Resorption
The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats.
Bone Resorption
The role of TGF? receptor 1-smad3 signaling in regulating the osteoclastic mode affected by fluoride.
Bone Resorption
The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim report.
Bone Resorption
The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
Bone Resorption
Three Scrophularia Species (Scrophularia buergeriana, S. koraiensis, and S. takesimensis) Inhibit RANKL-Induced Osteoclast Differentiation in Bone Marrow-Derived Macrophages.
Bone Resorption
Thyroid-stimulating hormone maintains bone mass and strength by suppressing osteoclast differentiation.
Bone Resorption
TLR4 mediates alveolar bone resorption in experimental peri-implantitis through regulation of CD45+ cell infiltration, RANKL/OPG ratio, and inflammatory cytokine production.
Bone Resorption
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
Bone Resorption
TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Bone Resorption
Tomographic, Histological, and Immunohistochemical Evidences on the Use of N-Butyl-2-Cyanoacrilate for Onlay Graft Fixation in Rabbits.
Bone Resorption
Tooth hard tissue stimulates bone remodeling as a potential motive force during tooth eruption.
Bone Resorption
Total and regional bone mass and biochemical markers of bone remodeling in metastatic prostate cancer.
Bone Resorption
TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation.
Bone Resorption
TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.
Bone Resorption
Transient Effect of 17?-estradiol on Osteoporosis in Ovariectomized Rats Accompanied with Unilateral Disuse in the Early Phase.
Bone Resorption
Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation.
Bone Resorption
Tumor necrosis factor ? augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
Bone Resorption
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Bone Resorption
Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
Bone Resorption
U.S. Montmorency Tart Cherry Juice Decreases Bone Resorption in Women Aged 65-80 Years.
Bone Resorption
Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.
Bone Resorption
Upregulation of mmu_circ_0001066 attenuates the inhibitory effect of bisphosphonates on osteoclastogenesis.
Bone Resorption
Usefulness of biochemical markers of bone turnover in rats after clodronate administration.
Bone Resorption
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Bone Resorption
Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
Bone Resorption
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
Bone Resorption
Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis.
Bone Resorption
Voluntary running of defined distances alters bone microstructure in C57BL/6 mice fed a high-fat diet.
Bone Resorption
Water extract of tendril of Cucurbita Moschata Duch. suppresses RANKL-induced osteoclastogenesis by down-regulating p38 and ERK signaling.
Bone Resorption
Yi Shen Juan Bi Pill Ameliorates Bone Loss and Destruction Induced by Arthritis Through Modulating the Balance of Cytokines Released by Different Subpopulations of T Cells.
Bone Resorption
Yougui pills exert osteoprotective effects on rabbit steroid-related osteonecrosis of the femoral head by activating ?-catenin.
Bone Resorption
[Advances of clinical diagnosis of osteodystrophy complicated by chronic renal failure]
Bone Resorption
[Age related changes of serum sex hormone levels and tartrate-resistant acid phosphatase activity in healthy women]
Bone Resorption
[Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice]
Bone Resorption
[Biological profile of tartrate-resistant acid phosphatase as a marker of bone resorption]
Bone Resorption
[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)]
Bone Resorption
[Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]
Bone Resorption
[Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum]
Bone Resorption
[Effect of recombinant human osteoprotegerin on osteoclasts stimulated by polyethylene particles]
Bone Resorption
[EFFECT OF STAPHYLO CO CCAL PEPTID O GLYCAN ON OSTEO CL AST DIFFERENTIATION].
Bone Resorption
[Effect of staphylococcal lipoteichoic acid on differentiation of RAW264.7 cells into osteoclasts].
Bone Resorption
[Experimental study on inhibitory effect of zoledronic acid on the action style of the osteoclast].
Bone Resorption
[Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]
Bone Resorption
[Potential mechanism of transcription factor peroxisome proliferator-activated receptor-gamma coactivator-1 beta on promoting osteoclastogenesis].
Bone Resorption
[Research progress of Rehmanniae Radix in prevention and treatment of osteoporosis].
Bone Resorption
[Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker]
Bone Resorption
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]
Bone Resorption
[The usefulness of biochemical markers of bone remodelling in the diagnosis and follow-up of Paget's disease of bone, primary hyperparathyroidism, tumoral hypercalcemia and postmenopausal osteoporosis. I. The markers of bone formation]
Bone Resorption
[Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers]
Brain Diseases
Lipin1 Is Involved in the Pathogenesis of Diabetic Encephalopathy through the PKD/Limk/Cofilin Signaling Pathway.
Brain Edema
[Activity of lysosomal enzymes in rabbit brain during the development of edema]
Brain Ischemia
Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
Brain Neoplasms
Adenocarcinoma of the prostate presenting initially as an intracerebral tumor.
Brain Neoplasms
[Histochemical study of acid phosphatase strongly activated by zinc acetate and its behavior in the early phases of brain tumor development induced in rats by N-ethyl-N-nitrosourea]
Branchioma
The lining of branchial cysts studied by electron microscopy and enzyme histochemistry.
Breast Diseases
[Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)]
Breast Neoplasms
Abnormal serum alkaline and acid phosphatase isoenzymes in female breast cancer patients.
Breast Neoplasms
Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.
Breast Neoplasms
Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells.
Breast Neoplasms
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway.
Breast Neoplasms
Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
Breast Neoplasms
Calcium, inorganic phosphates, alkaline and acid phosphatase activities in breast cancer patients in Calabar, Nigeria.
Breast Neoplasms
Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Breast Neoplasms
Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells.
Breast Neoplasms
Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
Breast Neoplasms
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Breast Neoplasms
Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids.
Breast Neoplasms
Evaluation of bone metabolic markers in breast cancer with bone metastasis.
Breast Neoplasms
Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Breast Neoplasms
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Breast Neoplasms
Histochemical studies of human breast tumors: Activity of alkaline phosphatase, acid phosphatase and glucose-6-phosphate dehydrogenase.
Breast Neoplasms
Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP).
Breast Neoplasms
MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Breast Neoplasms
Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.
Breast Neoplasms
Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
Breast Neoplasms
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Breast Neoplasms
Role of betulinic acid derivative SH-479 in triple negative breast cancer and bone microenvironment.
Breast Neoplasms
Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Breast Neoplasms
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Breast Neoplasms
Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Breast Neoplasms
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF?2/T?R and CD44 in MDA-MB-231 breast cancer cells.
Breast Neoplasms
Tartrate-resistant Acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Breast Neoplasms
Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Breast Neoplasms
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Breast Neoplasms
Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
Breast Neoplasms
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
Breast Neoplasms
The effect of treatment with 4-hydroxyandrostenedione or medroxyprogesterone acetate on human breast tumour regression.
Breast Neoplasms
The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
Breast Neoplasms
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Breast Neoplasms
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
Breast Neoplasms
[Acid phosphatase activity in breast dysplasias and in carcinomas of the breast]
Breast Neoplasms
[Plasma granulocyte-macrophage colony stimulating factor (GM-CSF) and activity of enzymes in granulocytes of breast cancer patients]
Breast Neoplasms
[Prostatic acid phosphatase, beta-choriogonadotropin and alpha fetoprotein in the serum of patients with breast cancer]
Breast Neoplasms
[The significance of acid phosphatase activity in the cytologic diagnosis of thyroid malignancy (author's transl)]
Breast Neoplasms, Male
Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
Bronchial Spasm
Characterization of serum lysosomal enzymatic activities. III. Effect of infectious influenza in Egyptian equines.
Bronchitis
[Cytologic and certain cytoenzymologic characteristics of sputum in chronic nonspecific lung diseases]
Bronchitis
[Elastase and acid phosphatase activity in bronchoalveolar lavage fluid during chronic bronchitis]
Bronchitis, Chronic
[Morphological investigations of bronchial biopsy material in chronic bronchitis and asthma bronchiale (author's transl)]
Burkitt Lymphoma
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
carboxypeptidase taq deficiency
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Carcinogenesis
Acid phosphatase and deoxyribonucleic acid studies in D.M.B.A. induced experimental oral carcinogenesis in hamster cheek pouch.
Carcinogenesis
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
Carcinogenesis
The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis.
Carcinogenesis
[Enzymatic and immunologic activity of lymphocytes during chemical carcinogenesis]
Carcinoid Tumor
Evidence of hybrid cell of thyroid follicular cell and carcinoid cell in strumal carcinoid.
Carcinoid Tumor
Grossly elevated serum prostatic acid phosphatase in a patient with carcinoid.
Carcinoid Tumor
Identification of a novel alpha-amylase by expression of a newly cloned human amy3 cDNA in yeast.
Carcinoid Tumor
Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen.
Carcinoid Tumor
Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies.
Carcinoid Tumor
Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study.
Carcinoid Tumor
Serum prostatic acid phosphatase: an increase associated with a metastatic carcinoid tumor.
Carcinoid Tumor
Strumal carcinoids of the ovary. An immunohistologic and ultrastructural study.
Carcinoma
"Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin.
Carcinoma
A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate.
Carcinoma
A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines.
Carcinoma
A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
Carcinoma
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
Carcinoma
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
Carcinoma
A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
Carcinoma
A simple immunohistochemical method for the detection of prostatic acid phosphatase.
Carcinoma
ACID AND ALKALINE PHOSPHATASE ACTIVITY IN TRANSPLANTABLE GU'ERIN EPITHELIOMA IN RATS. I. ACID PHOSPHATASE.
Carcinoma
Acid phosphatase content of prostatic exprimate from patients with advanced prostatic carcinoma: a potential prognostic and therapeutic index.
Carcinoma
Acid phosphatase elevation following prostatic examination in the earlier diagnosis of prostatic carcinoma.
Carcinoma
Acid phosphatase for monitoring prostatic carcinoma. Comparison of radioimmunoassay and enzymatic techniques.
Carcinoma
Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Carcinoma
Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate.
Carcinoma
Acid phosphatase localization in prostatic carcinoma. A comparison of monoclonal antibody to heteroantisera.
Carcinoma
Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen.
Carcinoma
An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
Carcinoma
An objective look at acid phosphatase determinations: a comparison of biochemical and immunological methods.
Carcinoma
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Carcinoma
Antitumor activity and DNA-binding investigations of isoeuxanthone and its piperidinyl derivative.
Carcinoma
Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens.
Carcinoma
Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
Carcinoma
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.
Carcinoma
Avian prostatic acid phosphatase: estrogen regulation in the oviduct and epithelial cell-derived ovarian carcinomas.
Carcinoma
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Carcinoma
Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma.
Carcinoma
Bilateral orbital metastases from prostate carcinoma: case presentation and CT findings.
Carcinoma
Biochemical and immunological relationships of prostatic and leukocytic acid phosphatases and their subcellular localization.
Carcinoma
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Carcinoma
Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders.
Carcinoma
Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
Carcinoma
Calcium inactivation of acid phosphatase in the normal human prostate and in carcinoma of the prostate.
Carcinoma
CALCIUM INACTIVATION OF ACID PHOSPHATASE IN THE NORMAL HUMAN PROSTATE AND IN CARCINOMA OF THE PROSTATE.
Carcinoma
Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Carcinoma
Carcinoma of the prostate presenting with massive pleural effusion and elevated pleural acid phosphatase.
Carcinoma
Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.
Carcinoma
Carcinoma of the prostate; determination of the acid phosphatase of the blood serum as an aid in diagnosis.
Carcinoma
Cationic liposome-mediated incorporation of prostatic acid phosphatase protein into human prostate carcinoma cells.
Carcinoma
Change of total and prostatic serum acid phosphatase levels following hyperglycemic treatment in patients with prostatic carcinoma.
Carcinoma
Changes of enzyme activities recognized in lymphocytes from patients with carcinoma of the gastrointestinal tract.
Carcinoma
Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Carcinoma
Characterization of Rab27a and JFC1 as constituents of the secretory machinery of prostate-specific antigen in prostate carcinoma cells.
Carcinoma
Characterization of the metabolism of perinecrotic cells in solid tumors by enzyme histochemistry.
Carcinoma
Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
Carcinoma
Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
Carcinoma
Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
Carcinoma
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Carcinoma
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
Carcinoma
Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
Carcinoma
Clinical value of different methods for determination of acid phosphatase in prostatic cancer.
Carcinoma
Comparative clinical features of stage A1 and stage A2 prostate cancers. Is the concept of stage A changing from the current status?
Carcinoma
Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
Carcinoma
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Carcinoma
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Carcinoma
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
Carcinoma
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
Carcinoma
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Carcinoma
Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.
Carcinoma
Correlation between serum values of prostatic acid phosphatase and morphometric analysis in the cytologic diagnosis of prostatic carcinoma.
Carcinoma
Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Carcinoma
Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.
Carcinoma
Creatine kinase isoenzyme (CK-BB) by RIA as a follow-up marker in stage D cancer of the prostate: comparison with PAP RIA.
Carcinoma
Cytologic features of prostatic adenocarcinoma in urine: a clinicopathologic and immunocytochemical study.
Carcinoma
Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate--results of a nationwide overview.
Carcinoma
Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
Carcinoma
Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
Carcinoma
Determination of serum acid and alkaline phosphatase using 4-methylumbelliferyl phosphate.
Carcinoma
Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
Carcinoma
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Carcinoma
Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
Carcinoma
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
Carcinoma
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Carcinoma
Distribution and some properties of acid phosphatase in the 7,12-dimethylbenz(alpha) anthracene-induced rat-mammary carcinoma.
Carcinoma
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
Carcinoma
Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
Carcinoma
Electron-microscopic studies on the activity of the reactions of acid phosphatase in rats with transplantable Guérin epithelioma.
Carcinoma
Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher's disease, prostatic carcinoma and multiple myeloma.
Carcinoma
Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Carcinoma
Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
Carcinoma
Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids.
Carcinoma
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Carcinoma
Estimation of serum acid phosphatase in the diagnosis of metastasizing carcinoma of the prostate.
Carcinoma
Estrogens in carcinoma of the prostate. Effects on enzymes and polypeptide hormones.
Carcinoma
Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Carcinoma
Evaluation of commercial immunoperoxidase kits in diagnosis of prostate carcinoma.
Carcinoma
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
Carcinoma
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Carcinoma
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Carcinoma
Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
Carcinoma
Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Carcinoma
Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
Carcinoma
Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.
Carcinoma
FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors.
Carcinoma
Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Carcinoma
Ghost cell odontogenic carcinoma of the mandible: A case report demonstrating expression of tartrate-resistant acid phosphatase (TRAP) and vitronectin receptor.
Carcinoma
Heterogeneity and prognostic significance of macrophages in human colonic carcinomas.
Carcinoma
HISTOCHEMICAL DIFFERENTIATION OF CARCINOMA OF THE PROSTATE GLAND FROM OTHER TUMORS BY A MODIFIED ACID PHOSPHATASE REACTION.
Carcinoma
Histochemical studies of the activities and locations of -glucuronidase and acid phosphatase in the Guerin T8 epithelioma.
Carcinoma
Histoenzymological features of epithelial cells in lesions of oral mucosa in cysts and ameloblastomas of jaws.
Carcinoma
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
Carcinoma
Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes.
Carcinoma
Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
Carcinoma
Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
Carcinoma
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Carcinoma
Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
Carcinoma
Immunological and colorimetric determination of prostatic acid phosphatase--technical and clinical reappraisal in symptomatic patients.
Carcinoma
Immunoperoxidase demonstration of prostatic acid phosphatase in aspiration biopsy cytology (ABC).
Carcinoma
Immunoperoxidase localization of prostatic acid phosphatase in prostatic carcinoma with sarcomatoid changes.
Carcinoma
Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
Carcinoma
Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Carcinoma
Immunoultrastructural demonstration of prostatic acid phosphatase isoenzyme 2 in prostatic carcinoma.
Carcinoma
Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer.
Carcinoma
Increased prostate-type acid phosphatase activity in serum and typical bone lesions simulating the presence of prostatic carcinoma.
Carcinoma
Influence of luteinizing hormone-releasing hormone analogues on serum levels of prostatic acid phosphatase and prostatic specific antigen in patients with metastatic carcinoma of the prostate.
Carcinoma
Influence of tumor grade on survival and on serum acid phosphatase levels in metastatic carcinoma of the prostate.
Carcinoma
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards.
Carcinoma
Limitations of prostatic acid phosphatase determination in carcinoma of phostate.
Carcinoma
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
Carcinoma
Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
Carcinoma
Massive hepatomegaly and an elevated serum acid phosphatase associated with a retrovesical carcinoma.
Carcinoma
Metastatic prostatic carcinoma to supradiaphragmatic lymph nodes. A clinicopathologic and immunohistochemical study.
Carcinoma
Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
Carcinoma
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Carcinoma
Monitoring of prostatic cancer by an enzyme-linked immunosorbent assay of serum prostatic acid phosphatase.
Carcinoma
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Carcinoma
New agents for prostatic cancer activated specifically by prostatic acid phosphatase.
Carcinoma
Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens.
Carcinoma
PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading.
Carcinoma
Planning and evaluation of diagnostic tests: failure of S-prostatic acid phosphatase in screening for early-stage prostatic carcinoma.
Carcinoma
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Carcinoma
Possible significance of the prostatic secretion acid phosphatase as a diagnostic and prognostic index in carcinoma of the prostate.
Carcinoma
Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.
Carcinoma
Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Carcinoma
Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.
Carcinoma
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Carcinoma
Prostacyclin in prostatic cancer: a better marker than bone scan or serum acid phosphatase?
Carcinoma
Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
Carcinoma
Prostate cancer screening using fine-needle aspiration cytology prior to open prostatectomy.
Carcinoma
Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Carcinoma
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
Carcinoma
Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma.
Carcinoma
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Carcinoma
Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma.
Carcinoma
Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Carcinoma
Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker.
Carcinoma
Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
Carcinoma
Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
Carcinoma
Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates.
Carcinoma
Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
Carcinoma
Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Carcinoma
Prostatic serum acid phosphatase as an aid in the diagnosis of prostatic carcinoma; preliminary report.
Carcinoma
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Carcinoma
Protection of prostatic acid phosphatase activity in human serum samples by plasmin inhibitors.
Carcinoma
Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Carcinoma
Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
Carcinoma
Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
Carcinoma
Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.
Carcinoma
Radioimmunoassay of serum prostatic acid phosphatase in prostatic carcinoma. A comparative study with an enzymatic assay.
Carcinoma
Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
Carcinoma
Rapid rise of serum acid phosphatase after irradiation of metastatic carcinoma of prostate.
Carcinoma
Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
Carcinoma
Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.
Carcinoma
Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
Carcinoma
Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
Carcinoma
Retroperitoneal metastatic disease due to carcinoma of the prostate: value of serum prostatic acid phosphatase in identifying retroperitoneal metastasis originating from carcinoma of prostate.
Carcinoma
Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
Carcinoma
Separation and characterization of epithelial cells from prostates and prostatic carcinomas: a review.
Carcinoma
Separation of cells with histochemically demonstrable acid phosphatase activity from suspensions of cells from human prostatic carcinomas in an isokinetic gradient of Ficoll in tissue culture medium.
Carcinoma
Separation of tissue and serum acid phosphatase isoenzymes by ion-exchange column chromatography.
Carcinoma
Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
Carcinoma
Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma.
Carcinoma
Serum and seminal markers in the diagnosis of disorders of the genital tract of the dog: a mini-review.
Carcinoma
Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
Carcinoma
Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.
Carcinoma
Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
Carcinoma
Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay.
Carcinoma
Serum prostatic acid phosphatase levels in patients with carcinoma of the prostate.
Carcinoma
Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases.
Carcinoma
Skin metastasis, an uncommon course of prostate carcinoma: a report of two cases.
Carcinoma
Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
Carcinoma
Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells.
Carcinoma
Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
Carcinoma
Studies on prostatic carcinoma cell lines. Their acid phosphatase productivity and various sex hormone effects on the cells.
Carcinoma
The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells.
Carcinoma
The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma.
Carcinoma
The concentration and distribution of acid phosphatase in the human stomach, with particular reference to gastric carcinoma.
Carcinoma
The development of the acid phosphatase test for prostatic carcinoma: the Sixth Ferdinand C. Valentine Memorial Lecture.
Carcinoma
The distribution of S-100 protein in hyperplastic and neoplastic prostatic epithelium.
Carcinoma
The effect of cancer chemotherapy on lysosomal enzymic activities (acid phosphatase) of Ehrlich ascites carcinoma cells.
Carcinoma
The efficacy of serum prostate specific antigen as a tumour marker in prostatic carcinoma: a comparison with serum acid phosphatase.
Carcinoma
The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells.
Carcinoma
The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry.
Carcinoma
The prognostic significance of an elevated serum acid phosphatase level in advanced prostatic carcinoma.
Carcinoma
The prognostic significance of histological grading and pathological staging in carcinoma of the prostate.
Carcinoma
The prognostic value of acid phosphatase and beta-glucuronidase activity in biopsy specimens from patients with reactivated prostatic cancer.
Carcinoma
The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions.
Carcinoma
The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
Carcinoma
The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
Carcinoma
The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast.
Carcinoma
The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
Carcinoma
The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma.
Carcinoma
The value of clinical laboratory tests. IV. The estimation of serum acid phosphatase in the diagnosis of carcinoma of the prostate.
Carcinoma
The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Carcinoma
The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
Carcinoma
Total protein and acid phosphatase concentrations in prostatic fluid from patients with BPH compared to carcinoma.
Carcinoma
Transient high serum prostate-specific acid phosphatase measured by radioimmunoassay in prostatic infarction.
Carcinoma
Transitional cell carcinoma of the urinary bladder with osteoclast-type giant cells: a report of two cases and review of the literature.
Carcinoma
Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.
Carcinoma
Tyrosyl kinase activity is inversely related to prostatic acid phosphatase activity in two human prostate carcinoma cell lines.
Carcinoma
Unusual radiologic features of metastatic prostatic carcinoma confirmed by immunohistochemical study.
Carcinoma
Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Carcinoma
Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate.
Carcinoma
Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Carcinoma
Value of acid phosphatase in screening for carcinoma in patients with prostatism in Nigeria.
Carcinoma
Waterhammer pulse associated with metastatic carcinoma from the prostate and extreme elevation of blood acid phosphatase.
Carcinoma
[A comparism between lysosomal enzyme activity in normal ectocervical squamous epithelium and squamous carcinoma of the ectocervix]
Carcinoma
[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma]
Carcinoma
[Acid phosphatase in blood (substrate: alpha-naphthylphosphate): reference values and diagnostic significance]
Carcinoma
[Acid phosphatase of the normal prostate and prostatic carcinoma. Differentiation based on the action of ionized calcium.]
Carcinoma
[Activity of reactions for acid phosphatase in transplantable rat's epithelioma Guérin's epithelioma]
Carcinoma
[Bladder carcinoma with osteoclast-type giant cells. A case with a rare presentation. Review of the literature]
Carcinoma
[Bone marrow acid phosphatase determination in patients with carcinoma of the prostate (author's transl)]
Carcinoma
[Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)]
Carcinoma
[Correlation of gastroscopic, pathohistologic, cytologic and cytochemical analysis of ulcer lesions and other pathologic changes in the gastric mucosa. Preliminary study]
Carcinoma
[Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors]
Carcinoma
[Demonstration of acid phosphatase in the gastric juice and its importance in the diagnosis of stomach carcinoma]
Carcinoma
[Determination of cytotoxic properties of the blood serum by the acid phosphatase reaction in the ascitic cells of Ehrlich's carcinoma]
Carcinoma
[Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)]
Carcinoma
[Diurnal variation of the elevated acid phosphatase activity in cases of prostate carcinoma (author's transl)]
Carcinoma
[Enzyme cytochemistry and morphometric study of the effects of macrophages on A549 pulmonary alveolar cell carcinoma cell line]
Carcinoma
[Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)]
Carcinoma
[Enzymological study of prostatic cancer. VI. Serum acid phosphatase level and prognosis of patients with prostatic carcinoma (author's transl)]
Carcinoma
[Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate]
Carcinoma
[Immunohistochemical study on the therapeutic effects on prostatic carcinoma using monoclonal and polyclonal antibodies for prostatic acid phosphatase]
Carcinoma
[Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma]
Carcinoma
[Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma]
Carcinoma
[Lysosomal enzymes in neoplastic pathology of the cervix uteri. Study of acid phosphatase, as a diagnostic test, in vaginal secretions of patients with pre-invasive and invasive carcinoma of the cervix]
Carcinoma
[Multiple forms of some enzymes in tissue of rectal carcinoma after x-ray treatment]
Carcinoma
[N-acetyl-beta-glucosaminidase, beta-glucronidase and acid phosphatase in neutrophils of patients with laryngeal carcinoma]
Carcinoma
[Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]
Carcinoma
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
Carcinoma
[Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results]
Carcinoma
[Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience]
Carcinoma
[Studies on human prostatic carcinoma cell lines: evaluation of acid phosphatase productivity and effects of sex hormones on the cells]
Carcinoma
[The contribution of radio-isotopes to urological investigation (author's transl)]
Carcinoma
[The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)]
Carcinoma
[The electrophoretic pattern of acid phosphatase in the prostatic fluid in hypertrophy and in carcinoma of the prostate.]
Carcinoma
[The nuclear roundness factor as a parameter in the anatomoclinical correlation of prostatic carcinoma]
Carcinoma
[The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma]
Carcinoma
[The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method]
Carcinoma
[Usefulness of the prostate-specific antigen in monitoring prostatic carcinoma. Its correlation with acid phosphatase]
Carcinoma
[Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase]
Carcinoma in Situ
Histoenzymological features of epithelial cells in lesions of oral mucosa in cysts and ameloblastomas of jaws.
Carcinoma, Acinar Cell
Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
Carcinoma, Adenoid Cystic
Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen.
Carcinoma, Basal Cell
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Carcinoma, Ductal
Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
Carcinoma, Ductal
Histochemically demonstrable enzyme activities and their independence of the hormone receptor content in female breast carcinoma.
Carcinoma, Endometrioid
Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation.
Carcinoma, Hepatocellular
A cytochemical study of acid phosphatase, thiamine pyrophosphatase and horseradish peroxidase in the Golgi-GERL complex of hepatoma ascites cells.
Carcinoma, Hepatocellular
Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
beta-Lapachone induced cell death in human hepatoma (HepA2) cells.
Carcinoma, Hepatocellular
Cytochemical localization of lectin labeled vesicles in GERL region of hepatoma ascites cells.
Carcinoma, Hepatocellular
Cytochemical studies of acid phosphatase, adenosine triphosphatase and lactic dehydrogenase activity in thioacetamide-induced hepatoma.
Carcinoma, Hepatocellular
Deviations in isozyme patterns of acid phosphatase and esterase, and in ultrastructures of Yoshida ascites hepatomas from rat hepatocytes.
Carcinoma, Hepatocellular
DNA and protein content as cellular biochemical parameters. A discussion with two examples: acid phosphatase and cathepsin D in rat liver and hepatoma and acid phosphatase in human breast normal tissue and adenocarcinoma.
Carcinoma, Hepatocellular
Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Carcinoma, Hepatocellular
Isozymic changes of acid phosphatase and esterase in regenerating rat liver after partial hepatectomy in relation to cell differentiation.
Carcinoma, Hepatocellular
Quinidine-induced decrease of intracellular esterase activity in a hepatoma cell line.
Carcinoma, Hepatocellular
Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
Carcinoma, Hepatocellular
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Carcinoma, Hepatocellular
[Acid phosphatase in the liver of the normal rat and the rat with Yoshida ascites hepatoma after stimulation with phytohemagglutinins and a physiological solution]
Carcinoma, Hepatocellular
[Acid phosphatase isoenzyme composition of the lysosomes of normal and tumor cells]
Carcinoma, Hepatocellular
[Cytochemical study of cells of primary and disseminated ascite Yoshida tumor cells]
Carcinoma, Hepatocellular
[Effect of radiation on the activity of lactate dehydrogenase and acid phosphatase isoenzymes of Zajdela hepatoma]
Carcinoma, Hepatocellular
[Isoenzymes of acid phosphatase and esterase in ortho-aminoazotoluene-induced hepatomas]
Carcinoma, Hepatocellular
[The influence of tumor growth on natural cytotoxicity and activity of some lysosomal enzymes of human effector cells and the C3HA mouse splenocytes]
Carcinoma, Islet Cell
Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.
Carcinoma, Lewis Lung
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Carcinoma, Lewis Lung
Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Carcinoma, Lewis Lung
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Carcinoma, Medullary
Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.
Carcinoma, Non-Small-Cell Lung
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
Carcinoma, Non-Small-Cell Lung
microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
Carcinoma, Non-Small-Cell Lung
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Carcinoma, Papillary
Papillary adenocarcinomas of the prostate. An immunohistochemical study.
Carcinoma, Renal Cell
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Carcinoma, Renal Cell
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
Carcinoma, Renal Cell
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
Carcinoma, Small Cell
Elevated prostate markers in metastatic small cell carcinoma of unknown primary.
Carcinoma, Small Cell
Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
Carcinoma, Squamous Cell
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Carcinoma, Squamous Cell
Histoenzymological features of epithelial cells in epidermoid carcinomas of oral mucosa and in ameloblastomas of jaws.
Carcinoma, Squamous Cell
Histoenzymological features of epithelial cells in lesions of oral mucosa in cysts and ameloblastomas of jaws.
Carcinoma, Squamous Cell
Prostate carcinoma with squamous differentiation: an analysis of 33 cases.
Carcinoma, Squamous Cell
[Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors]
Carcinoma, Squamous Cell
[Histoenzymological characteristics of epithelial cells in oral mucosal lesions and jaw cysts. Diagnostic significance]
Carcinoma, Transitional Cell
Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Carcinoma, Transitional Cell
Cytologic features of prostatic adenocarcinoma in urine: a clinicopathologic and immunocytochemical study.
Carcinoma, Transitional Cell
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Carcinoma, Transitional Cell
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Carcinoma, Transitional Cell
Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
Carcinoma, Transitional Cell
Transitional cell carcinoma of the urinary bladder with osteoclast-type giant cells: a report of two cases and review of the literature.
Cardiomegaly
Differential regulation of diacylglycerol kinase isozymes in cardiac hypertrophy.
Cardiomyopathy, Dilated
[The indices of the proteinase-peroxidase and phosphatase activities of the blood polymorphonuclear leukocytes in the differential diagnosis of dilated cardiomyopathy and idiopathic myocarditis]
Cardiovascular Diseases
Acid phosphatase, genetic polymorphism and cardiovascular risk factors in a pediatric population.
Cardiovascular Diseases
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Cardiovascular Diseases
Serum tartrate-resistant acid phosphatase isoform 5a (TRACP5a) as a potential risk marker in cardiovascular disease.
Cataract
Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
Cataract
Cataracts in the aging rat lens. Morphology and acid phosphatase histochemistry of incipient forms.
Cataract
Lens epithelium and radiation cataract. V. Observations on acid phosphatase and meridional row nuclear fragmentation.
Cataract
Lysosomal enzymes in tear fluids from patients with Terrien's marginal corneal degeneration.
Cataract
Ultrastructural and acid phosphatase histochemical analysis of developmental lens abnormalities in rats with X-ray-induced cataract mutation.
Chagas Disease
The Role of DmCatD, a Cathepsin D-Like Peptidase, and Acid Phosphatase in the Process of Follicular Atresia in Dipetalogaster maxima (Hemiptera: Reduviidae), a Vector of Chagas' Disease.
Chagas Disease
Trypanosoma cruzi: experimental Chagas' disease in rhesus monkeys. II. Ultrastructural and cytochemical studies of peroxidase and acid phosphatase activities.
Chediak-Higashi Syndrome
Primary and secondary lysosomes in megakaryocytes and platelets from cattle with the Chediak-Higashi syndrome.
Cherubism
Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Cholera
Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Cholera
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Cholera
Retrograde and transganglionic transport of horseradish peroxidase-conjugated cholera toxin B subunit, wheatgerm agglutinin and isolectin B4 from Griffonia simplicifolia I in primary afferent neurons innervating the rat urinary bladder.
Cholestasis
Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis.
Cholestasis
Quantitative changes in acid phosphatase, alkaline phosphatase and 5'-nucleotidase activity in rat liver after experimentally induced cholestasis.
Cholestasis
[Metabolic changes in rat brain histaminergic neurons in dynamics of subhepatic cholestasis]
Choline Deficiency
Dietary choline deficiency and excess induced intestinal inflammation and alteration of intestinal tight junction protein transcription potentially by modulating NF-?B, STAT and p38 MAPK signaling molecules in juvenile Jian carp.
Chondroblastoma
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Chondrocalcinosis
Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs.
Chondrosarcoma
Spatholobus suberectus inhibits osteoclastogenesis and stimulates chondrogenesis.
Chondrosarcoma
[The comparative biochemical and morphological characteristics of chondrosarcoma and giant-cell tumor of the bone]
Chorioamnionitis
Phagocytosis of chorion laeve trophoblasts in patients with chorioamnionitis-associated preterm delivery: ultrastructural and enzyme-histochemical observations.
Choriocarcinoma
Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway.
Chronic Kidney Disease-Mineral and Bone Disorder
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
Chronic Kidney Disease-Mineral and Bone Disorder
Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
Chronic Kidney Disease-Mineral and Bone Disorder
Evaluation of different bone markers in hemodialyzed patients.
Chronic Kidney Disease-Mineral and Bone Disorder
Nature of mononuclear cells positive for acid phosphatase activity in bone marrow of patients with renal osteodystrophy.
Chronic Kidney Disease-Mineral and Bone Disorder
New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.
Chronic Kidney Disease-Mineral and Bone Disorder
Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Chronic Kidney Disease-Mineral and Bone Disorder
[Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker]
Chronic Kidney Disease-Mineral and Bone Disorder
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]
Chronic Periodontitis
Alkaline phosphatase and acid phosphatase levels in saliva and serum of patients with healthy periodontium, gingivitis, and periodontitis before and after scaling with root planing: A clinico-biochemical study.
Classical Swine Fever
[Activation of proteinases and acid phosphatase in swine leukocytes infected with the swine classical plague virus]
Cleft Palate
Differentiation of cyclophosphamide-treated hamster secondary palate: ultrastructural and biochemical observations.
Cleft Palate
Genesis of hadacidin-induced cleft palate in hamster: morphogenesis, electron microscopy, and determination of DNA synthesis, cAMP, and enzyme acid phosphatase.
Coccidiosis
[Histochemistry of acid phosphatase in small intestine mucosa in experimental coccidiosis in suckling piglets]
Coinfection
Combined effects of Chinese medicine feed and ginger extract bath on co-infection of Ichthyophthirius multifiliis and Dactylogyrus ctenopharyngodonid in grass carp.
Colitis
High vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model.
Colitis
Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats.
Colitis
Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs.
Collagen Diseases
Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients.
Colonic Neoplasms
Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer.
Colorectal Neoplasms
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Colorectal Neoplasms
Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Colorectal Neoplasms
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Colorectal Neoplasms
Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colon.
Colorectal Neoplasms
[Serum levels of acid phosphatase, beta-choriongonadotropin and alpha fetoprotein in patients with colorectal cancer]
Communicable Diseases
[Histochemical studies on alkaline and acid phosphatase of neutrophile leucocytes in infectious disease]
Cone Dystrophy
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Congenital Abnormalities
Erythrocyte acid phosphatase polymorphism: relationship with birth weight, duration of gestation, and congenital abnormalities.
Congenital Abnormalities
Increased dietary phosphorous prevents vertebral deformities in triploid Atlantic salmon (Salmo salar L.)
Congenital Abnormalities
[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases.
Connective Tissue Diseases
Connective tissue diseases: Apoptosis-resistant T cells in SLE: role for the regulatory B subunits of PP2A phosphatase.
Corneal Dystrophies, Hereditary
Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus.
Coronary Artery Disease
ACP1 Genetic Polymorphism and Coronary Artery Disease: An Association Study.
Coronary Artery Disease
ACP1 Genetic Polymorphism and Coronary Artery Disease: Evidence of Effects on Clinical Parameters of Cardiac Function.
Coronary Artery Disease
Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.
Coronary Artery Disease
The interaction of ACP1, ADA1, diabetes and gender in coronary artery disease.
Coronary Disease
Serum and erythrocytic acid phosphatase in norms and in coronary heart disease.
Cryptorchidism
The effect of cryptorchidism on the quantitative histology, histochemistry and hydrolytic enzyme activity of the rat testis.
Cushing Syndrome
Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
Cystadenoma, Serous
[A comparison of the enzyme activities of alkaline and acid phosphatase, lactic acid dehydrogenase and leucine aminopeptidase from the wall and fluid of human ovarian follicles, cysts and serous cystadenomas (author's transl)]
Cystic Fibrosis
Diagnosis of cystic fibrosis homozygotes and heterozygotes from plasma and fibroblast cultures. A three-generation family study.
Cystic Fibrosis
[Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis.]
Cysticercosis
The activity of alkaline and acid phosphatase and non-specific esterase in experimental bovine cysticercosis at different stages of development.
Cysts
Dephosphorylation of cyst wall proteins by a secreted lysosomal acid phosphatase is essential for excystation of Giardia lamblia.
Cysts
Differences and similarities of nurse cells in cysts of Trichinella spiralis and T. pseudospiralis.
Cysts
Effects of mebendazole, albendazole, and praziquantel on alkaline phosphatase, acid phosphatase, and adenosine triphosphatase of Echinococcus granulosus cysts harbored in mice.
Cysts
Mixed Epithelial-Stromal Tumor (MEST) of Seminal Vesicle: A Proposal for Unified Nomenclature.
Cysts
Submicroscopic localization of acid phosphatase in the dental cyst epithelium.
Cysts
[A comparison of the enzyme activities of alkaline and acid phosphatase, lactic acid dehydrogenase and leucine aminopeptidase from the wall and fluid of human ovarian follicles, cysts and serous cystadenomas (author's transl)]
Cysts
[Cytochemical studies on Besnoitia jellisoni cysts. Distribution of acid phosphatase and polysaccharide at the ultrastructural level]
Cysts
[Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)]
Dehydration
Adrenocortical involvement during diverse stress in soft-shelled turtle Lissemys p. punctata Bonnoterre.
Dehydration
Improvements in dehydration and cement line staining for methacrylate embedded human bone biopsies.
Dehydration
On the involvement of the Golgi apparatus and GERL in processing of secretion products and some enzyme activities in the rat pituitary mammotroph.
Dehydration
[Increase in intracellular acid phosphatase activity in dehydrated Saccharomyces cerevisae yeasts]
Dehydration
[The effect of fixation, dehydration and polymethacrylate imbedding on the results of immuno- and enzymehistochemical studies on lymphatic tissue and bone marrow]
Dental Plaque
Hydrolysis of triclosan monophosphate by dental plaque and selected species of oral micro-organisms.
Dental Plaque
Ultrastructural localization of alkaline and acid phosphatase activities in dental plaque.
Dental Plaque
[Ultrastructural cytochemistry of acid phosphatase and pyrophosphatase in human dental plaque]
Dermatitis
[Differential diagnosis of allergic and non-allergic dermatitis by measuring the levels of acid phosphatase in neutrophils and peripheral blood lymphocytes]
Diabetes Mellitus
Acid phosphatase in peripheral blood lymphocyte lysosomes in patients with diabetes mellitus.
Diabetes Mellitus
Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
Diabetes Mellitus
Bone Turnover Markers as a New Predicting Factor for Non-union After Spinal Fusion Surgery.
Diabetes Mellitus
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Diabetes Mellitus
Phosphatases in human urine with emphasis on the correlation between acid phosphatase and diabetes mellitus.
Diabetes Mellitus
Skeletal Muscle Mass Index Is Positively Associated With Bone Mineral Density in Hemodialysis Patients.
Diabetes Mellitus
[Acid phosphatase in lymphocytes of patients with diabetes mellitus complicated by infection]
Diabetes Mellitus
[Acid phosphatase in the lymphocytes of patients with diabetes mellitus treated with insulin and oral antidiabetics]
Diabetes Mellitus, Experimental
Effect of streptozotocin diabetes on acid phosphatase and selected glycosidase activities of serum and various rat organs.
Diabetes Mellitus, Type 1
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner.
Diabetes Mellitus, Type 1
Is there a role of ACP1-ADA1 genetic complex in immune reaction? Association with T1D and with past malarial morbidity.
Diabetes Mellitus, Type 2
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
Diabetes Mellitus, Type 2
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms.
Digestive System Diseases
Comparative characteristics of the cytochemical status of peritoneal and alveolar macrophages in the progeny of female rats with experimental liver disease.
Digestive System Diseases
[OCCURRENCE OF RAISED SERUM ACID PHOSPHATASE LEVELS IN PANCREATIC CANCER AND HEPATOBILIARY DISEASES.]
Diphtheria
The effect of receptor rapid-internalization signals on diphtheria toxin endocytosis and cell sensitivity.
Diphtheria
[INCREASE OF THE FREE, SOLUBLE AND TOTAL ACTIVITY OF ACID PHOSPHATASE IN THE KIDNEYS OF GUINEA PIGS TREATED WITH DIPHTHERIA TOXIN.]
Disseminated Intravascular Coagulation
[The effect of the lysosomal function of circulating neutrophils on hemostasis and on the morphological changes in the internal organs in the disseminated intravascular coagulation syndrome]
Diverticulum
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Down Syndrome
[Erythrocytic acid phosphatase isoenzyme patterns in Down's syndrome (author's transl)]
Dyslipidemias
ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese.
Eczema
[Differential diagnosis of allergic and non-allergic dermatitis by measuring the levels of acid phosphatase in neutrophils and peripheral blood lymphocytes]
Eczema
[The interrelationship between changes in the metabolic processes in the leukocytes and the concentration of mediators in the blood of eczema patients]
Encephalomyelitis, Autoimmune, Experimental
[The activity of proteolytic enzymes and acid phosphatase in nervous tissue at various states of the development of allergic encephalomyelitis]
Endometrial Neoplasms
Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Endometrial Neoplasms
Direct interaction of the Krüppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells.
Endometrial Neoplasms
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
Endometrial Neoplasms
Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2A.
Endometriosis
Cellular components in peritoneal fluid in infertile patients with and without endometriosis.
Endometriosis
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Endometriosis
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Endometriosis
Increased activation of pelvic macrophages in infertile women with mild endometriosis.
Endometriosis
Peritoneal fluid in patients with and without endometriosis: prostanoids and macrophages and their effect on the spermatozoa penetration assay.
Endometriosis
Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis.
Enteritis
Condensed tannins decreased the growth performance and impaired intestinal immune function in on-growing grass carp (Ctenopharyngodon idella).
Enteritis
Dietary gossypol reduced intestinal immunity and aggravated inflammation in on-growing grass carp (Ctenopharyngodon idella).
Enteritis
Dietary iron deficiency impaired intestinal immune function of on-growing grass carp under the infection of Aeromonas hydrophila: Regulation of NF-?B and TOR signaling.
Enteritis
Dietary zinc deficiency reduced growth performance, intestinal immune and physical barrier functions related to NF-?B, TOR, Nrf2, JNK and MLCK signaling pathway of young grass carp (Ctenopharyngodon idella).
Enteritis
Threonine deficiency decreased intestinal immunity and aggravated inflammation associated with NF-?B and target of rapamycin signalling pathways in juvenile grass carp (Ctenopharyngodon idella) after infection with Aeromonas hydrophila.
Enzootic Bovine Leukosis
High yield synthesis of the bovine leukemia virus (BLV) p24 major internal protein in Saccharomyces cerevisiae.
Eosinophilia
Histological and histochemical examinations of myocardium of rats kept on low-magnesium diet and receiving methotrexate.
Eosinophilia
The effect of uteroferrin and recombinant GM-CSF on hematopoietic parameters in normal female pigs (Sus scrofa).
Eosinophilic Granuloma
Langerhans' cells and macrophages in eosinophilic granuloma. An enzyme-histochemical, enzyme-cytochemical, and ultrastructural study.
Erysipelas
[Histochemical studies on the alkaline and acid phosphatase content of the synovial tissue of swine with erysipelas]
Essential Hypertension
[Effects of plasmapheresis on lymphocytic energy enzymes in hypertension]
Extranodal Extension
Adverse implications of acid phosphatase levels in the upper range of normal.
Fasciitis
Tartrate-resistant acid phosphatase containing cells in nodular fasciitis, proliferative fasciitis, and proliferative myositis.
Fatty Liver
Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1.
Fibroadenoma
Quantitative study of the lysosomes of epithelial cells from human mammary glands and fibroadenoma during proliferative and secretory phase of the menstrual cycle.
Fibrocystic Breast Disease
[Acid phosphatase activity in breast dysplasias and in carcinomas of the breast]
Fibrocystic Breast Disease
[Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)]
Fibromatosis, Gingival
Acid phosphatase and beta-glucuronidase activities in mast cells, macrophages, plasma cells and lymphocytes in gingival fibromatosis.
Fibrosarcoma
LncRNA TUG1 positively regulates osteoclast differentiation by targeting v-maf musculoaponeurotic fibrosarcoma oncogene homolog B.
Fluorosis, Dental
[Rapamycin activates autophagy by inhibiting mTOR pathway to alleviate early osteoporosis in rats with skeletal fluorosis].
Folic Acid Deficiency
Folic acid deficiency impairs the gill health status associated with the NF-?B, MLCK and Nrf2 signaling pathways in the gills of young grass carp (Ctenopharyngodon idella).
Folic Acid Deficiency
Immunity decreases, antioxidant system damages and tight junction changes in the intestine of grass carp (Ctenopharyngodon idella) during folic acid deficiency: Regulation of NF-?B, Nrf2 and MLCK mRNA levels.
Food Hypersensitivity
Development of a BALB/c mouse model for food allergy: comparison of allergy-related responses to peanut agglutinin, ?-lactoglobulin and potato acid phosphatase.
Foodborne Diseases
[The activity of acid phosphatase and its isoenzymes in patients with food poisonings]
Gallstones
Lysosomal enzyme activities in gallbladder mucosa of gallstone-free subjects and patients with gallstones.
Ganglion Cysts
[Protective effect of exogenous glial cell line derived neurotrophic factor on neurons after sciatic nerve injury in rats]
Gastrointestinal Neoplasms
[Electron-microscopic studies of the activity of acid phosphatase reactions in the liver of patients with gastrointestinal cancer]
Gaucher Disease
Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.
Gaucher Disease
Affinity separation of an acid phosphatase from rat tissues and Gaucher spleen with immobilized Cibacron Blue.
Gaucher Disease
Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase.
Gaucher Disease
Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease.
Gaucher Disease
Bone-marrow-serum acid phosphatase in lipid histocytosis resembling Gaucher's disease.
Gaucher Disease
Changes of serum hexosaminidase for the presumptive diagnosis of type I Gaucher disease in Tay-Sachs carrier screening.
Gaucher Disease
Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.
Gaucher Disease
Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy.
Gaucher Disease
Determination of serum acid and alkaline phosphatase using 4-methylumbelliferyl phosphate.
Gaucher Disease
Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
Gaucher Disease
Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher's disease, prostatic carcinoma and multiple myeloma.
Gaucher Disease
Evaluation of three biochemical markers in the monitoring of Gaucher disease.
Gaucher Disease
Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
Gaucher Disease
GAUCHER'S DISEASE (WITH ELEVATED SERUM ACID PHOSPHATASE LEVEL) MASQUERADING AS CIRRHOSIS OF THE LIVER.
Gaucher Disease
High acid phosphatase level indicating Gaucher's disease in patient with prostatism.
Gaucher Disease
Isolation and characterization of a tartrate-sensitive splenic acid phosphatase in Gaucher's disease.
Gaucher Disease
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease.
Gaucher Disease
Studies on the nature of the increased serum acid phosphatase in Gaucher's disease.
Gaucher Disease
Study of acid phosphatase in sera of Gaucher's disease patients, subcellular tissue fractions and platelet extracts.
Gaucher Disease
Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease.
Gaucher Disease
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
Gaucher Disease
[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease]
Giant Cell Arteritis
Polymyalgia rheumatica and giant cell arteritis--rational diagnosis and treatment predicated and disordered prostaglandin metabolism.
Giant Cell Tumor of Bone
A study of the acid phosphatase in the cells of bone and soft parts tumors, and of other tumorous conditions.
Giant Cell Tumor of Bone
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Giant Cell Tumor of Bone
Giant cell tumor of bone: fine structural localization of acid phosphatase.
Giant Cell Tumor of Bone
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Giant Cell Tumor of Bone
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Giant Cell Tumor of Bone
Malignant giant cell tumor of bone. Fine structure and localization of acid phosphatase.
Giant Cell Tumor of Bone
Microphotometric quantitation of enzyme activities in giant cell tumor of bone. A case study.
Giant Cell Tumor of Bone
Serum acid phosphatase as a tumour marker in giant cell tumour of bone.
Giant Cell Tumor of Bone
Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.
Giant Cell Tumor of Bone
Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Giant Cell Tumor of Bone
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Giant Cell Tumor of Bone
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
Giant Cell Tumor of Bone
The ultrastructural localization of secretory acid phosphatase in giant cell tumor of bone.
Giant Cell Tumors
A study of the acid phosphatase in the cells of bone and soft parts tumors, and of other tumorous conditions.
Giant Cell Tumors
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Giant Cell Tumors
Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumours of bone.
Giant Cell Tumors
Giant cell tumor of bone. Variations in patterns of appearance of different cell types.
Giant Cell Tumors
Giant cell tumor of bone: fine structural localization of acid phosphatase.
Giant Cell Tumors
Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Giant Cell Tumors
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Giant Cell Tumors
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Giant Cell Tumors
Malignant giant cell tumor of bone. Fine structure and localization of acid phosphatase.
Giant Cell Tumors
Microphotometric quantitation of enzyme activities in giant cell tumor of bone. A case study.
Giant Cell Tumors
New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
Giant Cell Tumors
Osteoclast origin of giant cells in giant cell tumors of bone: ultrastructural and cytochemical study of six cases.
Giant Cell Tumors
Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.
Giant Cell Tumors
Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Giant Cell Tumors
Serum total acid phosphatase for monitoring the clinical course of giant cell tumors of bone--26 patients with 5 local recurrences.
Giant Cell Tumors
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Giant Cell Tumors
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Giant Cell Tumors
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
Giant Cell Tumors
The ultrastructural localization of secretory acid phosphatase in giant cell tumor of bone.
Giant Cell Tumors
[Demonstration of osteoclastic acid phosphatase in the serum of patients with giant cell tumors. Preliminary study]
Gingivitis
Alkaline phosphatase and acid phosphatase levels in saliva and serum of patients with healthy periodontium, gingivitis, and periodontitis before and after scaling with root planing: A clinico-biochemical study.
Gingivitis
[Acid phosphatase of the human gingiva in health and in chronic catarrhal and hypertrophic gingivitis, and in alveolar pyorrhea]
Glaucoma
[Chemiluminescence and activity of acid phosphatase in the drainage zone of the eye in glaucoma patients]
Glaucoma
[The acid phosphatase, alkaline phosphatase, lactate dehydrogenase, and succinate dehydrogenase in the endothelium on the trabecular meshwork in primary glaucoma]
Glioblastoma
Acid and alkaline phosphatase activities in homogenates and subcellular fractions of human brain tumors.
Glioblastoma
How reliable are in vitro IC50 values? Values vary with cytotoxicity assays in human glioblastoma cells.
Glioblastoma
Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain.
Glioma
Modification of opioid receptor activity by acid phosphatase in neuroblastoma x glioma NG108-15 hybrid cells.
Glomerulonephritis
A case of congenital nephrotic syndrome associated with partial deficiency of lecithin cholesterol acyltransferase (LCAT) and hypothyroidism.
Glomerulonephritis
Changes in lysosome populations in the rat kidney cortex induced by passive Heymann glomerulonephritis.
Glomerulonephritis
Enzyme histochemistry in plastic-embedded sections of normal and diseased kidneys.
Glomerulonephritis
Histochemistry of glomerular cells in animal models of crescentic glomerulonephritis.
Glomerulonephritis
Intracellular routes of a lysosome marker enzyme, acid phosphatase, in proximal convoluted tubule cells of human kidney in glomerulonephritis as studied by electron cytochemistry.
Glomerulonephritis
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
glucan 1,4-alpha-glucosidase deficiency
Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Association between ACP(1) genetic polymorphism and favism.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Glucosephosphate Dehydrogenase Deficiency
Association between ACP(1) genetic polymorphism and favism.
Glucosephosphate Dehydrogenase Deficiency
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Glycogen Storage Disease Type II
Combination of acid phosphatase positivity and rimmed vacuoles as useful markers in the diagnosis of adult-onset Pompe disease lacking specific clinical and pathological features.
Glycogen Storage Disease Type II
Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis.
Glycogen Storage Disease Type II
Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy.
Goiter
[Acid phosphatase of leukocytes in patients with diffuse toxic goiter in evaluating the stage of the disease]
Gonorrhea
[Study of the activity of acid phosphatase in biological materials from patients with gonorrhea]
Granuloma
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.
Granuloma
Increased resistance to mycobacterial infection in the absence of interleukin-10.
Granuloma
Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.
Granuloma
Studies of heterogeneity of angiotensin-converting enzyme and acid phosphatase in granulomatous lesions of skin.
Granuloma
The sulphokinase, arylsulphatase-B and acid phosphatase activities of carrageenin granuloma in rats of different ages.
Granuloma
Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.
Granuloma
[Histochemical study on experimental silicotic granuloma; succinic dehyrogenase and acid phosphatase.]
Granulomatous Disease, Chronic
Acid Phosphatase Cytochemistry of Phagocytizing Leukocytes from Patients with Chronic Granulomatous Disease.
Granulomatous Disease, Chronic
Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients.
Hearing Loss
TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.
Heart Arrest
Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate.
Heart Arrest
[Characteristics of the activation of lysosomal enzymes in the rat liver after death and during resuscitation]
Heart Failure
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Heart Failure
Histochemical and ultrastructural alterations of lysosomes and acid phosphatase reaction in human chronic hypoxic myocardium.
Heart Failure
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
Hemangioma
Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK.
Hemangioma, Cavernous, Central Nervous System
A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.
Hemochromatosis
Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload.
Hepatitis
BETA-GLUCURONIDASE AND ACID PHOSPHATASE ACTIVITIES OF LYSOSOMAL PREPARATIONS FROM HUMAN LIVER TISSUE OBTAINED BY NEEDLE BIOPSY FROM SUBJECTS WITH ACUTE HEPATITIS AND CIRRHOSIS.
Hepatitis
Lysosomal enzyme activities in normals and in patients with chronic liver diseases.
Hepatitis
[Activity of lysosomal enzymes acid phosphatase and beta-glucuronidase in patients with viral hepatitis]
Hepatitis
[Change in the state of liver lysosomes and lymphocytes during development of secondary immunodeficiency and in chronic toxic hepatitis]
Hepatitis
[The activities of acid phosphatase (ACP) and Mg++ adenosine triphosphatase in acute hepatitis with submassive necrosis]
Hepatitis
[The significance of E and EAC rosettes, acid phosphatase and beta-glucuronidase activity in lymphocyte rosettes, and the level of glycogen in peripheral blood leukocytes in patients with viral hepatitis]
Hepatitis B
Controlled fed-batch fermentation of recombinant Saccharomyces cerevisiae to produce hepatitis B surface antigen.
Hepatitis B
Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons.
Hepatitis B
Expression of the hepatitis B surface antigen gene containing the preS2 region in Saccharomyces cerevisiae.
Hepatitis C
Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation.
Hepatitis, Chronic
Lysosomal enzyme activities in normals and in patients with chronic liver diseases.
Hepatitis, Chronic
Prostatic acid phosphatase and prostate specific antigen in liver disease.
Hepatitis, Chronic
[The activity of alkaline and acid phosphatase in chronic hepatitis and cirrhosis of the liver]
Hepatolenticular Degeneration
Electron probe microanalysis of liver in Wilson's disease. Simultaneous assay for copper and for lead deposited by acid phosphatase activity in lysosomes.
Hepatolenticular Degeneration
Studies on the pathogenesis of hepatolenticular degeneration. I. Acid phosphatase activity in copper-loaded rat livers.
Hepatomegaly
Associations between polymorphic variety and disease susceptibility in two New Guinea populations.
Hepatomegaly
Massive hepatomegaly and an elevated serum acid phosphatase associated with a retrovesical carcinoma.
Herpes Simplex
Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. III. Cytochemical localization of lysosomal enzymes in infected cells.
Herpes Simplex
Influence of 2,4,6-triamino-pyrimidyl-5-azobenzene on the activities of acid phosphatase, alkaline phosphatase and lactate dehydrogenase in cell cultures infected with herpes simplex virus type 1.
Herpes Simplex
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
Herpes Simplex
[Comparative analysis of functional activity of peripheral blood phagocytes in HIV-infected patients and in those with recurrent herpes simplex]
Herpes Zoster
[Effects of infrasound on activities of 3beta hydroxysteroid dehydrogenase and acid phosphatase of polygonal cells in adrenal cortex zona fasciculate in mice]
Hirschsprung Disease
Light and electronmicroscopy of the bowel in an unusual form of Hirschsprung's disease.
Histiocytic Sarcoma
Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain-Barré, and a unique chromosome abnormality.
Histiocytic Sarcoma
Malignant histiocytosis: a clinical, histologic, and immunohistochemical study of 20 cases.
Histiocytoma, Malignant Fibrous
[Determination of tartrate-resistant acid phosphatase in malignant fibrous histiocytomas. Studies of routine formalin-fixed and paraffin-embedded material]
Histiocytoma, Malignant Fibrous
[The ultrastructure and histochemical characteristics of the cells of malignant fibrous histiocytoma in rats]
Histiocytosis
Increasing values of serum acid phosphatase in a child with Mycoplasma pneumoniae-associated hemophagocytic histiocytic syndrome.
Histiocytosis
Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients.
Histiocytosis, Langerhans-Cell
Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities.
HIV Infections
A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.
HIV Infections
Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences.
HIV Infections
Impact of semen-derived amyloid (SEVI) on sperm viability and motility: its implication in male reproductive fitness.
HIV Infections
Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.
Hodgkin Disease
Acid phosphatase activity in monocytes and sera of patients with Hodgkin's disease.
Hodgkin Disease
Activity and intracellular localization of lysosomal acid phosphatase in lymphocytes from patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
Hodgkin Disease
Cytochemical, ultrastructural and immunological studies of circulating Reed-Sternberg cells.
Hodgkin Disease
Disordered macrophage development in Hodgkin's disease shown by quantitative cytochemistry.
Hodgkin Disease
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Hodgkin Disease
Study of the acid phosphatase and the RNA with a view to the morphologic diagnosis of Hodgkin's disease.
Hodgkin Disease
[The rosette test with sensitized sheep erythrocytes, acid phosphatase and alpha-naphthylacetate esterase in an acid medium: comparative immunocytochemical T-cell exhibition in Hodgkin's disease]
Huntington Disease
Acid-beta-glycerophosphatase reaction products in the central nervous system mitochondria following x-ray irradiation.
Hutchinson's Melanotic Freckle
Histochemical findings in different types of malignant melanoma: biological and clinical significance.
Hydronephrosis
Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation.
Hyperaldosteronism
Enzyme histocytochemical studies in human adrenocortical adenomas. [I]. Primary aldosteronism.
Hypercalcemia
Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain-Barré, and a unique chromosome abnormality.
Hypercalcemia
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
Hypercholesterolemia
Soy milk powder supplemented with phytosterol esters reduced serum cholesterol level in hypercholesterolemia independently of lipoprotein E genotype: a random clinical placebo-controlled trial.
Hyperemia
Toxicity assessment of pyriproxyfen in vertebrate model zebrafish embryos (Danio rerio): A multi biomarker study.
Hypergammaglobulinemia
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
Hyperglycemia
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Hyperglycemia
Hyperglycemia alters enzyme activity and cell number in spinal sensory ganglia.
Hyperinsulinism
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Hyperlipidemias
[The preanalytical stage of under measuring of concentration of catalytic activity of enzymes: the characteristics and tasks of standardization].
Hyperparathyroidism
Bone mass protective potential mediated by bovine milk basic protein requires normal calcium homeostasis in mice.
Hyperparathyroidism
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Hyperparathyroidism
Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase.
Hyperparathyroidism
[Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia]
Hyperparathyroidism, Primary
Osteoclast cytomorphometry in patients with femoral neck fracture.
Hyperparathyroidism, Primary
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Hyperparathyroidism, Primary
Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
Hyperparathyroidism, Primary
[Quasi-distribution-free multivariate assessment of clinico-chemical patient data using of van der Waerden's X-transformation]
Hyperparathyroidism, Secondary
Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
Hyperparathyroidism, Secondary
Effects of Calcitriol on Type 5b Tartrate-Resistant Acid Phosphatase and Interleukin-6 in Secondary Hyperparathyroidism.
Hyperparathyroidism, Secondary
Endosteal surfaces in hyperparathyroidism: an enzyme cytochemical study on low-temperature-processed, glycol-methacrylate-embedded bone biopsies.
Hyperparathyroidism, Secondary
Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase.
Hyperparathyroidism, Secondary
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Hypersensitivity
Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy.
Hypersensitivity
Diagnosis of quinine hypersensitivity, use of platelet factor 3 and acid phosphatase availability tests.
Hypersensitivity
Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.
Hypersensitivity
Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3).
Hypersensitivity
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
Hypersensitivity
Raf60, a novel component of the Rpd3 histone deacetylase complex required for Rpd3 activity in Saccharomyces cerevisiae.
Hypersensitivity
RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae.
Hypersensitivity
Studies of heterogeneity of angiotensin-converting enzyme and acid phosphatase in granulomatous lesions of skin.
Hypersensitivity
The study of the acid phosphatase of macrophagal lysosomes in delayed-type hypersensitivity.
Hypersensitivity
[Acid phosphatase determination in macrophages in delayed type hypersensitivity]
Hypersensitivity
[Permeability of cutaneous macrophage lysosomal membrane in delayed hypersensitivity to streptococcal antigens]
Hypersensitivity
[Study of macrophage lysosomal acid phosphatase in hypersensitivity of the delayed type]
Hypertension
Acid phosphatase activity in the aorta of spontaneously hypertensive rats and the effect of various antihypertensive drugs.
Hypertension
Aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, monoamine oxidase, malondialdehyde, and acid phosphatase in rat brain capillaries and kidney glomeruli in experimental hypertension.
Hypertension
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Hypertension
Determining the association between hypertension and bone metabolism markers in osteoporotic patients.
Hypertension
Healing process of autogenous bone graft in spontaneously hypertensive rats treated with losartan: an immunohistochemical and histomorphometric study.
Hypertension
Semiquantitative histochemical investigation of lysosomal enzyme activities in the aortic endothelial cells of rats with renal hypertension.
Hypertension
Skeletal Muscle Mass Index Is Positively Associated With Bone Mineral Density in Hemodialysis Patients.
Hypertension
[Determination of dehydrogenase and acid phosphatase activity in the lymphocytes in hypertension and vasorenal hypertension]
Hypertension
[The contribution of radio-isotopes to urological investigation (author's transl)]
Hypertension, Renal
Semiquantitative histochemical investigation of lysosomal enzyme activities in the aortic endothelial cells of rats with renal hypertension.
Hyperthyroidism
Dorsolateral prostatic phosphomonoesterases and adenosine triphosphatases in hypo- and hyperthyroid rats.
Hyperthyroidism
Effect of thyroid hormones on activity of nonspecific phosphohydrolases in blood serum, tissues and liver mitochondrial fraction of white rat.
Hyperthyroidism
Energy Metabolism in the Bone is Associated with Histomorphometric Changes in Rats with Hyperthyroidism.
Hyperthyroidism
Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets.
Hyperthyroidism
Ventral prostatic phosphomonoesterases and adenosine triphosphatases in hypo- and hyperthyroid albino rats.
Hyperthyroidism
[A histochemical study of gastric adenosine triphosphatase, alkaline and acid phosphatase in experimental hypo- and hyperthyroidism]
Hyperthyroidism
[Serum levels of the tartrate-resistant isoenzyme, acid phosphatase, for the evaluation of bone remodeling in hyperthyroidism]
Hypocalcemia
The pathogenesis of infantile malignant osteopetrosis: bone mineral metabolism and complications in five infants.
Hypogonadism
A critical estimation of the effect of chorionic gonadotropic hormone treatment on male hypogonadism by prostatic production of acid phosphatase.
Hypokinesia
Effects of a seven-day hypokinesia on the digestive tract of nonpregnant and pregnant rats.
Hypophosphatemia
The pathogenesis of infantile malignant osteopetrosis: bone mineral metabolism and complications in five infants.
Hypotension
Changes in plasma levels of lysosomal and non lysosomal enzymes during hemorrhagic hypotension.
Hypothyroidism
Dorsolateral prostatic phosphomonoesterases and adenosine triphosphatases in hypo- and hyperthyroid rats.
Hypothyroidism
Effect of altered thyroid status on lysosomal enzymes and thymidylate synthetase activity in tumors and livers of host animals.
Hypothyroidism
Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets.
Hypothyroidism
Specific activities of seminal vesicular phosphomonoesterases and Mg2+-,Ca2+- and Na+/K(+)-adenosine triphosphatases in hypo- and hyperthyroid albino rats.
Hypothyroidism
[Blast transformation and the activity of acid phosphatase of circulating lymphocytes in experimental hypothyroidism]
Hypothyroidism
[Cytochemical examination of peripheral blood neutrophils of patients with hypothyroidism]
Hypoxia-Ischemia, Brain
The cytochemistry of anoxic and anoxic-ischemic encephalopathy in rats. I. Alterations in neuronal lysosomes identified by acid phosphatase activity.
Idiopathic Pulmonary Fibrosis
Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Immune System Diseases
Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy.
Immune System Diseases
ACP1 Genetic Polymorphism and Coronary Artery Disease: An Association Study.
Infections
An isoenzyme marker possibly associated with the susceptibility of Biomphalaria glabrata populations to Schistosoma mansoni.
Infections
Antioxidant and immune responses of the Oriental river prawn Macrobrachium nipponense to the isopod parasite Tachaea chinensis.
Infections
Bioinformatics analysis on the differentiation of bone mesenchymal stem cells into osteoblasts and adipocytes.
Infections
Canine bone marrow cell cultures infected with canine distemper virus: an in vitro model of Paget's disease.
Infections
Change in the isoenzyme composition of acid phosphatase in murine peritoneal macrophages exposed to or infected with Trypanosoma cruzi.
Infections
Changes in blood chemical components during experimentally induced Theileria annulata infections in cattle.
Infections
Changes in lysosomal enzymes of peritoneal exudate cells in albino rats and Mastomys natalensis during Plasmodium berghei infection.
Infections
Characterization of the inflammatory cells in progressing tumor-like alveolar hydatid cyst. 2. Cell surface receptors, endocytosed immune complexes and lysosomal enzyme content.
Infections
Comparative development of Brugia pahangi and variation in acid hydrolase enzyme titers in.
Infections
Comparison of protein profiles and enzymes in non-mycorrhizal and mycorrhizal roots of Pennisetum pedicellatum.
Infections
Coxiella burnetii exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells.
Infections
Decrease of acid phosphatase activity in murine peritoneal macrophages infected with Leishmania donovani.
Infections
Design and characterization of high-affinity synthetic peptides as bioreceptors for diagnosis of cutaneous leishmaniasis.
Infections
Diagnostic value of determination of acid and alkaline phosphatase levels in the seminal plasma of infertile males.
Infections
Dietary Choline-Enhanced Skin Immune Response of Juvenile Grass Carp Might Be Related to the STAT3 and NF-kB Signaling Pathway (Ctenopharyngodon idella).
Infections
Dietary iron deficiency impaired intestinal immune function of on-growing grass carp under the infection of Aeromonas hydrophila: Regulation of NF-?B and TOR signaling.
Infections
Dietary vitamin C deficiency depressed the gill physical barriers and immune barriers referring to Nrf2, apoptosis, MLCK, NF-?B and TOR signaling in grass carp (Ctenopharyngodon idella) under infection of Flavobacterium columnare.
Infections
Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas.
Infections
Dynamics of arbuscular mycorrhizal fungi and glomalin in the rhizosphere of Artemisia ordosica Krasch. in Mu Us sandland, China
Infections
Early transcriptional response to the parasitic dinoflagellate Hematodinium in hepatopancreas of Portunus trituberculatus.
Infections
Effect of enterotoxigenic Escherichia coli heat stable toxin on intestinal lysosomal enzymes in the suckling rat.
Infections
Effect of entomopathogenic nematode of Heterorhabditis indica infection on immune and antioxidant system in lepidopteran pest Spodoptera litura (Lepidoptera: Noctuidae).
Infections
Effect of lead and ancylostomiasis on phosphatases of heart in Swiss albino mice.
Infections
Effects of hesperidin on the growth performance, antioxidant capacity, immune responses and disease resistance of red swamp crayfish (Procambarus clarkii).
Infections
Effects of Specific Electric Field Stimulation on the Release and Activity of Secreted Acid Phosphatases from Leishmania tarentolae and Implications for Therapy.
Infections
Enzymatic study of tonsil tissue alkaline and acid phosphatase in children with recurrent tonsillitis and tonsil hypertrophy.
Infections
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Infections
Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection.
Infections
Heterologous expression and characterization of recombinant purple acid phosphatase from red kidney bean.
Infections
HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma.
Infections
HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro.
Infections
Immunochemical identification of a new molecular form of acid phosphatase of host origin arising during infection of potato tubers by Phytophthora erythroseptica Pethybr.
Infections
In vivo and in vitro analysis of lysosomes and acid phosphatase activity in human chagasic placentas.
Infections
Infection of epithelial cells by pathogenic neisseriae reduces the levels of multiple lysosomal constituents.
Infections
Influence of Vesicular-Arbuscular Mycorrhizal Fungi on the Response of Potato to Phosphorus Deficiency.
Infections
Legionella pneumophila major acid phosphatase and its role in intracellular infection.
Infections
Leishmania mexicana: a cytochemical and quantitative study of lysosomal enzymes in infected rat bone marrow-derived macrophages.
Infections
Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase.
Infections
Lysosomal enzyme activities in susceptible and refractory strains of Biomphalaria glabrata during the course of infection with Schistosoma mansoni.
Infections
Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii.
Infections
Mesoporous bioactive glasses equipped with stimuli-responsive molecular gates for the controlled delivery of levofloxacin against bacteria.
Infections
Modulation of lysosomal protease-esterase and lysozyme in Kupffer cells and peritoneal macrophages infected with Nocardia asteroides.
Infections
Mycobacterial growth and ultrastructure in mouse L-929 fibroblasts and bone marrow-derived macrophages: evidence that infected fibroblasts secrete mediators capable of modulating bacterial growth in macrophages.
Infections
Observations on natural and experimental interactions between Schistosoma bovis and S. curassoni from West Africa.
Infections
Permeability changes of plasma and lysosomal membranes in HeLa cells infected with rabbit poxvirus.
Infections
Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine.
Infections
Qualitative and quantitative histochemical changes in the caecum and liver of turkeys infected with Histomonas meleagridis.
Infections
Reversible decrease of fluoride resistant acid phosphatase-positive neurons after herpes simplex virus infection.
Infections
SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization.
Infections
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Infections
Spleen and kidney of Atlantic salmon (Salmo salar L.) show histochemical changes early in the course of experimentally induced infectious salmon anaemia (ISA).
Infections
The Acid Phosphatase AcpA Is Secreted In Vitro and in Macrophages by Francisella spp.
Infections
The activity of alkaline and acid phosphatase and non-specific esterase in experimental bovine cysticercosis at different stages of development.
Infections
The effect of human cytomegalovirus on selected functions of peripheral blood monocytes.
Infections
The Secreted Acid Phosphatase Domain-Containing GRA44 from Toxoplasma gondii Is Required for c-Myc Induction in Infected Cells.
Infections
Trichinella spp.: differential expression of acid phosphatase and myofibrillar proteins in infected muscle cells.
Infections
Trypanosoma cruzi-secreted vesicles have acid and alkaline phosphatase activities capable of increasing parasite adhesion and infection.
Infections
[Acid phosphatase in lymphocytes of patients with diabetes mellitus complicated by infection]
Infections
[Changes in the serum acid phosphatase activity of guinea pigs poisoned with C1 perfringens type A toxin and a mixture of toxin and a broth culture filtrate]
Infections
[Comparative analysis of functional activity of peripheral blood phagocytes in HIV-infected patients and in those with recurrent herpes simplex]
Infections
[Cytochemical study of granulocyte enzymes in germ-free animals with adenovirus infections]
Infections
[Cytomorphological and cytochemical studies on the multiplication of bovine reovirus type 1 in a cell culture]
Infections
[Enzyme, enzyme-histochemical and immunohistological studies in chronic erysipelas polyarthritis of swine]
Infections
[High dose of enzyme replacement therapy was successful for the pulmonary involvement in a case of type 2 Gaucher disease].
Infections
[Study of lysosomal enzymes in chick embryo fibroblasts infected with microorganisms of family Halprowiaceae (Chlamydiaceae)]
Infectious Mononucleosis
[Acid phosphatase isoenzyme, beta-glucuronidase and non-specific esterase activity in certain morphological groups of atypical mononuclear cells in circulating blood in infectious mononucleosis]
Infertility
[Clinical and experimental studies on male infertility. 2. Experimental studies. Histochemical demonstration of acid phosphatase activity in the testes of mice and their responce to the drugs for the male infertility (author's transl)]
Infertility, Male
Seminal plasma fructose, zinc, magnesium and acid phosphatase in cases of male infertility.
Infertility, Male
[Analyse of zinc and acid phosphatase in seminal plasma and sperm parameters of infertile male]
Infertility, Male
[Clinical and experimental studies on male infertility. 2. Experimental studies. Histochemical demonstration of acid phosphatase activity in the testes of mice and their responce to the drugs for the male infertility (author's transl)]
Influenza, Human
A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer.
Influenza, Human
Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry.
Influenza, Human
Characterization of serum lysosomal enzymatic activities. III. Effect of infectious influenza in Egyptian equines.
Influenza, Human
Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity.
Influenza, Human
[Activity of blood serum and organic acid phosphatase and of nucleotidase in the mouse organs following exposure of the organism to the toxic effect of influenza virus.]
Influenza, Human
[Effect of influenza on activities of nucleotidase and acid phosphatase in mouse organs.]
Insulin Resistance
Co-administration of omega-3 fatty acids and metformin showed more desirable effects than the single therapy on indices of bone mineralisation but not gluco-regulatory and antioxidant markers in diabetic rats.
Insulin Resistance
Effects of bariatric weight loss surgery on glucose metabolism, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese adults.
Insulin Resistance
Effects of exercise on insulin sensitivity, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents.
Insulin Resistance
Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans.
Insulin Resistance
TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1.
Insulin Resistance
Zinc-?2-Glycoprotein Modulates AKT-Dependent Insulin Signaling in Human Adipocytes by Activation of the PP2A Phosphatase.
Insulin Resistance
[Erythrocytic acid phosphatase genetic polymorphism and cardiovascular risk in health children and adolescents]
Intestinal Volvulus
Acid phosphatase patterns in microfilariae of Onchocerca volvulus s.l. from the Upper Orinoco Basin, Venezuela.
Intestinal Volvulus
Histochemical enzyme-staining patterns of onchocerca volvulus microfilariae and their occurrence in different onchocerciasis areas.
Intestinal Volvulus
The development of Onchocerca ochengi in surrogate temperate Simuliidae, with a note on the infective larva.
Iron Deficiencies
Dietary iron deficiency impaired intestinal immune function of on-growing grass carp under the infection of Aeromonas hydrophila: Regulation of NF-?B and TOR signaling.
Iron Deficiencies
The decreased growth performance and impaired immune function and structural integrity by dietary iron deficiency or excess are associated with TOR, NF-?B, p38MAPK, Nrf2 and MLCK signaling in head kidney, spleen and skin of grass carp (Ctenopharyngodon idella).
Iron Deficiencies
The impaired immune function and structural integrity by dietary iron deficiency or excess in gill of fish after infection with Flavobacterium columnare: Regulation of NF-?B, TOR, JNK, p38MAPK, Nrf2 and MLCK signalling.
Iron Overload
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.
Iron Overload
Studies on the rat liver following iron overload. Electron probe x-ray microanalysis of acid phosphatase and iron.
Ischemic Stroke
Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5.
Jaundice, Neonatal
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase.
Joint Diseases
[Clinical studies of intra-articular injections of Arteparon. Retrospective study following the treatment of 754 patients]
Keratitis
Species identification and molecular characterization of Acanthamoeba isolated from contact lens paraphernalia.
Keratoconus
Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas.
Keratoconus
Involvement of Sp1 elements in the promoter activity of genes affected in keratoconus.
Keratoconus
Kruppel-like factor 6 (KLF6) affects the promoter activity of the alpha1-proteinase inhibitor gene.
Keratoconus
Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus.
Keratosis, Seborrheic
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Ketosis
[Experimental studies on the ketogenic effect of high doses of proteins in dairy cows]
Kidney Diseases
[Urinary acid phosphatase and beta-glucuronidase activities in kidney diseases and following kidney transplantation]
Kidney Failure, Chronic
A distinct bone phenotype in ADPKD patients with end-stage renal disease.
Kidney Failure, Chronic
Activity of some lysosomal enzymes in peritoneal macrophages of patients with end-stage renal failure treated by intermittent peritoneal dialysis.
Kidney Failure, Chronic
Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Kidney Failure, Chronic
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Kidney Failure, Chronic
Changes in activity of selected lysosomal enzymes in peritoneal macrophages of renal failure patients on peritoneal dialysis.
Kidney Failure, Chronic
Circulating biochemical markers of bone remodeling in uremic patients.
Kidney Failure, Chronic
Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
Kidney Failure, Chronic
Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Kidney Failure, Chronic
New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.
Kidney Failure, Chronic
Study of the activity of erythrocyte acid phosphatase in chronic renal failure.
Kidney Failure, Chronic
Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
Kidney Failure, Chronic
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Kidney Failure, Chronic
[Biochemical markers of bone metabolism and bone tissue losses after allotransplantation of the cadaveric kidney: a cross-sectional]
Kidney Failure, Chronic
[Study of tartrate resistant acid phosphatase in patients with chronic renal failure on maintenance hemodialysis]
Kidney Failure, Chronic
[Total activity of glucosaminidase and acid phosphatase and its isoenzymes in the serum and urine of children with chronic renal failure]
Kidney Neoplasms
Enzyme histochemistry in plastic-embedded sections of normal and diseased kidneys.
Laryngeal Neoplasms
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Laryngeal Neoplasms
Intracellular enzymatic response of lymphocytes and neutrophils in patients with cancer of the larynx.
Laryngeal Neoplasms
[Lysosomal acid phosphatase of lymphocytes in patients with cancer of the larynx (authors transl)]
Legionnaires' Disease
In vitro secretion kinetics of proteins from Legionella pneumophila in comparison to proteins from non-pneumophila species.
Leiomyoma
Is there an association between uterine leiomyomas and acid phosphatase locus 1 polymorphism?
Leiomyosarcoma
Leiomyosarcoma of the heart and its pulmonary metastasis, both with prominent osteoclast-like multinucleated giant cells expressing tartrate-resistant acid phosphatase activity.
Leishmaniasis
Design and characterization of high-affinity synthetic peptides as bioreceptors for diagnosis of cutaneous leishmaniasis.
Leishmaniasis
[Enzymes of the peripheral blood leukocytes from the vertebrate host in an experimental Leishmania infection. 1. Neutrophil acid phosphatase]
Leishmaniasis, Cutaneous
Effect of Prophylactic Vaccination with the Membrane-Bound Acid Phosphatase Gene of Leishmania mexicana in the Murine Model of Localized Cutaneous Leishmaniasis.
Leishmaniasis, Cutaneous
Effects of Specific Electric Field Stimulation on the Release and Activity of Secreted Acid Phosphatases from Leishmania tarentolae and Implications for Therapy.
Leishmaniasis, Cutaneous
[Enzymes of the peripheral blood leukocytes from the vertebrate host in an experimental Leishmania infection. 1. Neutrophil acid phosphatase]
Leprosy
Electron microscopy of peroxidase and acid phosphatase in leprous and uninfected armadillo macrophages: a macrophage subpopulation contains peroxisomes and lacks bacilli.
Leprosy
Genetic markers and leprosy in South African negroes: Part II. Erythrocyte enzyme polymorphisms.
Leprosy
Phagocytosis in leprosy. I. The levels of "diaphorase", beta-glucuronidase, acid phosphatase, alkaline phosphatase and lipase in circulating leucocytes.
Leukemia
(-)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In Vitro.
Leukemia
A customized retroviral vector confers marker gene expression in osteoclast lineage cells.
Leukemia
Acid phosphatase and alpha-naphthyl acetate esterase in neoplastic and non-neoplastic lymphocytes. A statistical analysis.
Leukemia
Acid phosphatase in leukemic blasts: characterization by isoelectric focusing in polyacrylamide gel.
Leukemia
Actinomycin D induction of acid phosphatase in synchronized L5178Y mouse leukemia cells.
Leukemia
Alisertib induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells.
Leukemia
Cytochemical evaluation of cytostatic drugs action in chronic granulocytic and lymphatic leukemia.
Leukemia
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Leukemia
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Leukemia
Effective treatment of a refractory hairy cell leukemia variant with splenic pre-irradiation and alemtuzumab.
Leukemia
Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase.
Leukemia
Evidence that tartrate-resistant acid phosphatases from osteoclastomas and hairy cell leukemia spleen are members of a multigene family.
Leukemia
Exceptional thermal stability of therapeutical enzymes entrapped in alumina sol-gel matrices.
Leukemia
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases.
Leukemia
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Leukemia
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Leukemia
Hepatic involvement in hairy cell leukemia: diagnosis by tartrate-resistant acid phosphatase enzyme histochemistry on formalin fixed and paraffin-embedded liver biopsy specimens.
Leukemia
High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A.
Leukemia
Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.
Leukemia
Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Leukemia
Increased prostate-type acid phosphatase activity in serum and typical bone lesions simulating the presence of prostatic carcinoma.
Leukemia
Influence of chemotherapy on some cytochemical reactions in patients with acute leukemia.
Leukemia
Isoelectric focusing pattern of acid phosphatase in normal splenic tissue, in the lysosomal fraction of viable splenic lymphocytes and in cases of hairy cell leukemia.
Leukemia
Isozymes of acid esterase and acid phosphatase in permanent human hematopoietic cell lines.
Leukemia
KLF2 (kruppel like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Leukemia
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses.
Leukemia
Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta.
Leukemia
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia
Phosphatases of leukocytes. II. Isolation and characterization of acid phosphatase of normal leukocytes and leukocytes from patients with chronic granulocytic leukemia.
Leukemia
Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase.
Leukemia
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Leukemia
Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Leukemia
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
Leukemia
The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.
Leukemia
The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia.
Leukemia
Transient expression of the tartrate-resistant acid phosphatase (TRAP) gene in hamster cells: a pilot study.
Leukemia
Ultrastruct and tartrate-resistant acid phosphatase localization in a T-cell hairy-cell leukemia cell line.
Leukemia
Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
Leukemia
Visualization of the ribosome-lamella complex in plastic-embedded biopsy specimens as an aid to diagnosis of hairy-cell leukemia.
Leukemia
[A disc electrophoretic study on acid phosphatase in leukemia and lymphoma cells, with special reference to tartrate resistant isozymzymol]
Leukemia
[Activity of lysosomal hydrolase and acid phosphatase in T- and B-lymphocytes of healthy people and patients with chronic lymphatic leukemia (CLL)]
Leukemia
[Contribution of cytochemistry and delayed hypersensitivity skin tests in the diagnosis and prognosis of chronic lymphoproliferative syndromes]
Leukemia
[Correlation of the cytochemical classification of acute leukemia in children with the course of their disease (author's transl)]
Leukemia
[Detection of tartrate-resistant isoenzyme 5 of acid phosphatase in the white blood cells by disc electrophoresis in a case of hairy cell leukemia]
Leukemia
[Differential diagnostic significance of cytochemical studies of acid phosphatase and beta-glucuronidase in acute leukemia]
Leukemia
[Existence of tartaric acid-resistant acid phosphatase in adult T cell leukemia and B-CLL and its significance (author's transl)]
Leukemia
[Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)]
Leukemia
[Isoenzymes of acid phosphatase in blood cells of normal subjects and patients with leukemia (author's transl)]
Leukemia
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
Leukemia
[Leukemic infiltration of gastrointestinal system: unusual complication of hairy cell leukemia]
Leukemia
[Selective staining of T-lymphoblastic leukemia cells by glycyl-prolyl-4-methoxy-beta-naphthylamiden-peptidase (DAP IV) (author's transl)]
Leukemia
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]
Leukemia, Erythroblastic, Acute
Cytochemical detection of erythroblastic enzymes in acquired dyserythropoiesis.
Leukemia, Erythroblastic, Acute
Erythroleukemia cell lines HEL and K-562: changes in isoenzyme profiles and morphology during induction of differentiation.
Leukemia, Erythroblastic, Acute
Isoenzyme studies in human leukemia-lymphoma cell lines--V. Induction of differentiation by T-cell derived differentiation-inducing activity.
Leukemia, Erythroblastic, Acute
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Hairy Cell
Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase.
Leukemia, Hairy Cell
Biochemical characterization of the tartrate-resistant acid phosphatase of human spleen with leukemic reticuloendotheliosis as a pyrophosphatase.
Leukemia, Hairy Cell
Comparison of tartrate-resistant acid phosphatase in normal mouse tissues to that in the reticulum cells of leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience.
Leukemia, Hairy Cell
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Leukemia, Hairy Cell
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Leukemia, Hairy Cell
Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase.
Leukemia, Hairy Cell
Evidence that tartrate-resistant acid phosphatases from osteoclastomas and hairy cell leukemia spleen are members of a multigene family.
Leukemia, Hairy Cell
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases.
Leukemia, Hairy Cell
Flow cytoenzymology of intracellular tartrate-resistant acid phosphatase.
Leukemia, Hairy Cell
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Leukemia, Hairy Cell
Hairy cell leukemia (leukemic reticuloendotheliosis) in serous effusions.
Leukemia, Hairy Cell
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Leukemia, Hairy Cell
Hepatic involvement in hairy cell leukemia: diagnosis by tartrate-resistant acid phosphatase enzyme histochemistry on formalin fixed and paraffin-embedded liver biopsy specimens.
Leukemia, Hairy Cell
Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Leukemia, Hairy Cell
Immunological and biochemical evidence for identity of tartrate-resistant isoenzymes of acid phosphatases from human serum and tissues.
Leukemia, Hairy Cell
Isoelectric focusing pattern of acid phosphatase in normal splenic tissue, in the lysosomal fraction of viable splenic lymphocytes and in cases of hairy cell leukemia.
Leukemia, Hairy Cell
Kinetic properties of tartrate-resistant acid phosphatase isolated from human spleen with leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Leukemic reticuloendotheliosis. The role of tartrate-resistant acid phosphatase in diagnosis and splenectomy in treatment.
Leukemia, Hairy Cell
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses.
Leukemia, Hairy Cell
Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta.
Leukemia, Hairy Cell
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Hairy Cell
Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase.
Leukemia, Hairy Cell
Reassessment of a cytochemical test for differential diagnosis of leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
Leukemia, Hairy Cell
Studies of intracellular distribution of acid phosphatase 5 in the spleen cells of leukemic reticuloendotheliosis by isopycnic gradient centrifugation.
Leukemia, Hairy Cell
Tartrate-resistant (band 5) acid phosphatase activity measured by electrophoresis on acrylamide gel.
Leukemia, Hairy Cell
Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Tartrate-resistant acid phosphatase reactions not specific for hairy cell leukemia.
Leukemia, Hairy Cell
The cytochemistry of tartrate-resistant acid phosphatase. Technical considerations.
Leukemia, Hairy Cell
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
Leukemia, Hairy Cell
The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.
Leukemia, Hairy Cell
The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia.
Leukemia, Hairy Cell
Transient expression of the tartrate-resistant acid phosphatase (TRAP) gene in hamster cells: a pilot study.
Leukemia, Hairy Cell
Ultrastructural cytochemical demonstration of tartrate-resistant acid phosphatase isoenzyme activity in "hairy cells" of leukemic reticuloendotheliosis.
Leukemia, Hairy Cell
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
Leukemia, Hairy Cell
[Contribution of cytochemistry and delayed hypersensitivity skin tests in the diagnosis and prognosis of chronic lymphoproliferative syndromes]
Leukemia, Hairy Cell
[Detection of tartrate-resistant isoenzyme 5 of acid phosphatase in the white blood cells by disc electrophoresis in a case of hairy cell leukemia]
Leukemia, Hairy Cell
[Hairy cell leukemia: diagnosis using monoclonal antibodies in flow cytometry]
Leukemia, Hairy Cell
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
Leukemia, Hairy Cell
[Leukemic infiltration of gastrointestinal system: unusual complication of hairy cell leukemia]
Leukemia, Hairy Cell
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]
Leukemia, Lymphocytic, Chronic, B-Cell
Acid hydrolases as markers of maturation in B-cell chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Acid phosphatase cytochemistry of mitrogen-transformed normal and chronic lymphocytic leukemia lymphocytes.
Leukemia, Lymphocytic, Chronic, B-Cell
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Leukemia, Lymphocytic, Chronic, B-Cell
Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
Leukemia, Lymphocytic, Chronic, B-Cell
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Morphological and cytochemical changes of peripheral blood lymphocyte lysosomes in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Lymphocytic, Chronic, B-Cell
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Leukemia, Lymphocytic, Chronic, B-Cell
Reassessment of a cytochemical test for differential diagnosis of leukemic reticuloendotheliosis.
Leukemia, Lymphocytic, Chronic, B-Cell
The dynamics of morphological and cytoenzymatic changes in peripheral blood lymphocyte lysosomes in patients with chronic lymphocytic leukemia during treatment.
Leukemia, Lymphocytic, Chronic, B-Cell
[Activity of lysosomal hydrolase and acid phosphatase in T- and B-lymphocytes of healthy people and patients with chronic lymphatic leukemia (CLL)]
Leukemia, Lymphocytic, Chronic, B-Cell
[Chronic T-cell lymphoid leukemia with helper cell phenotype]
Leukemia, Lymphoid
12-0-Tetradecanoylphorbol 13-acetate (TPA)-induced enzymatic change of human non-T, non-B lymphoid leukemia cell lines.
Leukemia, Lymphoid
Existence of tartrate-resistant acid phosphatase activity in differentiated lymphoid leukemic cells.
Leukemia, Lymphoid
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Leukemia, Lymphoid
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Lymphoid
The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature.
Leukemia, Lymphoid
Visualization of the ribosome-lamella complex in plastic-embedded biopsy specimens as an aid to diagnosis of hairy-cell leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Differences in distribution of ribonuclease isoenzymes in cytosol and granules in normal human granulocytes and in granulocytes of patients with chronic granulocytic leukemia (CGL).
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Phosphatases of leukocytes. II. Isolation and characterization of acid phosphatase of normal leukocytes and leukocytes from patients with chronic granulocytic leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Ultrastructural study of chronic myeloid leukemia in blast crisis using myeloperoxidase and acid phosphatase reactions.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Composition of acid phosphatase in normal leukocytes and in chronic granulocytic leukemia]
Leukemia, Myeloid
Effects of retinoids on induction of differentiation of cultured mouse myeloid leukemia cells.
Leukemia, Myeloid
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Myeloid
Phosphatases of leukocytes. II. Isolation and characterization of acid phosphatase of normal leukocytes and leukocytes from patients with chronic granulocytic leukemia.
Leukemia, Myeloid, Acute
Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Leukemia, Myelomonocytic, Chronic
Elevated serum acid phosphatase in chronic myelomonocytic leukemia.
Leukemia, Prolymphocytic
Cytochemistry of acid hydrolases in chronic B- and T-cell leukemias.
Leukemia, Prolymphocytic
Prolymphocytic leukemia with T cell properties and tartrate resistant acid phosphatase.
Leukemia, T-Cell
Expression of human T-cell leukemia virus type I envelope protein in Saccharomyces cerevisiae.
Leukemia, T-Cell
[Existence of tartaric acid-resistant acid phosphatase in adult T cell leukemia and B-CLL and its significance (author's transl)]
Leukemia, T-Cell
[Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)]
Leukocytosis
Early diagnostic and prognostic criteria for health disorders in chemical workers.
Leukocytosis
Uteroferrin and recombinant bovine GM-CSF modulate the myelosuppressive effects of 5-fluorouracil in young female pigs (Sus scrofa).
Leukocytosis
[The effect of insulin on the function of the lysosomal apparatus of the neutrophilic leukocytes during the formation of a stress syndrome]
Leukodystrophy, Metachromatic
Juvenile-onset metachromatic leukodystrophy: biochemical and electrophysiologic studies.
Leukopenia
Myelosuppression in the pig (Sus scrofa): uteroferrin reduces the myelosuppressive effects of 5-fluorouracil in young pigs.
Leukopenia
Uteroferrin and recombinant bovine GM-CSF modulate the myelosuppressive effects of 5-fluorouracil in young female pigs (Sus scrofa).
Leukopenia
[A differential cytochemical acid phosphatase granulocytogram in the study of leukopenia]
Leukoplakia
Deficiency of beta-glucuronidase in neutrophils from patients with precancerous states of the larynx.
Leukoplakia
Lymphocytes, neutrophils and serum immunoglobulins in patients with precancerous states of the larynx.
Leukoplakia
The lymphocyte cytochemical equipment and serum immunoglobulins in patients with precancerous states of the larynx.
Leukoplakia
[Enzyme and isoenzyme activity in patients with malignant tumors of the oral mucosa]
Leukoplakia, Oral
Studies in oral leukoplakias. 9. Alkaline and acid phosphatase in normal and leukoplakic epithelium before and after vitamin A application.
Lichen Planus
[Electron microscopic and histochemical research on lysosomes and acid phosphatase of epithelial cells of the normal oral mucosa and in lichen ruber planus]
Lipidoses
[Monocytes/macrophages and lipidosis of the human aortic intima in atherosclerosis]
Lipodystrophy
Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility.
Liver Cirrhosis
[Extracellular breakdown of collagen as affected by lysosomal enzymes during the involution of liver cirrhosis]
Liver Cirrhosis
[Lysosome participation in collagen resorption by hepatocytes during regression of liver cirrhosis]
Liver Diseases
Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
Liver Diseases
Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
Liver Failure
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Liver Neoplasms
Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
long-chain-3-hydroxyacyl-coa dehydrogenase deficiency
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Lung Diseases
Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Lung Diseases
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Lung Diseases, Interstitial
Carcinoma of the prostate presenting as interstitial lung disease.
Lung Injury
Pollution characteristics and toxic effects of PM1.0 and PM2.5 in Harbin, China.
Lung Neoplasms
Activity of some lysosomal enzymes in peripheral blood lymphocytes of patients with lung cancer. A cytochemical study.
Lung Neoplasms
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
Lung Neoplasms
Chemotherapy agents induce tartrate-resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients.
Lung Neoplasms
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Lung Neoplasms
Cytochemical study of neutrophils from peripheral blood of patients with lung cancer.
Lung Neoplasms
LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.
Lung Neoplasms
microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
Lung Neoplasms
Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data.
Lung Neoplasms
Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5.
Lung Neoplasms
Serum acid phosphatase activities in patients with lung cancer: a biochemical and immunohistochemical analysis of 25 cases.
Lung Neoplasms
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Lung Neoplasms
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.
Lung Neoplasms
The Relationship Between Inflammatory Biomarkers and Symptom Distress in Lung Cancer Patients Undergoing Chemotherapy.
Lupus Erythematosus, Discoid
[A trial of detecting acid phosphatase by cytochemical methods for assessing the functional status of the leukocytes in discoid lupus erythematosus]
Lupus Erythematosus, Systemic
Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus.
Lymphadenopathy
Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations.
Lymphadenopathy
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases.
Lymphatic Metastasis
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Lymphatic Metastasis
Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
Lymphatic Metastasis
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Lymphatic Metastasis
Operative staging of apparently localized adenocarcinoma of the prostate: results in fifty unselected patients. I. Experimental design and preliminary results.
Lymphatic Metastasis
Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary?
Lymphatic Metastasis
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Lymphatic Metastasis
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Lymphatic Metastasis
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Lymphatic Metastasis
Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Lymphatic Metastasis
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Lymphatic Metastasis
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Lymphoma
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Lymphoma
Cytochemical examination of acid phosphatase and beta-glucuronidase enzymes in low-grade B cell non-Hodgkin's lymphomas.
Lymphoma
Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas.
Lymphoma
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Lymphoma
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Lymphoma
Peripheral T cell lymphoma in adults: morphological and phenotypical study of four cases.
Lymphoma
Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells.
Lymphoma
T-cell lymphomas of the stomach: morphological and immunological studies characterizing two cases of T-cell lymphoma.
Lymphoma
Tartrate resistant acid phosphatase positive splenic lymphoma: a relatively benign condition occurring in a time-space cluster?
Lymphoma
Transformation of hairy cell leukemia to high-grade lymphoma: a case report and review of the literature.
Lymphoma
[A disc electrophoretic study on acid phosphatase in leukemia and lymphoma cells, with special reference to tartrate resistant isozymzymol]
Lymphoma
[Enzyme cytochemical studies of malignant cutaneous lymphomas using simple smear preparations]
Lymphoma
[Evaluation of tartrate-resistant acid phosphatase activity in lymphoma cells of the bone marrow]
Lymphoma
[Malignant lymphoma with "hairy" lymphocytes in the blood and splenomegaly--a new variant of lymphoproliferative diseases]
Lymphoma, B-Cell
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Lymphoma, B-Cell
Dietary protein levels regulated antibacterial activity, inflammatory response and structural integrity in the head kidney, spleen and skin of grass carp (Ctenopharyngodon idella) after challenged with Aeromonas hydrophila.
Lymphoma, B-Cell
Dietary vitamin C deficiency depressed the gill physical barriers and immune barriers referring to Nrf2, apoptosis, MLCK, NF-?B and TOR signaling in grass carp (Ctenopharyngodon idella) under infection of Flavobacterium columnare.
Lymphoma, B-Cell
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Lymphoma, B-Cell
Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma.
Lymphoma, B-Cell
Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma.
Lymphoma, B-Cell
Protective effect of zinc on N-methyl-N-nitrosourea and testosterone-induced prostatic intraepithelial neoplasia in the dorsolateral prostate of Sprague Dawley rats.
Lymphoma, B-Cell
[Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis]
Lymphoma, Follicular
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Lymphoma, Follicular
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Lymphoma, Large B-Cell, Diffuse
Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
Lymphoma, Non-Hodgkin
Abnormalities of esterase and glycogen in developing macrophages in non-Hodgkin's lymphoma: a quantitative cytochemical study.
Lymphoma, Non-Hodgkin
An enzyme histochemical study of non-Hodgkin's lymphoma and allied disease.
Lymphoma, Non-Hodgkin
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Lymphoma, Non-Hodgkin
[Cytochemical analysis of acid phosphatase and beta glucuronidase in B-cell non-Hodgkin's lymphoma of low-grade malignancy]
Lymphoma, T-Cell
Cell surface antigen phenotypes and enzyme expression patterns of two murine T-cell lymphomas derived from early and/or mature thymus cells.
Lymphoma, T-Cell, Cutaneous
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
Lymphoproliferative Disorders
Acid phosphatase and acid esterase activity in neoplastic and non-neoplastic lymphoid cells. A semiquantitative evaluation related to immunological markers in 112 cases.
Lymphoproliferative Disorders
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases.
Lymphoproliferative Disorders
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
Lymphoproliferative Disorders
[Lymphocyte acid phosphatase in several lymphoproliferative disorders preliminary report (author's transl)]
Lymphoproliferative Disorders
[Role of alpha-interferon in the treatment of hairy cell leukemia]
Macular Degeneration
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Magnesium Deficiency
[Effect of magnesium deficiency on activity of lysosomal acid phosphatase in mice lymphocytes]
Malaria
Genetic analysis of two enzyme polymorphisms in a malaria vector mosquito: octanol dehydrogenase and acid phosphatase in Anopheles culicifacies Giles.
Malaria
Phosphatidic acid homeostasis regulated by a type-2 phosphatidic acid phosphatase represents a novel druggable target in malaria intervention.
Malnutrition
Effects of prenatal malnutrition on development of oral tissue in neonatal rats.
Manganese Poisoning
Dihydronicotinamide-adenine dinucleotide (NADH2) diaphorase, thiamine pyrophosphatase and acid phosphatase in the spinal cords of rabbits with chronic manganese poisoning.
Mastitis
The activity of milk leukocytes in response to a water-soluble fraction of Mycobacterium phlei in bovine subclinical mastitis.
Measles
[The cytochemical marking of lymphocyte subpopulations in determining the immunoreactivity status of children vaccinated with a live measles vaccine]
Melanoma
A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics.
Melanoma
Activity of some respiratory and lysosomal enzymes of lymphocytes in golden hamster with induced melanoma.
Melanoma
Effect of trypan blue on the activity of lysosomal enzymes, tumor growth and cell ultrastructure in B16 melanotic melanoma in mice.
Melanoma
Histochemical findings in different types of malignant melanoma: biological and clinical significance.
Melanoma
Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Melanoma
In vitro and in vivo antimelanoma effect of ethyl ester cyclohexyl analog of ethylenediamine dipropanoic acid.
Melanoma
Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study.
Melanoma
Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
Melanoma
Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
Melanoma
Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth.
Melanoma, Amelanotic
Activity of some lysosomal hydrolases in the homogenates of transplantable melanotic and amelanotic melanoma in golden hamster (Mesocricetus auratus, Waterhouse).
Melanoma, Experimental
Differences in induction of lysosomal protease activity by protease inhibitors in B16 melanoma cell lines.
Melanoma, Experimental
Induction and inhibition of cathepsin B and hemoglobin-hydrolase activity in murine B16 melanoma by thiol protease inhibitors.
Memory Disorders
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Meningitis
Acid phosphatase activity of cerebrospinal fluid cells in bacterial and abacterial meningitis.
Meningitis, Aseptic
Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.
Meningitis, Bacterial
CSF lysosomal hydrolase activity as an aid in the diagnosis of bacterial meningitis.
Mercury Poisoning
The effect of experimental methyl mercury poisoning on the distribution of acid phosphatase during autolysis in cat liver.
Metabolic Syndrome
Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome.
Metabolic Syndrome
The adipokine tartrate-resistant acid phosphatase 5a in serum correlates to adipose tissue expansion in obesity.
Metrorrhagia
Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
Microphthalmos
Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Microphthalmos
Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor.
Microphthalmos
The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor.
Microphthalmos
The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter.
Microphthalmos
The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Monoclonal Gammopathy of Undetermined Significance
Enzymecytochemistry and immunohistochemistry in monoclonal gammopathy and reactive plasmacytosis.
Monoclonal Gammopathy of Undetermined Significance
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
Monoclonal Gammopathy of Undetermined Significance
[Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies]
Mouth Neoplasms
[Enzyme and isoenzyme activity in patients with malignant tumors of the oral mucosa]
Mucolipidoses
Electrophoretic analysis of glycoprotein enzymes in the sialidoses and mucolipidoses.
Mucolipidoses
Immunocytochemical localization of lysosomal acid phosphatase in normal and "I-cell" fibroblasts.
Mucolipidoses
Tartrate-inhibitable acid phosphatase. Purification from placenta, characterization and subcellular distribution in fibroblasts.
Mucopolysaccharidoses
Mutant Enzymatic and Cytological Phenotypes in Cultured Human Fibroblasts.
Mucopolysaccharidosis I
Mutant Enzymatic and Cytological Phenotypes in Cultured Human Fibroblasts.
Multiple Endocrine Neoplasia Type 2b
Seminal fructose and acid phosphatase in vasectomised men.
Multiple Myeloma
Activity and intracellular localization of lysosomal acid phosphatase in lymphocytes from patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
Multiple Myeloma
Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher's disease, prostatic carcinoma and multiple myeloma.
Multiple Myeloma
Enzymecytochemistry and immunohistochemistry in monoclonal gammopathy and reactive plasmacytosis.
Multiple Myeloma
Membrane translocation of Bruton kinase in multiple myeloma cells is associated with osteoclastogenic phenotype in bone metastatic lesions.
Multiple Myeloma
Morphological and isoenzymatic differentiation of B-chronic lymphocytic leukaemia cells induced by phorbolester.
Multiple Myeloma
Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients.
Multiple Myeloma
Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglobulinemias.
Multiple Myeloma
Plasma cell acid phosphatase score in multiple myeloma and related disorders.
Multiple Myeloma
Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.
Multiple Myeloma
Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma.
Multiple Myeloma
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Multiple Myeloma
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Multiple Myeloma
Unusual bone metastasis as the initial symptom of gastric cancer--a report of four cases.
Multiple Myeloma
[Biological and clinical significance of plasma-cell acid phosphatase in multiple myeloma]
Multiple Myeloma
[Correlation of cytogenetic changes with VEGF and TRacp-5b levels among 60 elderly patients with multiple myeloma].
Multiple Myeloma
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
Multiple Myeloma
[Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies]
Multiple Sclerosis
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
Multiple Sclerosis
The cellular origin of lysosomal enzymes in the plaque in multiple sclerosis. II. A histochemical study with combined demonstration of myelin and acid phosphatase.
Multiple Sclerosis
[Activity of various lysosomal hydrolases in peripheral blood granulocytes in patients with multiple sclerosis]
Muscular Atrophy
Localization of non-specific esterase and acid phosphatase in human fibroblast from skeletal muscle atrophy.
Muscular Diseases
Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes.
Muscular Diseases
Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis.
Muscular Dystrophies
Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
Muscular Dystrophy, Duchenne
Erythrocyte enzyme allotypes in the X-linked recessive disorders, Duchenne muscular dystrophy and haemophilia-A hemizygotes and heterozygotes.
Myalgia
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
Mycoses
Acid phosphatases in the haemolymph of the desert locust, Schistocerca gregaria, infected with the entomopathogenic fungus Metarhizium anisopliae.
Mycoses
The hydrolytic enzymes produced by fungi strains isolated from the sand and soil of recreational areas
Mycoses
[The histamine-serotonin-monoamine oxidase system in patients with foot mycosis during treatment]
Myeloproliferative Disorders
Platelet lysosomal enzymes are normal in myeloproliferative disorders.
Myeloproliferative Disorders
The value of the ultrastructural pattern of myeloperoxidase (MPO), platelet peroxidase (PPO) and acid phosphatase in identification of blastic cell types during acute transformation of chronic myeloproliferative disorders (cMPD).
Myocardial Infarction
Effect of steroids on cardiac lymph content of lysosomal enzyme acid phosphatase in experimental myocardial infarction.
Myocardial Infarction
Synergistic effect of nicorandil and amlodipine on lysosomal hydrolases during experimental myocardial infarction in rats.
Myocardial Infarction
[Quantitative shifts in acid phosphatase isoenzymes in the blood in myocardial infarct]
Myocardial Infarction
[The determination of acid phosphatase in myocardial infarct and in transient forms of the anginal coronary syndrome]
Myocardial Ischemia
Release of lysosomal enzymes during ischemic injury of canine myocardium.
Myocarditis
[Effects of strophanthin, mefenamic acid and dexamethasone on the inflammatory and reparative processes in the heart in experimental myocarditis]
Myocarditis
[The indices of the proteinase-peroxidase and phosphatase activities of the blood polymorphonuclear leukocytes in the differential diagnosis of dilated cardiomyopathy and idiopathic myocarditis]
Myopia
Lysosomal enzymes in tear fluids from patients with Terrien's marginal corneal degeneration.
Myopia
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Myositis
Enzyme patterns in human endocytotic multinucleate giant cells--a histochemical study.
Myositis
Tartrate-resistant acid phosphatase containing cells in nodular fasciitis, proliferative fasciitis, and proliferative myositis.
Myotonia
Changes of metabolism during experimentally induced myotonia of rats. II. Alterations in creatine kinase and acid phosphatase activities: a possible mechanism in the development of muscle damage.
Necrobiotic Disorders
[Histopathologic and histochemical examination of rat liver after prolonged experimental application of potassium bichromate]
Neoplasm Metastasis
Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate.
Neoplasm Metastasis
Acid phosphatase: its influence on the management of carcinoma of the prostate.
Neoplasm Metastasis
Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
Neoplasm Metastasis
Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer.
Neoplasm Metastasis
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Neoplasm Metastasis
Biochemical markers and skeletal metabolism in carcinoma of the prostate. Use of decision matrix theory and ROC analysis.
Neoplasm Metastasis
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Neoplasm Metastasis
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Neoplasm Metastasis
Bone marrow acid phosphatase by radioimmunoassay: 3 years of experience.
Neoplasm Metastasis
Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Neoplasm Metastasis
Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
Neoplasm Metastasis
Carcinoma of the prostate in childhood and adolescence: report of a case and review of the literature.
Neoplasm Metastasis
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.
Neoplasm Metastasis
Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts.
Neoplasm Metastasis
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Neoplasm Metastasis
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray.
Neoplasm Metastasis
Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
Neoplasm Metastasis
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Neoplasm Metastasis
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Neoplasm Metastasis
Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
Neoplasm Metastasis
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.
Neoplasm Metastasis
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Neoplasm Metastasis
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Neoplasm Metastasis
Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
Neoplasm Metastasis
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
Neoplasm Metastasis
Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Neoplasm Metastasis
Conservative management with symptomatic treatment and delayed hormonal manipulation is justified in men with locally advanced carcinoma of the prostate.
Neoplasm Metastasis
Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
Neoplasm Metastasis
Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
Neoplasm Metastasis
Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
Neoplasm Metastasis
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Neoplasm Metastasis
Diagnostic and therapeutic utility of monoclonal antibodies in urologic oncology.
Neoplasm Metastasis
Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.
Neoplasm Metastasis
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Neoplasm Metastasis
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Neoplasm Metastasis
DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.
Neoplasm Metastasis
Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.
Neoplasm Metastasis
Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation.
Neoplasm Metastasis
Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Neoplasm Metastasis
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Neoplasm Metastasis
Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
Neoplasm Metastasis
Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Neoplasm Metastasis
Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
Neoplasm Metastasis
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Neoplasm Metastasis
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Neoplasm Metastasis
Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy.
Neoplasm Metastasis
Implications of Serum Bone Turnover Markers in Prostate Cancer Patients With Bone Metastasis.
Neoplasm Metastasis
Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.
Neoplasm Metastasis
Initial chemotherapeutic trials in patients with inoperable or recurrent cancer of the prostate.
Neoplasm Metastasis
Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
Neoplasm Metastasis
Leiomyosarcoma of the heart and its pulmonary metastasis, both with prominent osteoclast-like multinucleated giant cells expressing tartrate-resistant acid phosphatase activity.
Neoplasm Metastasis
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group.
Neoplasm Metastasis
Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group.
Neoplasm Metastasis
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinoma.
Neoplasm Metastasis
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ? Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
Neoplasm Metastasis
MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Neoplasm Metastasis
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Neoplasm Metastasis
Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Neoplasm Metastasis
Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.
Neoplasm Metastasis
Modulation of acid phosphatase and lactic dehydrogenase in hexachlorocyclohexane-induced hepatocarcinogenesis in mice.
Neoplasm Metastasis
MULTIMODAL IMAGING AND HISTOLOGIC CORRELATION OF ISOLATED METASTASIS OF PROSTATE ADENOCARCINOMA TO THE CHOROID.
Neoplasm Metastasis
Nodal involvement as a prognostic indicator in patients with prostatic carcinoma.
Neoplasm Metastasis
Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary?
Neoplasm Metastasis
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Neoplasm Metastasis
Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
Neoplasm Metastasis
Predicting the probability of bone metastasis through histological grading of prostate carcinoma: a retrospective correlative analysis of 81 autopsy cases with antemortem transurethral resection specimen.
Neoplasm Metastasis
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Neoplasm Metastasis
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Neoplasm Metastasis
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
Neoplasm Metastasis
Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer.
Neoplasm Metastasis
Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Neoplasm Metastasis
Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data.
Neoplasm Metastasis
Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Neoplasm Metastasis
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
Neoplasm Metastasis
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Neoplasm Metastasis
Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Neoplasm Metastasis
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Neoplasm Metastasis
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.
Neoplasm Metastasis
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Neoplasm Metastasis
Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
Neoplasm Metastasis
Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
Neoplasm Metastasis
Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Neoplasm Metastasis
Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909-1963.
Neoplasm Metastasis
Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
Neoplasm Metastasis
Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Neoplasm Metastasis
Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
Neoplasm Metastasis
Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase.
Neoplasm Metastasis
Retroperitoneal metastatic disease due to carcinoma of the prostate: value of serum prostatic acid phosphatase in identifying retroperitoneal metastasis originating from carcinoma of prostate.
Neoplasm Metastasis
Seeding and perineal implantation of prostatic cancer in the track of the biopsy needle: three case reports and a review of the literature.
Neoplasm Metastasis
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Neoplasm Metastasis
Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.
Neoplasm Metastasis
Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
Neoplasm Metastasis
Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Neoplasm Metastasis
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Neoplasm Metastasis
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Neoplasm Metastasis
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Neoplasm Metastasis
Serum TPS, PSA, and PAP values in relapsing stage D2 adenocarcinoma of the prostate.
Neoplasm Metastasis
Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
Neoplasm Metastasis
Spongious bone density determination for staging and follow-up of patients with prostatic cancer.
Neoplasm Metastasis
Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Neoplasm Metastasis
Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
Neoplasm Metastasis
Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF?2/T?R and CD44 in MDA-MB-231 breast cancer cells.
Neoplasm Metastasis
Tartrate-resistant Acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear ?B ligand.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
Neoplasm Metastasis
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Neoplasm Metastasis
The assessment of disease aggressivity in stage D2 prostate cancer patients (review).
Neoplasm Metastasis
The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications.
Neoplasm Metastasis
The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy.
Neoplasm Metastasis
The prognostic significance of histological grading and pathological staging in carcinoma of the prostate.
Neoplasm Metastasis
The risk of dying of prostate cancer in patients with clinically localized disease.
Neoplasm Metastasis
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Neoplasm Metastasis
The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
Neoplasm Metastasis
The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
Neoplasm Metastasis
The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
Neoplasm Metastasis
The staging of M1 disease: the role of bone scan, Xray and other imaging techniques.
Neoplasm Metastasis
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.
Neoplasm Metastasis
Treatment of advanced prostatic cancer with anti-androgens alone and a combination of anti-androgen with anti-prolactin--a pilot study.
Neoplasm Metastasis
Tumor Necrosis Factor-? Produced by Osteoclasts Might Induce Intractable Pain in a Rat Spinal Metastasis Model of Breast Cancer.
Neoplasm Metastasis
Unusual bone metastasis as the initial symptom of gastric cancer--a report of four cases.
Neoplasm Metastasis
Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Neoplasm Metastasis
Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Neoplasm Metastasis
Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
Neoplasm Metastasis
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
Neoplasm Metastasis
[Clinical analysis and treatment of carcinoma of the prostate with bone metastasis]
Neoplasm Metastasis
[Clinical assessments on pre-treatment prognostic factors in 138 patients with advanced prostatic carcinoma (stage D2)]
Neoplasm Metastasis
[Clinical course of bone metastases by prostatic cancer studies with conventional X-ray]
Neoplasm Metastasis
[Clinical studies on endocrine therapy for prostatic carcinoma (5): Analyses of relapse from endocrine therapy]
Neoplasm Metastasis
[Correlation of vessel invasion and bone metastasis in prostatic adenocarcinoma. A clinico-pathological and immunohistochemical study of 33 cases of total prostatectomy]
Neoplasm Metastasis
[Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]
Neoplasm Metastasis
[Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma]
Neoplasm Metastasis
[Mucinous adenocarcinoma of the prostatic gland. Histochemical and immunohistochemical studies]
Neoplasm Metastasis
[Ophthalmoplegia in a patient with prostate cancer and bone metastases]
Neoplasm Metastasis
[PREVENTION OF THE BONES METASTASES OCCURRENCE IN THE PATIENTS WITH RENAL-CELL CANCER].
Neoplasm Metastasis
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
Neoplasm Metastasis
[Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy]
Neoplasm Metastasis
[TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
Neoplasm Metastasis
[Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer]
Neoplasm Metastasis
[The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)]
Neoplasm Metastasis
[The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]
Neoplasm, Residual
Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8.
Neoplasms
"Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin.
Neoplasms
8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.
Neoplasms
A Case of a Malignant Cutaneous Mixed Tumor (Chondroid Syringoma) of the Scapula Treated With Staged Margin-Controlled Excision.
Neoplasms
A combined approach to data mining of textual and structured data to identify cancer-related targets.
Neoplasms
A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A.
Neoplasms
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
Neoplasms
A methacrylate embedding technique for combined autoradiography and acid phosphatase histochemistry.
Neoplasms
A multivariate approach to the description of patient populations. An example of the analysis of the hormone profiles of patients with advanced prostate cancer.
Neoplasms
A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate.
Neoplasms
A Novel Screening Method to Establish Tumor-targeting Antibodies Reliable for Drug Delivery System.
Neoplasms
A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
Neoplasms
A report of the workshops on the current status of the histologic grading of prostate cancer.
Neoplasms
A single application of hydrogen sulphide induces a transient osteoclast differentiation with RANKL expression in the rat model.
Neoplasms
A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis.
Neoplasms
A study of the acid phosphatase in the cells of bone and soft parts tumors, and of other tumorous conditions.
Neoplasms
Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases.
Neoplasms
Acid phosphatase and non-specific alpha-naphthol acetate esterase activities of monocytes in patients with cancer of the digestive tract during surgical treatment.
Neoplasms
Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Neoplasms
Acid phosphatase in the blood serum of male patients with tumours of the genito-urinary tract.
Neoplasms
Acid phosphatase response in murine rhabdomyosarcoma for various tumour volumes and after different doses of neutron irradiation, alone or combined with exogenous ATP.
Neoplasms
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Neoplasms
Activity of some lysosomal enzymes in neutrophils from peripheral blood of patients with digestive tract cancer at different clinical stages of the disease. A cytochemical study.
Neoplasms
Activity of some lysosomal hydrolases in the homogenates of transplantable melanotic and amelanotic melanoma in golden hamster (Mesocricetus auratus, Waterhouse).
Neoplasms
Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread.
Neoplasms
An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells.
Neoplasms
An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
Neoplasms
An unusual variant of prostatic adenocarcinoma with metastasis to testis.A case report.
Neoplasms
Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group.
Neoplasms
Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.
Neoplasms
Anti-arthritic effect of pentosan polysulfate in rats with collagen-induced arthritis.
Neoplasms
Anti-Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma.
Neoplasms
Antigen Specific T-Cell Responses Against Tumor Antigens are Controlled by Regulatory T Cells in Patients With Prostate Cancer.
Neoplasms
Ascorbic acid and dehydroascorbic acid in HeLa cells: their effect on the collagen-peptidase activity of glucose-deficient cultures.
Neoplasms
Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations.
Neoplasms
Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug.
Neoplasms
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.
Neoplasms
Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
Neoplasms
B lymphocytic lymphoma (large cell) of possible splenic marginal zone origin presenting with prominent splenomegaly and unusual cordal red pulp distribution.
Neoplasms
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Neoplasms
Biochemical and electrophoretic properties of acid phosphatase isozymes and their distribution in cell functions from neoplastic prostatic tissues.
Neoplasms
Biochemical and immunological relationships of prostatic and leukocytic acid phosphatases and their subcellular localization.
Neoplasms
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
Neoplasms
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Neoplasms
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex).
Neoplasms
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Neoplasms
Biopsy of the prostate guided by transrectal ultrasonography: early experience in a teaching community hospital.
Neoplasms
Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.
Neoplasms
Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
Neoplasms
Bone formation and resorption markers as diagnostic tools for bone metastases evaluation.
Neoplasms
Bone turnover mediates preferential localization of prostate cancer in the skeleton.
Neoplasms
Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.
Neoplasms
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer.
Neoplasms
Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
Neoplasms
Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Neoplasms
Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Neoplasms
Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Neoplasms
Carcinoma of the prostate in childhood and adolescence: report of a case and review of the literature.
Neoplasms
Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
Neoplasms
Carcinoma of the prostate with soft tissue or non-regional lymphatic metastases at the time of diagnosis: a review of 47 cases.
Neoplasms
Carcinomas metastatic to follicular adenomas of the thyroid gland. Report of two cases.
Neoplasms
Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
Neoplasms
Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells.
Neoplasms
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
Neoplasms
Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
Neoplasms
Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
Neoplasms
Characterization of macrophage cell line A640-BB-2: A640-BB-2 resembles peritoneal exudate macrophages in cell morphology, tumor cell recognition, responsiveness to immunomodulator OK-432 and lysosomal enzyme activity.
Neoplasms
Characterization of two spliced variants of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells.
Neoplasms
Chemotherapy in metastatic, hormone refractory prostatic cancer using chlorambucil in combination with prednisolone versus conjugate, prednimustine (Leo 1031).
Neoplasms
Chlorella vulgaris or Spirulina platensis mitigate lead acetate-induced testicular oxidative stress and apoptosis with regard to androgen receptor expression in rats.
Neoplasms
Cholesterol embolism of bone marrow clinically masquerading as systemic or metastatic tumor.
Neoplasms
Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17 and LPIN2 genes.
Neoplasms
Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
Neoplasms
Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Neoplasms
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Neoplasms
Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts.
Neoplasms
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach.
Neoplasms
Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
Neoplasms
Clinical laboratory procedures in cancer diagnosis; serum prostatic acid phosphatase and vaginal fluid beta-glucuronidase.
Neoplasms
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Neoplasms
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
Neoplasms
Comparative analysis of fluctuation of serum tumor markers in advanced cancer of prostate.
Neoplasms
Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
Neoplasms
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Neoplasms
Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Neoplasms
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Neoplasms
Comparison of tartrate resistant acid phosphatase in a giant cell bone tumor and a spleen infiltrated with hairy cells.
Neoplasms
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Neoplasms
Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant acid phosphatase.
Neoplasms
Conversion of immunosuppressive monotherapy from cyclosporin a to tacrolimus reverses bone loss in rats.
Neoplasms
Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate.
Neoplasms
Correlation of Serum CCL3/MIP-1? Levels with Disease Severity in Postmenopausal Osteoporotic Females
Neoplasms
Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
Neoplasms
Cytochemical analysis of acid hydrolases expression during phorbol diester (TPA)-driven differentiation of B-chronic lymphocytic leukaemia cells in vitro.
Neoplasms
Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
Neoplasms
Cytochemical study of neutrophils from peripheral blood of patients with lung cancer.
Neoplasms
Cytoenzymology of benign and malignant tumours of the corpus uteri. II. Lysosomal enzymes in relation to Golgi apparatus.
Neoplasms
Deficiency of dietary niacin impaired intestinal mucosal immune function via regulating intestinal NF-?B, Nrf2 and MLCK signaling pathways in young grass carp (Ctenopharyngodon idella).
Neoplasms
Dendritic reticulum cell sarcoma? Four cases of a lymphoma probably derived from dendritic reticulum cells of the follicular compartment.
Neoplasms
Deoxynivalenol decreased intestinal immune function related to NF-?B and TOR signalling in juvenile grass carp (Ctenopharyngodon idella).
Neoplasms
Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
Neoplasms
Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.
Neoplasms
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Neoplasms
Development of seven new human prostate tumor xenograft models and their histopathological characterization.
Neoplasms
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
Neoplasms
Dietary alpha-linolenic acid/linoleic acid ratios modulate immune response, physical barrier and related signaling molecules mRNA expression in the gills of juvenile grass carp (Ctenopharyngodon idella).
Neoplasms
Dietary alpha-linolenic acid/linoleic acid ratios modulate intestinal immunity, tight junctions, anti-oxidant status and mRNA levels of NF-?B p65, MLCK and Nrf2 in juvenile grass carp (Ctenopharyngodon idella).
Neoplasms
Dietary biotin deficiency decreased growth performance and impaired the immune function of the head kidney, spleen and skin in on-growing grass carp (Ctenopharyngodon idella).
Neoplasms
Dietary choline deficiency and excess induced intestinal inflammation and alteration of intestinal tight junction protein transcription potentially by modulating NF-?B, STAT and p38 MAPK signaling molecules in juvenile Jian carp.
Neoplasms
Dietary gossypol reduced intestinal immunity and aggravated inflammation in on-growing grass carp (Ctenopharyngodon idella).
Neoplasms
Dietary pyridoxine deficiency reduced growth performance and impaired intestinal immune function associated with TOR and NF-?B signalling of young grass carp (Ctenopharyngodon idella).
Neoplasms
Dietary vitamin C deficiency depresses the growth, head kidney and spleen immunity and structural integrity by regulating NF-?B, TOR, Nrf2, apoptosis and MLCK signaling in young grass carp (Ctenopharyngodon idella).
Neoplasms
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Neoplasms
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Neoplasms
Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma.
Neoplasms
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Neoplasms
DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.
Neoplasms
Does the pleomorphic xanthoastrocytoma exist? Problems in the application of immunological techniques to the classification of brain tumors.
Neoplasms
Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.
Neoplasms
Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
Neoplasms
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Neoplasms
Effect of administering cyclophosphamide and vitamin E on the levels of tumor-marker enzymes in rats with experimentally induced fibrosarcoma.
Neoplasms
Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity.
Neoplasms
Effect of constituents from samaras of Austroplenckia populnea (Celastraceae) on human cancer cells.
Neoplasms
Effect of dietary astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus).
Neoplasms
Effect of hormone treatment on prostatic acid phosphatase in a serially transplantable human prostatic adenocarcinoma (PC-82).
Neoplasms
Effect of Magnesium Supplementation on Circulating Biomarkers of Cardiovascular Disease.
Neoplasms
Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Neoplasms
Effect of photoperiod on growth performance and quality characteristics of tibia and femur in layer ducks during the pullet phase.
Neoplasms
Effect of Propionibacterium acnes or BCG on enzyme activities in spleen lymphocytes of Donryu strain rats.
Neoplasms
Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
Neoplasms
Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progression.
Neoplasms
Effects of alkaloids from Sophora flavescens on osteoblasts infected with Staphylococcus aureus and osteoclasts.
Neoplasms
Effects of the cathepsin K inhibitor with mineral trioxide aggregate cements on osteoclastic activity.
Neoplasms
Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats.
Neoplasms
Effects of tumour cell culture supernatants on some biochemical activities of macrophages.
Neoplasms
Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.
Neoplasms
Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Neoplasms
Enhanced therapeutic benefit of quercetin-loaded phytosome nanoparticles in ovariectomized rats.
Neoplasms
Enhancement of osteogenesis post-splenectomy does not attenuate bone loss in ovariectomized rats.
Neoplasms
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement.
Neoplasms
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Neoplasms
Enzyme activity profiles in mouse teratocarcinomas. A quantitative ultramicroscale analysis.
Neoplasms
Enzyme histochemical studies on transplantable pancreatic adenocarcinomas in Syrian golden hamsters.
Neoplasms
Enzyme histochemistry is useful to assess viability of tumor tissue after microwave coagulation therapy (MCT): metastatic adenocarcinoma treated by lateral segmentectomy after MCT.
Neoplasms
Establishment and characterization of transplantable tumor derived from a spontaneous malignant fibrous histiocytoma in the mouse.
Neoplasms
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Neoplasms
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Neoplasms
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Neoplasms
Evaluation the effect of thiamin deficiency on intestinal immunity of young grass carp (Ctenopharyngodon idella).
Neoplasms
Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties.
Neoplasms
Exogenous phospholipids supplementation improves growth and modulates immune response and physical barrier referring to NF-?B, TOR, MLCK and Nrf2 signaling factors in the intestine of juvenile grass carp (Ctenopharyngodon idella).
Neoplasms
Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
Neoplasms
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases.
Neoplasms
Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.
Neoplasms
Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies.
Neoplasms
Extraskeletal osteoclastomas responsive to dexamethasone treatment in Paget bone disease.
Neoplasms
FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors.
Neoplasms
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophy.
Neoplasms
Fertaric Acid Protects from Octylphenol-Related Hepatotoxicity in Rats: Biochemical, Molecular, and Histopathological Studies.
Neoplasms
Fine structural localisation of acid phosphatase in neural tumours induced by N-ethyl-N-nitrosourea in rats.
Neoplasms
Fine-needle aspiration of metastatic prostatic neuroendocrine carcinomas: cytomorphologic and immunophenotypic features.
Neoplasms
Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumours of bone.
Neoplasms
Gene Expression in Osteolysis: Review on the Identification of Altered Molecular Pathways in Preclinical and Clinical Studies.
Neoplasms
Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Neoplasms
Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis.
Neoplasms
Giant cell tumor of bone. Variations in patterns of appearance of different cell types.
Neoplasms
Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Neoplasms
Giant dumbbell-shaped prostatic cystadenoma presenting as pelvic and scrotal mass.
Neoplasms
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies.
Neoplasms
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Neoplasms
Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells.
Neoplasms
Heterogeneity and prognostic significance of macrophages in human colonic carcinomas.
Neoplasms
Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
Neoplasms
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Neoplasms
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
Neoplasms
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.
Neoplasms
Histochemical and immunohistochemical characterization of cells constituting the giant cell tumor of bone.
Neoplasms
HISTOCHEMICAL DIFFERENTIATION OF CARCINOMA OF THE PROSTATE GLAND FROM OTHER TUMORS BY A MODIFIED ACID PHOSPHATASE REACTION.
Neoplasms
Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.
Neoplasms
HISTOCHEMICAL STUDIES ON ALKALINE AND ACID PHOSPHATASE IN THE LIVERS OF TWENTY-SEVEN PATIENTS OPERATED ON FOR CANCERS OF THE ABDOMINAL ORGANS.
Neoplasms
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Neoplasms
Histogenesis of Kaposi's sarcoma associated with AIDS: a histologic, immunohistochemical and enzyme histochemical study.
Neoplasms
Histological grading, histochemistry, and electron microscopy of scirrhous carcinoma of the breast.
Neoplasms
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Neoplasms
Human cytokine response to Texas crotaline envenomation before and after antivenom administration.
Neoplasms
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Neoplasms
Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study.
Neoplasms
Hydrogen sulfide regulates bone remodeling and promotes orthodontic tooth movement.
Neoplasms
I?BET151 inhibits osteoclastogenesis via the RANKL signaling pathway in RAW264.7 macrophages.
Neoplasms
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.
Neoplasms
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.
Neoplasms
Identification of elicitor-responsive proteins in rice leaves by a proteomic approach.
Neoplasms
Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Neoplasms
Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer.
Neoplasms
Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
Neoplasms
Immunofluorescent identification of antibodies specific for prostatic acid phosphatase.
Neoplasms
Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
Neoplasms
Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
Neoplasms
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Neoplasms
Immunological and biochemical evidence for identity of tartrate-resistant isoenzymes of acid phosphatases from human serum and tissues.
Neoplasms
Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients.
Neoplasms
Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice.
Neoplasms
Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody.
Neoplasms
Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain.
Neoplasms
Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.
Neoplasms
Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy.
Neoplasms
Increasing Dietary Fish Oil Reduces Adiposity and Mitigates Bone Deterioration in Growing C57BL/6 Mice Fed a High-Fat Diet.
Neoplasms
Induction of autoimmune arthritis after direct injection of bone marrow cells from arthritis-prone SKG/Jcl mice into bone cavity of normal mice.
Neoplasms
Induction of tumor specific cytotoxic T lymphocytes in prostate cancer using prostatic acid phosphatase derived HLA-A2402 binding peptide.
Neoplasms
Infiltration by macrophages and lymphocytes in transplantable mouse sarcoma after irradiation with high-intensity focused ultrasound.
Neoplasms
Inflammation with restricted lysosomal proteolysis during early ascites carcinoma invasion of mouse parietal peritoneum. A medium and high-voltage electron microscopic and cytochemical study.
Neoplasms
Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy.
Neoplasms
Influence of adjuvant therapy with green tea extract in the treatment of experimental periodontitis.
Neoplasms
Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
Neoplasms
Influence of tumor grade on survival and on serum acid phosphatase levels in metastatic carcinoma of the prostate.
Neoplasms
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards.
Neoplasms
Interaction of tumor and surrounding tissue of mice inoculated B16 melanoma variants in terms of enzyme activity.
Neoplasms
Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Neoplasms
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Neoplasms
Intermittent therapy with 1,25 vitamin D and calcitonin prevents cyclosporin-induced alveolar bone loss in rats.
Neoplasms
Intracellular enzymatic response of lymphocytes and neutrophils in patients with cancer of the larynx.
Neoplasms
Intravesical botryoid adenocarcinoma of the prostate: report of an unusual growth pattern of prostatic carcinoma simulating a urinary bladder tumor.
Neoplasms
Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo.
Neoplasms
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Neoplasms
Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
Neoplasms
Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
Neoplasms
KLF2 (kruppel like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Neoplasms
Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.
Neoplasms
Lipin-1 determines lung cancer cell survival and chemotherapy sensitivity by regulation of endoplasmic reticulum homeostasis and autophagy.
Neoplasms
Localization of parathyroid hormone-related protein in osteoclasts by in situ hybridization and immunohistochemistry.
Neoplasms
Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.
Neoplasms
Low or excess levels of dietary cholesterol impaired immunity and aggravated inflammation response in young grass carp (Ctenopharyngodon idella).
Neoplasms
Lymphangiography and fine-needle aspiration biopsy: ineffective for staging early prostate cancer.
Neoplasms
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Neoplasms
Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
Neoplasms
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ? Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
Neoplasms
Lysosomal acid phosphatase: activity and isoenzymes in separated normal human blood cells.
Neoplasms
Lysosomal enzymes in macrophages of colonic tumors induced in rats by 1,2-dimethylhydrazine dihydrochloride.
Neoplasms
Lysosomal enzymes in peripheral blood lymphocytes of patients with gastric cancer.
Neoplasms
Magnolol prevents ovariectomy?induced bone loss by suppressing osteoclastogenesis via inhibition of the nuclear factor??B and mitogen?activated protein kinase pathways.
Neoplasms
Malignant giant cell tumor of bone. Fine structure and localization of acid phosphatase.
Neoplasms
Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases.
Neoplasms
Malignant histiocytosis and related tumors. A clinicopathologic study of 42 cases using cytological, histochemical and ultrastructural parameters.
Neoplasms
Malignant histiocytosis. Immunohistochemical characterization on paraffin embedded tissue.
Neoplasms
Malignant lymphoma of true histiocytic origin: histiocytic sarcoma. A morphological, ultrastructural, immunological, cytochemical and clinical study of 10 cases.
Neoplasms
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases.
Neoplasms
Malignant neuroendocrine tumor of the jejunum with osteoclast-like giant cells. Enzyme histochemistry distinguishes tumor cells from giant cells.
Neoplasms
Management of high risk metastatic prostate cancer: the case for novel therapies.
Neoplasms
Manganese deficiency or excess caused the depression of intestinal immunity, induction of inflammation and dysfunction of the intestinal physical barrier, as regulated by NF-?B, TOR and Nrf2 signalling, in grass carp (Ctenopharyngodon idella).
Neoplasms
MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Neoplasms
Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
Neoplasms
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Neoplasms
Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Neoplasms
Measurement of eicosanoid release in keratinocyte cultures to investigate skin irritation and tumour promoting activity.
Neoplasms
Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Neoplasms
Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.
Neoplasms
Metabolomics analysis of the therapeutic effects of Qiwei Tongbi oral liquid on rheumatoid arthritis in rats.
Neoplasms
Microphotometric quantitation of enzyme activities in giant cell tumor of bone. A case study.
Neoplasms
Modification of the effects of hyperthermia and neutron radiation on the activity of acid phosphatase in CaNT tumors.
Neoplasms
Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.
Neoplasms
Molecular cloning of two alternatively spliced forms of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells.
Neoplasms
Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
Neoplasms
Morphometric and ultrastructure features of the ventral prostate of rats (Rattus norvegicus) submitted to long-term nicotine treatment.
Neoplasms
Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate.
Neoplasms
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Neoplasms
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Neoplasms
Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.
Neoplasms
Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy.
Neoplasms
Multivariate analysis of plasma hormones in patients with metastatic prostate cancer receiving combined LHRH-analog and antiandrogen therapy.
Neoplasms
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
Neoplasms
Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
Neoplasms
Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis.
Neoplasms
Neuroendocrine tumors of the liver and pancreas associated with elevated serum prostatic acid phosphatase.
Neoplasms
New hypotheses on the function of the avian shell gland derived from microarray analysis comparing tissue from juvenile and sexually mature hens.
Neoplasms
New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
Neoplasms
Nonsurgical management of patients with stage D1 adenocarcinoma of prostate: risks vs benefits.
Neoplasms
Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.
Neoplasms
Novel insights into the intestinal immune regulatory effects of (2-Carboxyethyl) dimethylsulfonium Bromide (Br-DMPT) in on-growing grass carp (Ctenopharyngodon idella).
Neoplasms
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.
Neoplasms
Nuclear binding of androgens and acid phosphatase activity in prostatic tumors of Nb rats.
Neoplasms
Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.
Neoplasms
On low acid phosphatase values of patients with known metastatic cancer of the prostate.
Neoplasms
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
Neoplasms
Optimal ?-lipoic acid strengthen immunity of young grass carp (Ctenopharyngodon idella) by enhancing immune function of head kidney, spleen and skin.
Neoplasms
Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression.
Neoplasms
Osteoclast origin of giant cells in giant cell tumors of bone: ultrastructural and cytochemical study of six cases.
Neoplasms
Osteopenic effects of high-fat diet-induced obesity on mechanically induced alveolar bone remodeling.
Neoplasms
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.
Neoplasms
Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.
Neoplasms
Papillary adenocarcinoma of the male urethra. Case report and review of the literature.
Neoplasms
Papillary carcinoma of the prostate, location, morphology, and immunohistochemistry: the histogenesis and entity of so-called endometrioid carcinoma.
Neoplasms
Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation.
Neoplasms
Paraganglioma of the prostatic urethra. A report of three cases and a review of the literature.
Neoplasms
Pathological changes on human breast cancer specimens ablated in vitro with high-intensity focused ultrasound.
Neoplasms
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
Neoplasms
Phenotypic heterogeneity of human T-cell malignancies: demonstration by monoclonal antibodies and cytochemical markers.
Neoplasms
Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.
Neoplasms
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.
Neoplasms
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Neoplasms
Porous titanium granules promote bone healing and growth in rabbit tibia peri-implant osseous defects.
Neoplasms
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Neoplasms
Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Neoplasms
Predication of the effect of carcinostatic agents on tumor-bearing host by the sensitivity test using acid phosphatase activity in vitro.
Neoplasms
Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Neoplasms
Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Neoplasms
Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study.
Neoplasms
Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men.
Neoplasms
Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report.
Neoplasms
Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen.
Neoplasms
Primary prostatic endodermal sinus tumor (yolk sac tumor) combined with a small focal seminoma.
Neoplasms
Primary signet ring cell carcinoma of the prostate: report and review of 42 cases.
Neoplasms
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.
Neoplasms
Prognostic factors in progression-free survival and corrected survival in patients with advanced prostatic cancer: results from a randomized study comprising 150 patients treated with orchiectomy or estrogens.
Neoplasms
Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Neoplasms
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Neoplasms
Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood.
Neoplasms
Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Neoplasms
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Neoplasms
Prostate specific antigen progression rates after radical prostatectomy or radiation therapy for localized prostate cancer.
Neoplasms
Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
Neoplasms
Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.
Neoplasms
Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
Neoplasms
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Neoplasms
Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study.
Neoplasms
Prostatic acid phosphatase in the serially transplantable human prostatic tumor lines PC-82 and PC-EW.
Neoplasms
Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma.
Neoplasms
Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice.
Neoplasms
Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings.
Neoplasms
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Neoplasms
Prostatic cancer. VII. Serum acid phosphatase response to cholinergic stimulation in prostatic cancer patients.
Neoplasms
Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Neoplasms
Prostatic carcinoma with endocrine features. A report of a neoplasm containing multiple immunoreactive hormonal substances.
Neoplasms
Prostatic origin of fucosyl transferase in human seminal plasma--a study on healthy controls and on men with infertility or with prostatic cancer.
Neoplasms
Prostatic serum acid phosphatase level in cancer of the prostate; diagnostic and clinical significance as illustrated by thirteen case histories.
Neoplasms
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Neoplasms
Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer.
Neoplasms
Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs.
Neoplasms
Protective Effect of Origanum Oil on Alterations of Some Trace Elements and Antioxidant Levels Induced by Mercuric Chloride in Male Rats.
Neoplasms
Protective effect of the effective part of Andrographis paniculata (Burm.f.) Nees on PM2.5-induced lung injury in rats by modulating the NF-?B pathway.
Neoplasms
Protective effect of zinc on N-methyl-N-nitrosourea and testosterone-induced prostatic intraepithelial neoplasia in the dorsolateral prostate of Sprague Dawley rats.
Neoplasms
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA Approved Therapeutic Cancer Vaccine.
Neoplasms
Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Neoplasms
Putrescine enhances intestinal immune function and regulates intestinal bacteria in weaning piglets.
Neoplasms
Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Neoplasms
Quantitative peroxidase-antiperoxidase complex-substrate mass determination in tissue sections by a dual wavelength method.
Neoplasms
R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer.
Neoplasms
R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
Neoplasms
Radiation therapy in the management of localized carcinoma of the prostate: a preliminary report.
Neoplasms
Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results.
Neoplasms
Radical prostatectomy or radiotherapy in carcinoma of prostate. The dilemma continues.
Neoplasms
Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Neoplasms
Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
Neoplasms
Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer.
Neoplasms
Receiver operator characteristic (ROC) curves and non-normal data: an empirical study.
Neoplasms
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
Neoplasms
Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression.
Neoplasms
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?
Neoplasms
Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason grading system.
Neoplasms
RENAL ORIGIN OF URINARY ACID PHOSPHATASE IN NORMAL AND IN PATIENTS WITH CANCER OF THE PROSTATE.
Neoplasms
Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer.
Neoplasms
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.
Neoplasms
Resolution of bony metastases after bilateral orchiectomy for carcinoma of prostate.
Neoplasms
Responses to Cytokine Inhibitors Associated with Cellular Composition in Models of Immune-Mediated Inflammatory Arthritis.
Neoplasms
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
Neoplasms
Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
Neoplasms
Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer.
Neoplasms
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
Neoplasms
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Neoplasms
Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Neoplasms
Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.
Neoplasms
Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Neoplasms
Serum and seminal markers in the diagnosis of disorders of the genital tract of the dog: a mini-review.
Neoplasms
Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Neoplasms
Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.
Neoplasms
Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
Neoplasms
Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.
Neoplasms
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Neoplasms
Serum total acid phosphatase for monitoring the clinical course of giant cell tumors of bone--26 patients with 5 local recurrences.
Neoplasms
Similarities between giant cell tumor of bone, giant cell tumor of tendon sheath, and pigmented villonodular synovitis concerning ultrastructural cytochemical features of multinucleated giant cells and mononuclear stromal cells.
Neoplasms
Single-step purification of prostatic acid phosphatase: immunoaffinity chromatography with a monoclonal antibody.
Neoplasms
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Neoplasms
Skene's gland adenocarcinoma with intestinal differentiation: A case report and literature review.
Neoplasms
Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients.
Neoplasms
Sodium butyrate improved intestinal immune function associated with NF-?B and p38MAPK signalling pathways in young grass carp (Ctenopharyngodon idella).
Neoplasms
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Neoplasms
Some biochemical characteristics of hormone-secreting pituitary tumors and of the host's anterior pituitary gland.
Neoplasms
Some factors other than neoplasms altering the prostatic fraction of acid phosphatase in the serum.
Neoplasms
Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates.
Neoplasms
Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Neoplasms
Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-?B pathways.
Neoplasms
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.
Neoplasms
Structural Characterization and Immunostimulatory Activity of a Homogeneous Polysaccharide from Sinonovacula constricta.
Neoplasms
Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.
Neoplasms
Studies of estrogen induced renal tumours in male Syrian hamsters. I. Cytochemical studies of lysosomal enzymes acid phosphatase and beta-glucuronidase.
Neoplasms
Studies on acid phosphatase isoenzymes in tumors of bone and soft parts (author's transl)]
Neoplasms
Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Neoplasms
Successful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report.
Neoplasms
Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Neoplasms
Surface engineering of titanium substrates with chitosan-atorvastatin conjugate for reduced inflammation responses and improved cytocompatibility.
Neoplasms
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
Neoplasms
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.
Neoplasms
Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats.
Neoplasms
Targeted therapy for prostate cancer: the Memorial Sloan-Kettering Cancer Center approach.
Neoplasms
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF?2/T?R and CD44 in MDA-MB-231 breast cancer cells.
Neoplasms
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.
Neoplasms
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Neoplasms
Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear ?B ligand.
Neoplasms
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
Neoplasms
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Neoplasms
Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression.
Neoplasms
Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
Neoplasms
Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis.
Neoplasms
The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
Neoplasms
The application of prostate specific membrane antigen in CART?cell therapy for treatment of prostate carcinoma (Review).
Neoplasms
The assessment of disease aggressivity in stage D2 prostate cancer patients (review).
Neoplasms
The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.
Neoplasms
The effect of human cytomegalovirus on selected functions of peripheral blood monocytes.
Neoplasms
The effect of treatment with 4-hydroxyandrostenedione or medroxyprogesterone acetate on human breast tumour regression.
Neoplasms
The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor.
Neoplasms
The effects of some tumor markers on human erythrocyte (HCA-I and HCA-II), bovine erythrocyte (BCA) and bovine lung (CA-IV) carbonic anhydrase enzyme activities in vitro.
Neoplasms
The efficacy of serum prostate specific antigen as a tumour marker in prostatic carcinoma: a comparison with serum acid phosphatase.
Neoplasms
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
Neoplasms
The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.
Neoplasms
The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
Neoplasms
The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
Neoplasms
The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry.
Neoplasms
The impaired intestinal mucosal immune system by valine deficiency for young grass carp (Ctenopharyngodon idella) is associated with decreasing immune status and regulating tight junction proteins transcript abundance in the intestine.
Neoplasms
The improved growth performance and enhanced immune function by DL-methionyl-DL-methionine are associated with NF-?B and TOR signalling in intestine of juvenile grass carp (Ctenopharyngodon idella).
Neoplasms
The Influence of Bone Type on the Gene Expression in Normal Bone and at the Bone-Implant Interface: Experiments in Animal Model.
Neoplasms
The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction.
Neoplasms
The loss of NDRG2 expression improves depressive behavior through increased phosphorylation of GSK3?.
Neoplasms
The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1.
Neoplasms
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinoma.
Neoplasms
The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer.
Neoplasms
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Neoplasms
The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
Neoplasms
The role of ?-zearalanol in reversing bone loss induced by ovarian hormone deficiency in rats.
Neoplasms
The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling.
Neoplasms
The role of new modalities in the early detection and diagnosis of prostate cancer.
Neoplasms
The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
Neoplasms
The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
Neoplasms
The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
Neoplasms
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Neoplasms
The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
Neoplasms
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
Neoplasms
The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue.
Neoplasms
The ultrastructural localization of secretory acid phosphatase in giant cell tumor of bone.
Neoplasms
The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature.
Neoplasms
The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.
Neoplasms
The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
Neoplasms
The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
Neoplasms
Thiamin deficiency induces impaired fish gill immune responses, tight junction protein expression and antioxidant capacity: Roles of the NF-?B, TOR, p38 MAPK and Nrf2 signaling molecules.
Neoplasms
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.
Neoplasms
Topical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling.
Neoplasms
Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
Neoplasms
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons.
Neoplasms
Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time.
Neoplasms
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Neoplasms
Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.
Neoplasms
Tumour lines from a spontaneous rat endometrial stromal sarcoma, showing dendritic cell-like and myofibroblastic cell-like phenotypes.
Neoplasms
Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.
Neoplasms
Tumour of female paraurethral duct. Immunohistochemical similarity with prostatic carcinoma.
Neoplasms
Ultrastructure of tumor cell interaction with alveolar macrophages stimulated by vitamin A.
Neoplasms
Unusual prostatic adenocarcinoma with endocrine basophilic FSH-immunoreactive cells.
Neoplasms
Urothelial and prostate carcinoma metastasizing to the same lymph node: a case report and review of the literature.
Neoplasms
Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma.
Neoplasms
Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Neoplasms
Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears.
Neoplasms
Validation of commonly used immunostains on cell-transferred cytologic specimens.
Neoplasms
Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.
Neoplasms
VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.
Neoplasms
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.
Neoplasms
Well-differentiated endocrine tumours of the middle ear and of the hindgut have immunocytochemical and ultrastructural features in common.
Neoplasms
Wild-type p53 gene transfer resulted in cell cycle arrest, but not apoptosis of newly established human malignant fibrous histiocytoma cell line.
Neoplasms
[A case of prostatic adenocarcinoma with pulmonary metastases--diagnosis by transbronchial lung biopsy and immunohistochemistry]
Neoplasms
[A primary adenocarcinoma of the seminal vesicles. Case report of a rare malignancy]
Neoplasms
[Acid phosphatase in the blood serum of male patients with tumors of the urinary and genital organs.]
Neoplasms
[Acid phosphatase isoenzyme composition of the lysosomes of normal and tumor cells]
Neoplasms
[Acid phosphatase of prostatic origin and its value in the diagnosis of cancer of the prostate.]
Neoplasms
[Action of some effectors and of Triton X-100 on the acid phosphatase in cerebral tumors studied histochemically]
Neoplasms
[Antitumor effects of aromatic retinoids (Ro 10-1670, Ro 10-9359) on the chemically-induced epithelial tumors]
Neoplasms
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
Neoplasms
[Blood acid phosphatase in apparently healthy subjects and in those with prostatic adenoma and cancer.]
Neoplasms
[Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma]
Neoplasms
[Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]
Neoplasms
[Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]
Neoplasms
[Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)]
Neoplasms
[Clinicopathological features of primary seminal vesicle adenocarcinoma: A report of 4 cases and review of the literature].
Neoplasms
[Clinicopathological study of nonpalpable and nonvisible (stage T1c) prostate cancer]
Neoplasms
[Comparative study in man of acid phosphatase levels in the colonic mucosa and corresponding tumor tissue]
Neoplasms
[Comparison of tumor markers versus their relative values to prostatic volume in detecting prostate cancer]
Neoplasms
[Correlation of gastroscopic, pathohistologic, cytologic and cytochemical analysis of ulcer lesions and other pathologic changes in the gastric mucosa. Preliminary study]
Neoplasms
[Correlation of vessel invasion and bone metastasis in prostatic adenocarcinoma. A clinico-pathological and immunohistochemical study of 33 cases of total prostatectomy]
Neoplasms
[Cytochemical analysis of acid phosphatase and beta glucuronidase in B-cell non-Hodgkin's lymphoma of low-grade malignancy]
Neoplasms
[Demonstration of osteoclastic acid phosphatase in the serum of patients with giant cell tumors. Preliminary study]
Neoplasms
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]
Neoplasms
[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy]
Neoplasms
[Early diagnosis of proststic cancer by determination of proststic acid phosphatase in the plasma.]
Neoplasms
[Effect of oxidative stress on periprosthetic osteolysis induced by TCP wear particles in mouse calvaria and its mechanism].
Neoplasms
[Effect of pulsed laser radiation on the lysosomes of Ehrlich ascitic tumor cells]
Neoplasms
[Electron-microscopic histochemistry of phosphohydrolases in the normal mucosa and in the cells of human gastric adenocarcinoma]
Neoplasms
[Enzyme and isoenzyme activity in patients with malignant tumors of the oral mucosa]
Neoplasms
[Enzyme cytochemical studies of malignant cutaneous lymphomas using simple smear preparations]
Neoplasms
[Enzyme cytochemistry and morphometric study of the effects of macrophages on A549 pulmonary alveolar cell carcinoma cell line]
Neoplasms
[Enzyme study in cancer of the prostate. Action of ionized calcium on acid phosphatase.]
Neoplasms
[Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis]
Neoplasms
[Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy]
Neoplasms
[Experience with transrectal ultrasonic studies in patients with prostatic tumors]
Neoplasms
[Histochemical and ultrastructural investigations on organ culture of malignant tumors (author's transl)]
Neoplasms
[HISTOCHEMICAL STUDIES ON ALKALINE AND ACID PHOSPHATASE IN THE LIVER OF PATIENTS OPERATED ON FOR CANCER OF THE ABDOMINAL ORGANS.]
Neoplasms
[Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method]
Neoplasms
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
Neoplasms
[Lysosomal acid phosphatase of lymphocytes in patients with cancer of the larynx (authors transl)]
Neoplasms
[Lysosomal enzymes in the neoplastic pathology of the uterine cervix. Study of acid phosphatase in the diagnostic test of vaginal secretions in patients with pre-invasive and invasive cancer of the uterine cervix. I. Methods and preliminary experiences]
Neoplasms
[Monoclonal anti-prostatic acid phosphatase antibodies (production and characterization)]
Neoplasms
[Morphohistochemical and electron microscopic characteristics of malignant tumors of the upper respiratory tract after combined local hyperthermia and radiotherapy]
Neoplasms
[Mucinous adenocarcinoma of the prostatic gland. Histochemical and immunohistochemical studies]
Neoplasms
[On the enzymo-histologic characteristic of cancers of the liver. I. Studies of the activity of alkaline phosphatase, acid phosphatase, lipase and nonspecific esterase]
Neoplasms
[PREVENTION OF THE BONES METASTASES OCCURRENCE IN THE PATIENTS WITH RENAL-CELL CANCER].
Neoplasms
[Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients]
Neoplasms
[Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]
Neoplasms
[PSAP expression in a primary presacral neuroendocrine tumor : Potential for confusion with prostate cancer.]
Neoplasms
[Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB]
Neoplasms
[Quantitative study of osteoclastic related factors in the process of bone reconstruction]
Neoplasms
[Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer]
Neoplasms
[Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract]
Neoplasms
[Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach]
Neoplasms
[Studies on acid phosphatase in prostatic cancer. II. Investigation of acid phosphatase isoenzymes by ion-exchange column chromatography in serum and bone marrow of the patient with prostatic cancer (author's transl)]
Neoplasms
[Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy]
Neoplasms
[Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer]
Neoplasms
[The influence of tumor growth on natural cytotoxicity and activity of some lysosomal enzymes of human effector cells and the C3HA mouse splenocytes]
Neoplasms
[The morphogenesis and histogenesis of an experimental malignant fibrous histiocytoma]
Neoplasms
[The significance of acid phosphatase activity in the cytologic diagnosis of thyroid malignancy (author's transl)]
Neoplasms
[The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer]
Neoplasms
[The ultrastructure and histochemical characteristics of the cells of malignant fibrous histiocytoma in rats]
Neoplasms
[Therapeutic effect and mechanism of silver needle heat conduction therapy combined with loxoprofen sodium patch in patients with knee osteoarthritis].
Neoplasms
[Urological neoplasms and enzyme. IV. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, and total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with dimethylnitrosamine]
Neoplasms
[Urological neoplasms and enzymes. V. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with lead acetate]
Neoplasms
[Value of prostate acid phosphatase determination and cytologic examination in the early diagnosis of cancer.]
Neoplasms
[Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate]
Neoplasms
[Various immunohistochemical markers of precancer and variants of prostate cancer]
Nephritis
Pharmacological studies on experimental nephritic rats (9). Changes in activities of urinary enzymes in the modified type of Masugi's nephritis and their sources.
Nephritis
[Pathogenetic significance of lipid peroxidation in damage of the proximal segment of the nephron in acute Masugi's nephritis]
Nephrotic Syndrome
Changes in the Dickkopf-1 and tartrate-resistant acid phosphatase 5b serum levels in preschool children with nephrotic syndrome.
Neuroblastoma
Electrophoretic patterns of glucose metabolizing enzymes and acid phosphatase in mouse and human neuroblastoma cells.
Neuroblastoma
FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Neuroblastoma
Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.
Neuroblastoma
In 'undifferentiated' PC12 cells, GERL is not segregated from the Golgi apparatus.
Neuroblastoma
Modification of opioid receptor activity by acid phosphatase in neuroblastoma x glioma NG108-15 hybrid cells.
Neurodegenerative Diseases
Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy.
Neuroendocrine Tumors
Neuroendocrine tumors of the liver and pancreas associated with elevated serum prostatic acid phosphatase.
Neuroendocrine Tumors
Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase.
Neurologic Manifestations
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Neurologic Manifestations
Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
Niemann-Pick Diseases
Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
Niemann-Pick Diseases
Studies on pyrophosphate diesterase activity in cultured human fibroblasts: a deficiency in Niemann-Pick disease.
Obesity
A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism.
Obesity
ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese.
Obesity
Apparent lack of effect of obesity on the soluble phosphatidic acid phosphatase activity in human adipose tissue.
Obesity
Caveolae-mediated endocytosis of the glucosaminoglycan-interacting adipokine tartrate resistant acid phosphatase 5a in adipocyte progenitor lineage cells.
Obesity
Expression and secretion of the novel adipokine tartrate-resistant acid phosphatase from adipose tissues of obese and lean women.
Obesity
Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility.
Obesity
Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus.
Obesity
Tartrate-resistant acid phosphatase type 5/ACP5 promotes cell cycle entry of 3T3-L1 preadipocytes by increasing IGF-1/Akt signaling.
Obesity
The adipokine tartrate-resistant acid phosphatase 5a in serum correlates to adipose tissue expansion in obesity.
Obesity
Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colon.
Obesity, Morbid
A study of acid phosphatase locus 1 in women with high fat content and normal body mass index.
Odontogenic Cysts
Enzyme histochemical studies on the formation of hyalin bodies in the epithelium of odontogenic cysts.
Odontogenic Cysts
In vitro growth characteristics of human odontogenic keratocysts and dentigerous cysts.
Odontogenic Cysts
Odontogenic keratocysts: a clinical and histological study with special reference to enzyme histochemistry.
Odontogenic Tumors
[Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]
Optic Atrophy
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Osteitis Deformans
Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Osteitis Deformans
Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone.
Osteoarthritis
Biomarkers for identifying the early phases of osteoarthritis secondary to medial patellar luxation in dogs.
Osteoarthritis
[Relation between serum enzymes and articular radionuclide tests in the diagnosis of osteoarthrosis and rheumatoid arthritis]
Osteoarthritis
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
Osteoarthritis
[The effect of intra-articular treatment with corticosteroids, polyvinylpyrrolidone and dimethyl sulfoxide on the composition of the synovial fluid in patients with rheumatoid arthritis]
Osteoarthritis
[Therapeutic effect and mechanism of silver needle heat conduction therapy combined with loxoprofen sodium patch in patients with knee osteoarthritis].
Osteoarthritis, Hip
[Morphometric and molecular biological features of femoral head tissue in different nosological entities of coxarthrosis].
Osteoarthritis, Knee
Lysosomal enzymes in serum and synovial fluid in patients with osteoarthritis.
Osteoarthritis, Knee
Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.
Osteoblastoma
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Osteochondrodysplasias
Acid phosphatase activity of chondroclasts from Fusarium-induced tibial dyschondroplastic cartilage.
Osteochondrosis
Cytology of polychrome-stained equine synovial fluid smears. Comparison with clinical findings, histologic specimens, Wright-Giemsa-stained smears and outcome.
Osteogenesis Imperfecta
Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
Osteogenesis Imperfecta
Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta.
Osteogenesis Imperfecta
Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
Osteolysis
Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Osteolysis
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders.
Osteolysis
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Osteolysis
Early detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates.
Osteolysis
Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells.
Osteolysis
Induction of osteoclast-like cell formation by leptin-induced soluble intercellular adhesion molecule secreted from cancer cells.
Osteolysis
Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices.
Osteolysis
Lymphocyte-activation gene 3(+) (LAG3(+)) forkhead box protein 3(-) (FOXP3(-)) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis.
Osteolysis
Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2: possible prognostic implications.
Osteolysis
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study.
Osteolysis
tBHQ Suppresses Osteoclastic Resorption in Xenogeneic-Treated Dentin Matrix-Based Scaffolds.
Osteolysis
[Effect of oxidative stress on periprosthetic osteolysis induced by TCP wear particles in mouse calvaria and its mechanism].
Osteolysis
[The effect of procyanidin on periprosthetic osteolysis caused by TCP wear particles in the mouse calvaria and its mechanism].
Osteomyelitis
Functional dissociation of the basolateral transcytotic compartment from the apical phago-lysosomal compartment in human osteoclasts.
Osteopetrosis
A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
Osteopetrosis
Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.
Osteopetrosis
Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.
Osteopetrosis
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.
Osteopetrosis
Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
Osteopetrosis
RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Osteopetrosis
Tartrate-resistant acid phosphatase activity in tibial osteoclasts and cells elicited by ectopic bone and suture implants in normal and osteopetrotic rats.
Osteophyte
Ectopic mineralization of cartilage and collagen-rich tendons and ligaments in Enpp1asj-2J mice.
Osteoporosis
A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Osteoporosis
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Osteoporosis
Application of bone transgenic zebrafish in anti-osteoporosis chemical screening.
Osteoporosis
Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.
Osteoporosis
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Osteoporosis
Chitooligosaccharides prevent osteopenia by promoting bone formation and suppressing bone resorption in ovariectomised rats: possible involvement of COX-2.
Osteoporosis
Chronic obstructive pulmonary disease severity in middle-aged and older men with osteoporosis associates with decreased bone formation.
Osteoporosis
Consumption of Vitamin D-and Calcium-Fortified Soft White Cheese Lowers the Biochemical Marker of Bone Resorption TRAP 5b in Postmenopausal Women at Moderate Risk of Osteoporosis Fracture.
Osteoporosis
Edgeworthia papyrifera Regulates Osteoblast and Osteoclast Differentiation In Vitro and Exhibits Anti-osteoporosis Activity in Animal Models of Osteoporosis.
Osteoporosis
Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17beta-estradiol.
Osteoporosis
Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE-/- mice.
Osteoporosis
Effects of the drug (BSZGC)-containing serum on proliferation of rat's osteoclasts and TRACP activity in vitro.
Osteoporosis
Grapefruit juice exerts anti-osteoporotic activities in a prednisolone-induced osteoporosis rat femoral fracture model, possibly via the RANKL/OPG axis.
Osteoporosis
Increased tartrate-resistant Acid phosphatase expression in osteoblasts and osteocytes in experimental osteoporosis in rats.
Osteoporosis
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
Osteoporosis
Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.
Osteoporosis
Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Osteoporosis
Postmenopausal Iron Overload Exacerbated Bone Loss by Promoting the Degradation of Type I Collagen.
Osteoporosis
Relevance of parathyroid hormone (PTH), vitamin 25(OH)D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases.
Osteoporosis
Roles of TNF-?, GSK-3? and RANKL in the occurrence and development of diabetic osteoporosis.
Osteoporosis
Rutin Isolated from Chrozophora tinctoria Enhances Bone Cell Proliferation and Ossification Markers.
Osteoporosis
Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study.
Osteoporosis
Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Osteoporosis
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
Osteoporosis
Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.
Osteoporosis
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Osteoporosis
U.S. Montmorency Tart Cherry Juice Decreases Bone Resorption in Women Aged 65-80 Years.
Osteoporosis
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
Osteoporosis
[Age related changes of serum sex hormone levels and tartrate-resistant acid phosphatase activity in healthy women]
Osteoporosis
[Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)]
Osteoporosis
[Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]
Osteoporosis
[Research progress of Rehmanniae Radix in prevention and treatment of osteoporosis].
Osteoporosis, Postmenopausal
17 beta-estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats.
Osteoporosis, Postmenopausal
New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women.
Osteoporosis, Postmenopausal
Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.
Osteoporosis, Postmenopausal
Zinc, biochemical markers of nutrition, and type I osteoporosis.
Osteoporosis, Postmenopausal
[Assessment of the alkaline (ALP) and acid phosphatase (ACP) in the blood serum of rats during experimental postmenopausal osteoporosis]
Osteosarcoma
A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents.
Osteosarcoma
Characterizations of recombinant human tartrate-resistant acid phosphatase from osteosarcoma: comparison study between recombinant and placental proteins.
Osteosarcoma
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Osteosarcoma
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Osteosarcoma
Human osteogenic sarcoma. Study of the ultrastructure, with special notes on the localization of alkaline and acid phosphatase.
Osteosarcoma
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
Osteosarcoma
Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss.
Osteosarcoma
Significance of "high" acid phosphatase activity in the serum of normal children.
Osteosarcoma
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Osteosarcoma
[Acid phosphatase indices during irradiation, UHF hyperthermia and chemotherapy of osteogenic sarcoma in children and adolescents]
Otitis
Alteration of adenoid tissue alkaline and acid phosphatase in children with secretory otitis media.
Otitis Media
Bone resorption in chronic otitis media. A light-microscopical and histochemical investigation of acid phosphatase activity.
Otitis Media
Ultrastructural evaluation of biochemical events of bone resorption in human chronic otitis media.
Otitis Media with Effusion
Alteration of adenoid tissue alkaline and acid phosphatase in children with secretory otitis media.
Otitis Media with Effusion
Certain oxidative and hydrolytic enzymes in the middle ear effusion in serous otitis media.
Ovarian Neoplasms
Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell.
Pancreatic Neoplasms
A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay.
Pancreatic Neoplasms
[OCCURRENCE OF RAISED SERUM ACID PHOSPHATASE LEVELS IN PANCREATIC CANCER AND HEPATOBILIARY DISEASES.]
Pancreatitis
Acid phosphatase activity in different organs as a marker of acute pancreatitis.
Pancreatitis
Hormonal and cholinergic effects on amylase and lysosomal enzyme activities in pancreatic tissue and ascites of rats with acute experimental pancreatitis.
Pancreatitis
Lysosomal-mitochondrial interrelationships in damage to the liver in acute experimental pancreatitis in dogs. Treatment with prostacyclin (PGI2).
Pancreatitis
PENTOXIFYLLINE PREVENTS LOSS OF PP2A PHOSPHATASE ACTIVITY AND RECRUITMENT OF HISTONE ACETYLTRANSFERASES TO PRO-INFLAMMATORY GENES IN ACUTE PANCREATITIS.
Pancreatitis
The effect of heparin on lysosomes of the dog pancreas during acute experimental pancreatitis.
Pancreatitis
[Activity and subcellular distribution of lysosomal enzymes in acute pancreatitis induced by CDE diet in mice]
Pancreatitis
[Protective effect of fructus gardeniae on pancreatic subcellular organs of the acute pancreatitis in rats]
Pancytopenia
Ultrastruct and tartrate-resistant acid phosphatase localization in a T-cell hairy-cell leukemia cell line.
Pancytopenia
[Leukemic infiltration of gastrointestinal system: unusual complication of hairy cell leukemia]
Papilloma
Deficiency of beta-glucuronidase in neutrophils from patients with precancerous states of the larynx.
Papilloma
Lymphocytes, neutrophils and serum immunoglobulins in patients with precancerous states of the larynx.
Papilloma
The lymphocyte cytochemical equipment and serum immunoglobulins in patients with precancerous states of the larynx.
Papilloma
[Papillomas of the mucous membranes of the larynx and pharynx. Relations between enzyme histochemistry and histological classification (author's transl)]
Paraproteinemias
Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
Paraproteinemias
Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gammopathies.
Paraproteinemias
[Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies]
Paraproteinemias
[Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies]
Parathyroid Neoplasms
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Paratuberculosis
Relationship of acid phosphatase activity to ultrastructural features in mice inoculated with Mycobacterium paratuberculosis.
Parkinson Disease
Bioinformatics analysis on the differentiation of bone mesenchymal stem cells into osteoblasts and adipocytes.
Pediatric Obesity
A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism.
Periodontal Diseases
Effect of gingival application of melatonin on alkaline and acid phosphatase, osteopontin and osteocalcin in patients with diabetes and periodontal disease.
Periodontal Diseases
Evaluating the levels of salivary alkaline and acid phosphatase activities as biochemical markers for periodontal disease: A case series.
Periodontal Diseases
Evaluation of salivary biomarkers of periodontitis among smokers and nonsmokers: A novel study.
Periodontal Diseases
Isolation, cloning, and expression of an acid phosphatase containing phosphotyrosyl phosphatase activity from Prevotella intermedia.
Periodontal Diseases
[Beta-glucuronidase, beta-acetylgalactosaminidase and acid phosphatase activities in whole saliva of the patients with periodontal disease (author's transl)]
Periodontitis
Alkaline phosphatase and acid phosphatase levels in saliva and serum of patients with healthy periodontium, gingivitis, and periodontitis before and after scaling with root planing: A clinico-biochemical study.
Periodontitis
Calcitriol suppresses lipopolysaccharide-induced alveolar bone damage in rats by regulating T helper cell subset polarization.
Periodontitis
Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis.
Periodontitis
Effect of locally administered novel biodegradable chitosan based risedronate/zinc-hydroxyapatite intra-pocket dental film on alveolar bone density in rat model of periodontitis.
Periodontitis
Evaluation of Biochemical Parameters Present in the Saliva of Patients with Chronic Periodontitis: Results from a Meta-Analysis.
Periodontitis
Evaluation of salivary biomarkers of periodontitis among smokers and nonsmokers: A novel study.
Periodontitis
High acid phosphatase level in the gingival tissues of periodontitis subjects.
Periodontitis
Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
Periodontitis
Role of enhancer of zeste homolog 2 in osteoclast formation and periodontitis development by downregulating microRNA-101-regulated VCAM-1.
Periodontitis
Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Periodontitis
Therapeutic Effects of Systemic Vitamin K2 and Vitamin D3 on Gingival Inflammation and Alveolar Bone in Rats With Experimentally Induced Periodontitis.
Periodontitis
TLR-4 targeting contributes to the recovery of osteoimmunology in periodontitis.
Periodontitis
[Comparative studies on lactate, proteins and enzymes in saliva of healthy and periodontitis sick juveniles]
Periodontitis
[The behavior of unspecific acid phosphatase in the human gingiva before and after the effect of aminofluorides]
Peripheral Nerve Injuries
Deceased expression of prostatic acid phosphatase in primary sensory neurons after peripheral nerve injury.
Peripheral Nerve Injuries
Mapping and plasticity of acid phosphatase afferents in the rat dorsal horn.
Persistent Infection
Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas.
Photosensitivity Disorders
Photosensitization effects on the solubility of acid phosphatase in nervous tissue.
Phyllodes Tumor
Giant cystosarcoma phyllodes of the prostate associated with adenocarcinoma.
Placenta, Retained
Reduced phagocytotic activity of macrophages in the bovine retained placenta.
Plague
[Activation of proteinases and acid phosphatase in swine leukocytes infected with the swine classical plague virus]
Plasmacytoma
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Platelet Storage Pool Deficiency
Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases.
Pleural Effusion
Carcinoma of the prostate presenting with massive pleural effusion and elevated pleural acid phosphatase.
Pleural Effusion
[Tuberculous pleural effusion and pleural effusion secondary to non-specific bacterial infection: biochemical differential diagnosis (author's transl)]
Pneumonia
Two-week inhalation toxicity of polymeric diphenylmethane-4, 4'-diisocyanate (PMDI) in rats: analysis of biochemical and morphological markers of early pulmonary response.
Pneumonia
[Immunological indices and the acid phosphatase activity of the blood serum in patients with suppurative and destructive complications of acute pneumonia during the treatment/process]
Pneumonia
[Importance of the cytochemical study of blood leukocyte enzyme activity in acute pneumonias]
Polycystic Kidney, Autosomal Dominant
A distinct bone phenotype in ADPKD patients with end-stage renal disease.
Polycythemia
Early diagnostic and prognostic criteria for health disorders in chemical workers.
Polycythemia Vera
Activity and intracellular localization of lysosomal acid phosphatase in lymphocytes from patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
Polymyalgia Rheumatica
Polymyalgia rheumatica and giant cell arteritis--rational diagnosis and treatment predicated and disordered prostaglandin metabolism.
Porcine Reproductive and Respiratory Syndrome
PP2A Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication by Deactivating irf3 and Limiting Type I Interferon Production.
Porphyria, Acute Intermittent
Absence of close linkage between acute intermittent porphyria and the ABO, Rh, P, acid phosphatase, Pr, orosmucoid and pepsinogen loci.
Porphyrias
Absence of close linkage between acute intermittent porphyria and the ABO, Rh, P, acid phosphatase, Pr, orosmucoid and pepsinogen loci.
Pre-Eclampsia
[Activity of acid phosphatase in the blood serum and placenta and cathepsin in the placenta in patients with late pregnancy toxemias]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acid phosphatase positivity in childhood acute lymphocytic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acid phosphatase staining pattern as an indicator of T-cell acute leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute lymphocytic leukemia with prominent azurophilic granulation and punctate acidic nonspecific esterase and phosphatase activity.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias".
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Non-T, non-B childhood acute lymphoblastic leukemia. Correlation between cytochemical markers and first complete remission.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Activity of acid phosphatase and the surface receptors of the lymphoblasts in the subclassification of lymphoblastic leukemia in children]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[The importance of studying the acid phosphatase of the blood serum and bone marrow lymphoblasts and polymorphonuclear neutrophils in the prognosis of the course of acute lymphoblastic leukemia]
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Acid phosphatase positivity in childhood acute lymphocytic leukemia.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Cytochemical comparison of immunologically characterized human leukaemia/lymphoma cell lines representing different levels of maturation.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Relation of some enzyme activities and argyrophilic proteins in childhood acute lymphoblastic leukemia.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
[Cytochemical characteristics of blast cells forming autologous rosettes in acute lymphoblastic leukemia in children]
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
[Immunological aspects of acute lymphoblastic leukemia (ALL) in children (author's transl)]
Pregnancy, Prolonged
An ultrahistochemical study of the distribution of acid and alkaline phosphatases in placentae from normal and complicated pregnancies.
Premature Ejaculation
[Semen biochemical markers and their significance in the patients with premature ejaculation]
Prostatic Diseases
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
Prostatic Diseases
A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
Prostatic Diseases
Acid phosphatase and zinc in semen of subjects with no clinical evidence of prostatic disease.
Prostatic Diseases
Acute and chronic retention of urine: relevance of raised serum prostatic acid phosphatase levels. A prospective study.
Prostatic Diseases
Case report. Two contrasting radiological presentations of prostatic adenocarcinoma in the jaws.
Prostatic Diseases
Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
Prostatic Diseases
Clinical application of prostatic markers. II. Circulating tumour markers in diagnosis and treatment.
Prostatic Diseases
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Prostatic Diseases
Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Prostatic Diseases
Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Prostatic Diseases
Diurnal variation of prostatic acid phosphatase (PAP) in urologic patients with nonprostatic disease.
Prostatic Diseases
Gamma-seminoprotein--a new tumour marker in prostatic cancer? Results of a pilot study.
Prostatic Diseases
Perspectives on serum acid phosphatase in prostatic disease. An evaluation of two methods.
Prostatic Diseases
Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease.
Prostatic Diseases
Serum prostatic acid phosphatase determination in prostatic diseases: a critical comparison of an enzymatic and a radioimmunologic assay.
Prostatic Diseases
The effect of rectal examination on serum acid phosphatase levels in benign and malignant prostatic disease.
Prostatic Diseases
[Determination of activity of acid phosphatase in serum in prostatic diseases]
Prostatic Diseases
[Immunological colorimetric determination of serum prostatic acid phosphatase activity in patients with prostatic diseases comparing with RIA and Kind-King modified methods]
Prostatic Diseases
[Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]
Prostatic Diseases
[Value of the determination of acid phosphatase of the blood in the diagnosis and prognosis of prostatic diseases. Comparisons of the results obtained with the technic of King and Jegatheesan and the technic of Babson and Read]
Prostatic Hyperplasia
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
Prostatic Hyperplasia
A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
Prostatic Hyperplasia
Acid phosphatase and 5-nucleotidase activities of human nodular prostatic hyperplasia as revealed by electron microscopy.
Prostatic Hyperplasia
Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Prostatic Hyperplasia
Amyloidosis presented with whitening and loss of hair which improved after dimethylsulfoxide (DMSO) treatment.
Prostatic Hyperplasia
An objective look at acid phosphatase determinations: a comparison of biochemical and immunological methods.
Prostatic Hyperplasia
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Prostatic Hyperplasia
Atrophy and apoptosis in ventral prostate of rats induced by 5alpha-reductase inhibitor, epristeride.
Prostatic Hyperplasia
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Prostatic Hyperplasia
Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.
Prostatic Hyperplasia
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Prostatic Hyperplasia
Clinical significance of serum acid phosphatase as measured by ELISA after treatment of benign prostatic hyperplasia.
Prostatic Hyperplasia
Clinical study on estramustine binding protein (EMBP) in human prostate.
Prostatic Hyperplasia
Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Prostatic Hyperplasia
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Prostatic Hyperplasia
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.
Prostatic Hyperplasia
Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Prostatic Hyperplasia
Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
Prostatic Hyperplasia
Differential suppression of serum prostatic acid phosphatase and prostate-specific antigen by 5-alpha-reductase inhibitor.
Prostatic Hyperplasia
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH).
Prostatic Hyperplasia
Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Prostatic Hyperplasia
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
Prostatic Hyperplasia
Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
Prostatic Hyperplasia
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
Prostatic Hyperplasia
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Prostatic Hyperplasia
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Prostatic Hyperplasia
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Prostatic Hyperplasia
Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer.
Prostatic Hyperplasia
Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer.
Prostatic Hyperplasia
Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Prostatic Hyperplasia
Immunocytochemistry of epithelial markers in citral-induced prostate hyperplasia in rats.
Prostatic Hyperplasia
Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice.
Prostatic Hyperplasia
Lack of association between prostate-specific acid phosphatase RFLP genotypes and prostatic cancer or benign prostatic hyperplasia.
Prostatic Hyperplasia
Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
Prostatic Hyperplasia
Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Prostatic Hyperplasia
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Prostatic Hyperplasia
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Prostatic Hyperplasia
Prostatic acid phosphatase by radioimmunoassay tumor marker in bone marrow.
Prostatic Hyperplasia
Prostatic acid phosphatase, purification and iodination using Iodogen.
Prostatic Hyperplasia
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
Prostatic Hyperplasia
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Prostatic Hyperplasia
Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
Prostatic Hyperplasia
Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
Prostatic Hyperplasia
Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
Prostatic Hyperplasia
Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma.
Prostatic Hyperplasia
Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Prostatic Hyperplasia
Significance of PSA and PAP in patients with or without prostatic cancer.
Prostatic Hyperplasia
TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
Prostatic Hyperplasia
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
Prostatic Hyperplasia
The distribution of S-100 protein in hyperplastic and neoplastic prostatic epithelium.
Prostatic Hyperplasia
The effect of prostatic massage on acid phosphatase in patients with and without benign prostatic hypertrophy.
Prostatic Hyperplasia
The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
Prostatic Hyperplasia
The histochemical demonstration of human prostatic acid phosphatase with phosphorylcholine.
Prostatic Hyperplasia
The role of prostatic specific antigen in monitoring prostatic cancer and its prognostic importance.
Prostatic Hyperplasia
The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
Prostatic Hyperplasia
Transient high serum prostate-specific acid phosphatase measured by radioimmunoassay in prostatic infarction.
Prostatic Hyperplasia
[A pelvic tumor unusual in terms of its volume and clinical expression]
Prostatic Hyperplasia
[An experimental study(I) on the inhibition of prostatic hyperplasia with extract of seeds of Brassica alba]
Prostatic Hyperplasia
[Blood acid phosphatase in apparently healthy subjects and in those with prostatic adenoma and cancer.]
Prostatic Hyperplasia
[Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma]
Prostatic Hyperplasia
[Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer]
Prostatic Hyperplasia
[Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer]
Prostatic Hyperplasia
[Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]
Prostatic Hyperplasia
[Immunochemical analysis of prostatic acid phosphatase. 2. Evaluation of normal individuals and patients with prostatic hypertrophy and a comparison with conventional methods]
Prostatic Hyperplasia
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
Prostatic Hyperplasia
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]
Prostatic Hyperplasia
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
Prostatic Hyperplasia
[Serum acid phosphatase levels following prostatic massage (author's transl)]
Prostatic Hyperplasia
[Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]
Prostatic Hyperplasia
[Significance of various examination methods in the management of prostatic cancer]
Prostatic Hyperplasia
[The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)]
Prostatic Hyperplasia
[The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method]
Prostatic Hyperplasia
[The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]
Prostatic Intraepithelial Neoplasia
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Prostatic Intraepithelial Neoplasia
Morphometric and ultrastructure features of the ventral prostate of rats (Rattus norvegicus) submitted to long-term nicotine treatment.
Prostatic Intraepithelial Neoplasia
The role of new modalities in the early detection and diagnosis of prostate cancer.
Prostatic Intraepithelial Neoplasia
[Various immunohistochemical markers of precancer and variants of prostate cancer]
Prostatic Neoplasms
A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate.
Prostatic Neoplasms
A new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer (SPIF).
Prostatic Neoplasms
A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate.
Prostatic Neoplasms
A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer.
Prostatic Neoplasms
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
Prostatic Neoplasms
Acid phosphatase for monitoring prostatic carcinoma. Comparison of radioimmunoassay and enzymatic techniques.
Prostatic Neoplasms
Acid phosphatase: defining a role in androgen-independent prostate cancer.
Prostatic Neoplasms
Acute gastrointestinal bleeding as the presenting manifestation of prostate cancer.
Prostatic Neoplasms
Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
Prostatic Neoplasms
Alteration of acid phosphatase isoenzyme in a human prostatic cancer cell line.
Prostatic Neoplasms
An assessment of serum acid and alkaline phosphatase determinations in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3'-monophosphate as substrate.
Prostatic Neoplasms
An enzyme-amplified monoclonal immunoenzymometric assay for prostatic acid phosphatase.
Prostatic Neoplasms
An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
Prostatic Neoplasms
An unusual increase in prostatic acid phosphatase not associated with prostatic cancer.
Prostatic Neoplasms
Anti-thyroid and antifungal activities, BSA interaction and acid phosphatase inhibition of methimazole copper(II) complexes.
Prostatic Neoplasms
Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer.
Prostatic Neoplasms
Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer.
Prostatic Neoplasms
Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
Prostatic Neoplasms
Aspects on reference values for tumor markers in human prostatic carcinoma.
Prostatic Neoplasms
Autologous dendritic cells pulsed with prostatic acid phosphatase (APC8015) for patients with hormone-refractory prostate cancer with a Gleason score
Prostatic Neoplasms
Avian prostatic acid phosphatase: estrogen regulation in the oviduct and epithelial cell-derived ovarian carcinomas.
Prostatic Neoplasms
Based on biomedical index data: Risk prediction model for prostate cancer.
Prostatic Neoplasms
BCG adjuvant immunotherapy in carcinoma of the prostate: an interim report.
Prostatic Neoplasms
Biochemical and immunologic techniques for acid phosphatase measurement in the diagnosis of prostate cancer.
Prostatic Neoplasms
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Prostatic Neoplasms
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex).
Prostatic Neoplasms
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Prostatic Neoplasms
Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
Prostatic Neoplasms
Bone marrow acid phosphatase in staging of prostatic cancer: how reliable is it?
Prostatic Neoplasms
Bone marrow and acid phosphatase by counterimmune electrophoresis: pre-treatment and post-treatment correlations.
Prostatic Neoplasms
Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Prostatic Neoplasms
Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
Prostatic Neoplasms
Calcification in human osteoblasts cultured in medium conditioned by the prostatic cancer cell line PC-3 and prostatic acid phosphatase.
Prostatic Neoplasms
Cancer of prostate metastatic to the skin diagnosed by immunoperoxidase staining.
Prostatic Neoplasms
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer.
Prostatic Neoplasms
Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Prostatic Neoplasms
Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.
Prostatic Neoplasms
Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
Prostatic Neoplasms
Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.
Prostatic Neoplasms
Changes in serum levels of prostatic acid phosphatase and prostate specific antigen after luteinizing hormone-releasing hormone analogue administration in patients with metastatic prostatic cancer in relation to glandular differentiation.
Prostatic Neoplasms
Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells.
Prostatic Neoplasms
Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
Prostatic Neoplasms
Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17 and LPIN2 genes.
Prostatic Neoplasms
Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
Prostatic Neoplasms
Clinical application of prostatic markers. II. Circulating tumour markers in diagnosis and treatment.
Prostatic Neoplasms
Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
Prostatic Neoplasms
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Prostatic Neoplasms
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
Prostatic Neoplasms
Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Prostatic Neoplasms
Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.
Prostatic Neoplasms
Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
Prostatic Neoplasms
Clinical value of different methods for determination of acid phosphatase in prostatic cancer.
Prostatic Neoplasms
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.
Prostatic Neoplasms
Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.
Prostatic Neoplasms
Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
Prostatic Neoplasms
Comparative evaluation of bone marrow acid phosphatase and bone scanning in staging of prostatic cancer.
Prostatic Neoplasms
Comparative evaluation of serum acid phosphatase, urinary cholesterol, and androgens in diagnosis of prostatic cancer.
Prostatic Neoplasms
Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Prostatic Neoplasms
Comparison of countercurrent immunoelectrophoretic assay with commercial radioimmunoassay kits for measuring prostatic acid phosphatase.
Prostatic Neoplasms
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Prostatic Neoplasms
Comparison of immunologic and enzymatic assay of prostatic acid phosphatase for follow-up and assessment of clinical status of stage D prostate cancer.
Prostatic Neoplasms
Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
Prostatic Neoplasms
Comparison of radioimmunological and conventional acid phosphatase assays in the serum of prostatic cancer patients.
Prostatic Neoplasms
Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.
Prostatic Neoplasms
Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
Prostatic Neoplasms
Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate.
Prostatic Neoplasms
Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
Prostatic Neoplasms
Correlation between tissular levels of prostatic acid phosphatase and prostate-specific antigen and hormonal response of metastatic prostatic cancer.
Prostatic Neoplasms
Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum.
Prostatic Neoplasms
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
Prostatic Neoplasms
Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Prostatic Neoplasms
Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
Prostatic Neoplasms
Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Prostatic Neoplasms
Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
Prostatic Neoplasms
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
Prostatic Neoplasms
Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Prostatic Neoplasms
Determination of prostate cancer biomarker acid phosphatase at a copper phthalocyanine-modified screen printed gold transducer.
Prostatic Neoplasms
Development of Parallel Reaction Monitoring Assays for the Detection of Aggressive Prostate Cancer Using Urinary Glycoproteins.
Prostatic Neoplasms
Diagnostic and therapeutic utility of monoclonal antibodies in urologic oncology.
Prostatic Neoplasms
Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.
Prostatic Neoplasms
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
Prostatic Neoplasms
Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
Prostatic Neoplasms
DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.
Prostatic Neoplasms
Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
Prostatic Neoplasms
Early stage prostatic cancer investigated by pelvic lymph node biopsy and bone marrow acid phosphatase.
Prostatic Neoplasms
Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
Prostatic Neoplasms
Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate.
Prostatic Neoplasms
Enzymatic prostatic acid phosphatase in the clinical staging of patients diagnosed with prostate cancer.
Prostatic Neoplasms
ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Prostatic Neoplasms
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Prostatic Neoplasms
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Prostatic Neoplasms
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Prostatic Neoplasms
Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
Prostatic Neoplasms
Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer.
Prostatic Neoplasms
Expression of a Human Prostatic Acid Phosphatase (PAP)-IgM Fc Fusion Protein in Plants Using
Prostatic Neoplasms
Expression of androgen receptor and prostate-specific antigen in male breast carcinoma.
Prostatic Neoplasms
Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
Prostatic Neoplasms
Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
Prostatic Neoplasms
Extremely high concentration of serum prostate-specific acid phosphatase in an untreated prostatic cancer patient.
Prostatic Neoplasms
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophy.
Prostatic Neoplasms
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Prostatic Neoplasms
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist.
Prostatic Neoplasms
From gene to protein: Prostatic acid phosphatase: Structure and expression of gene and protein*.
Prostatic Neoplasms
Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses.
Prostatic Neoplasms
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.
Prostatic Neoplasms
Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
Prostatic Neoplasms
Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming.
Prostatic Neoplasms
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Prostatic Neoplasms
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.
Prostatic Neoplasms
Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
Prostatic Neoplasms
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Prostatic Neoplasms
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.
Prostatic Neoplasms
Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.
Prostatic Neoplasms
Human prostatic acid phosphatase and prostate specific antigen: protein structure, gene organization, and expression in neoplastic and benign tissues.
Prostatic Neoplasms
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
Prostatic Neoplasms
HUMORAL IMMUNE RESPONSE AGAINST NON-TARGETED TUMOR ANTIGENS AFTER TREATMENT WITH SIPULEUCEL-T AND ITS ASSOCIATION WITH IMPROVED CLINICAL OUTCOME.
Prostatic Neoplasms
Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS.
Prostatic Neoplasms
Identification of cultured, human, malignant, prostatic epithelial cells.
Prostatic Neoplasms
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.
Prostatic Neoplasms
Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
Prostatic Neoplasms
Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Prostatic Neoplasms
Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
Prostatic Neoplasms
Immunofluorescent identification of antibodies specific for prostatic acid phosphatase.
Prostatic Neoplasms
Immunohistochemical Staining of Precursor Forms of Prostate-specific Antigen (proPSA) in Metastatic Prostate Cancer.
Prostatic Neoplasms
Immunologically measured serum markers and their role in the management of prostate cancer.
Prostatic Neoplasms
Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Prostatic Neoplasms
Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Prostatic Neoplasms
Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma.
Prostatic Neoplasms
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
Prostatic Neoplasms
Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells.
Prostatic Neoplasms
Importance of acid phosphatase in response criteria for prostate cancer.
Prostatic Neoplasms
In vivo behavior of 111In-labeled monoclonal anti-prostatic acid phosphatase antibody after intraprostatic and intravenous injections.
Prostatic Neoplasms
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
Prostatic Neoplasms
Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.
Prostatic Neoplasms
Induction of tumor specific cytotoxic T lymphocytes in prostate cancer using prostatic acid phosphatase derived HLA-A2402 binding peptide.
Prostatic Neoplasms
Influence of luteinizing hormone-releasing hormone analogues on serum levels of prostatic acid phosphatase and prostatic specific antigen in patients with metastatic carcinoma of the prostate.
Prostatic Neoplasms
Inhibition of cancer cell mitosis by reducing the availability of phosphate.
Prostatic Neoplasms
Inhibition of growth and increase of acid phosphatase by testosterone on androgen-independent murine prostatic cancer cells transfected with androgen receptor cDNA.
Prostatic Neoplasms
Instructed-Assembly of Small Peptides Inhibits Drug-Resistant Prostate Cancer Cells.
Prostatic Neoplasms
Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
Prostatic Neoplasms
Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
Prostatic Neoplasms
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Prostatic Neoplasms
Is the determination of prostatic acid phosphatase still worthwhile in prostate cancer patients?
Prostatic Neoplasms
Lack of association between prostate-specific acid phosphatase RFLP genotypes and prostatic cancer or benign prostatic hyperplasia.
Prostatic Neoplasms
Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
Prostatic Neoplasms
Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
Prostatic Neoplasms
Levels of prostate specific antigen that predict skeletal spread in prostate cancer.
Prostatic Neoplasms
Loss of prostatic acid phosphatase and ?-synuclein cause motor circuit degeneration without altering cerebellar patterning.
Prostatic Neoplasms
Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer.
Prostatic Neoplasms
Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
Prostatic Neoplasms
Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Prostatic Neoplasms
Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate.
Prostatic Neoplasms
Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.
Prostatic Neoplasms
Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Prostatic Neoplasms
Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.
Prostatic Neoplasms
Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.
Prostatic Neoplasms
Monitoring of prostatic cancer by an enzyme-linked immunosorbent assay of serum prostatic acid phosphatase.
Prostatic Neoplasms
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Prostatic Neoplasms
Multiple marker evaluation in prostatic cancer using prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase.
Prostatic Neoplasms
Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.
Prostatic Neoplasms
Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
Prostatic Neoplasms
Near-infrared fluorescence probe for the determination of acid phosphatase and imaging of prostate cancer cells.
Prostatic Neoplasms
New agents for prostatic cancer activated specifically by prostatic acid phosphatase.
Prostatic Neoplasms
On low acid phosphatase values of patients with known metastatic cancer of the prostate.
Prostatic Neoplasms
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
Prostatic Neoplasms
PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF-?B Signaling Pathway.
Prostatic Neoplasms
Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.
Prostatic Neoplasms
Pharmacokinetics and dosimetry of [111In] F(ab')2 fragments against prostatic acid phosphatase after intraprostatic injection for immunoscintigraphy in prostate cancer.
Prostatic Neoplasms
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.
Prostatic Neoplasms
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.
Prostatic Neoplasms
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.
Prostatic Neoplasms
Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Prostatic Neoplasms
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Prostatic Neoplasms
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Prostatic Neoplasms
Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
Prostatic Neoplasms
Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
Prostatic Neoplasms
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination.
Prostatic Neoplasms
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
Prostatic Neoplasms
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.
Prostatic Neoplasms
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.
Prostatic Neoplasms
Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer.
Prostatic Neoplasms
Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer.
Prostatic Neoplasms
Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Prostatic Neoplasms
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Prostatic Neoplasms
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
Prostatic Neoplasms
Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
Prostatic Neoplasms
Prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) immunoreactivity in benign seminal vesicle\ejaculatory duct epithelium: a potential pitfall in the diagnosis of prostate cancer in needle biopsy specimens.
Prostatic Neoplasms
Prostate specific antigen and prostate acid phosphatase declines after estramustine phosphate withdrawal: a case report.
Prostatic Neoplasms
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
Prostatic Neoplasms
Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
Prostatic Neoplasms
Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
Prostatic Neoplasms
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.
Prostatic Neoplasms
Prostate-specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancer.
Prostatic Neoplasms
Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Prostatic Neoplasms
Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer.
Prostatic Neoplasms
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Prostatic Neoplasms
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Prostatic Neoplasms
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
Prostatic Neoplasms
Prostate-specific antigen in mass screening for carcinoma of the prostate.
Prostatic Neoplasms
Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
Prostatic Neoplasms
Prostate-specific antigen: biochemistry, analytical methods, and clinical application.
Prostatic Neoplasms
Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
Prostatic Neoplasms
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
Prostatic Neoplasms
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.
Prostatic Neoplasms
Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Prostatic Neoplasms
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma.
Prostatic Neoplasms
Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma.
Prostatic Neoplasms
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Prostatic Neoplasms
Prostatic acid phosphatase in serum of patients with prostatic cancer is a specific phosphotyrosine acid phosphatase.
Prostatic Neoplasms
Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
Prostatic Neoplasms
Prostatic acid phosphatase measurement: its role in detection and management of prostatic cancer.
Prostatic Neoplasms
Prostatic acid phosphatase. Biomolecular features and assays for serum determination.
Prostatic Neoplasms
Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma.
Prostatic Neoplasms
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Prostatic Neoplasms
Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
Prostatic Neoplasms
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
Prostatic Neoplasms
Prostatic cancer. XII. Extremely elevated serum acid phosphatase associated with altered liver function.
Prostatic Neoplasms
Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow.
Prostatic Neoplasms
Prostatic cancer. VII. Serum acid phosphatase response to cholinergic stimulation in prostatic cancer patients.
Prostatic Neoplasms
Prostatic serum acid phosphatase in patients with localized prostatic cancer.
Prostatic Neoplasms
Prostatic serum acid phosphatase level in cancer of the prostate; diagnostic and clinical significance as illustrated by thirteen case histories.
Prostatic Neoplasms
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Prostatic Neoplasms
Protection of prostatic acid phosphatase activity in human serum samples by plasmin inhibitors.
Prostatic Neoplasms
Protein kinase C pathway is involved in regulating the secretion of prostatic acid phosphatase in human prostate cancer cells.
Prostatic Neoplasms
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3? signaling and inhibition of cellular prostatic acid phosphatase.
Prostatic Neoplasms
PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.
Prostatic Neoplasms
Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Prostatic Neoplasms
Purification of monoclonal antibodies raised against prostate-specific acid phosphatase for use in vivo in radioimaging of prostatic cancer.
Prostatic Neoplasms
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.
Prostatic Neoplasms
Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Prostatic Neoplasms
Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Prostatic Neoplasms
Radiation therapy for localized prostate cancer. Justification by long-term follow-up.
Prostatic Neoplasms
Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up.
Prostatic Neoplasms
Radioimmunoassay for prostatic acid phosphatase helps discriminate patients with prostatic cancer.
Prostatic Neoplasms
Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
Prostatic Neoplasms
Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Prostatic Neoplasms
Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.
Prostatic Neoplasms
Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
Prostatic Neoplasms
Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
Prostatic Neoplasms
Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.
Prostatic Neoplasms
Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancer.
Prostatic Neoplasms
Receiver operator characteristic (ROC) curves and non-normal data: an empirical study.
Prostatic Neoplasms
Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
Prostatic Neoplasms
Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
Prostatic Neoplasms
Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
Prostatic Neoplasms
RENAL ORIGIN OF URINARY ACID PHOSPHATASE IN NORMAL AND IN PATIENTS WITH CANCER OF THE PROSTATE.
Prostatic Neoplasms
Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
Prostatic Neoplasms
Routine acid phosphatase testing for screening and monitoring prostate cancer no longer justified.
Prostatic Neoplasms
Routine screening for prostatic cancer by assay of serum acid phosphatase: a modest proposal.
Prostatic Neoplasms
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
Prostatic Neoplasms
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Prostatic Neoplasms
Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Prostatic Neoplasms
Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic Acid phosphatase and human prostate cancer cells.
Prostatic Neoplasms
Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
Prostatic Neoplasms
Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening.
Prostatic Neoplasms
Sensitivity and specificity of acid phosphatase to detect prostate cancer using data from a hospital information system.
Prostatic Neoplasms
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Prostatic Neoplasms
Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Prostatic Neoplasms
Serum acid phosphatase in the assessment of response to systemic therapy in metastatic prostate cancer: comparison of radioimmune and enzymatic assays.
Prostatic Neoplasms
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Prostatic Neoplasms
Serum acid phosphatase of prostatic origin in the diagnosis of prostatic cancer: clinical evaluation of 2408 tests by the Fishman-Lerner method.
Prostatic Neoplasms
Serum acid phosphohydrolase (phosphatase) and ribonuclease in diagnosis of prostatic cancer.
Prostatic Neoplasms
Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer.
Prostatic Neoplasms
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Prostatic Neoplasms
Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
Prostatic Neoplasms
Serum TPS, PSA, and PAP values in relapsing stage D2 adenocarcinoma of the prostate.
Prostatic Neoplasms
Significance of a new stratification of alkaline phosphatase and extent of disease in patients with prostate carcinoma with bone metastasis.
Prostatic Neoplasms
Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies.
Prostatic Neoplasms
Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.
Prostatic Neoplasms
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
Prostatic Neoplasms
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.
Prostatic Neoplasms
Sipuleucel-T: a therapeutic cancer vaccine for the treatment of castration- or hormone-refractory prostate cancer.
Prostatic Neoplasms
Sonographic and pathological staging of patients with clinically localized prostate cancer.
Prostatic Neoplasms
Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.
Prostatic Neoplasms
Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells.
Prostatic Neoplasms
STUDIES OF FIBRINOLYSIS AND ACID PHOSPHATASE IN CANCER OF THE PROSTATE.
Prostatic Neoplasms
Studies on falsely negative serum acid phosphatase tests in disseminated prostatic cancer.
Prostatic Neoplasms
Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Prostatic Neoplasms
Successful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report.
Prostatic Neoplasms
Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Prostatic Neoplasms
Surveillance of patients with prostate cancer after treatment: the roles of serologic and imaging studies.
Prostatic Neoplasms
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
Prostatic Neoplasms
Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
Prostatic Neoplasms
Systemic treatment of advanced prostatic cancer: development of a new system for defining response.
Prostatic Neoplasms
TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
Prostatic Neoplasms
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
Prostatic Neoplasms
The 1993 ISOBM Abbott Award Lecture. Isozymes, tumor markers and oncodevelopmental biology.
Prostatic Neoplasms
The application of prostate specific membrane antigen in CART?cell therapy for treatment of prostate carcinoma (Review).
Prostatic Neoplasms
The contribution of prostatic acid phosphatase and prostatic specific antigen in the diagnosis of prostatic cancer.
Prostatic Neoplasms
The current role of prostatic acid phosphatase and prostate-specific antigen in the management of prostate cancer.
Prostatic Neoplasms
The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
Prostatic Neoplasms
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
Prostatic Neoplasms
The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate.
Prostatic Neoplasms
The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells.
Prostatic Neoplasms
The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
Prostatic Neoplasms
The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer.
Prostatic Neoplasms
The prognostic value of acid phosphatase and beta-glucuronidase activity in biopsy specimens from patients with reactivated prostatic cancer.
Prostatic Neoplasms
The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.
Prostatic Neoplasms
The prostatic acid phosphatase (ACPP) gene is localized to human chromosome 3q21-q23.
Prostatic Neoplasms
The role of prostatic specific antigen in monitoring prostatic cancer and its prognostic importance.
Prostatic Neoplasms
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature.
Prostatic Neoplasms
The staging of M1 disease: the role of bone scan, Xray and other imaging techniques.
Prostatic Neoplasms
The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.
Prostatic Neoplasms
The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
Prostatic Neoplasms
The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
Prostatic Neoplasms
The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
Prostatic Neoplasms
Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
Prostatic Neoplasms
Tissue polypeptide antigen (TPA) and prostatic acid phosphatase in serum of prostatic cancer patients.
Prostatic Neoplasms
Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma.
Prostatic Neoplasms
Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin.
Prostatic Neoplasms
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease.
Prostatic Neoplasms
Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time.
Prostatic Neoplasms
Two new, direct, and specific methods of acid phosphatase determination. National field trial.
Prostatic Neoplasms
Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
Prostatic Neoplasms
Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells.
Prostatic Neoplasms
Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literature.
Prostatic Neoplasms
Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancer.
Prostatic Neoplasms
URI Regulates KAP1 Phosphorylation and Transcriptional Repression via PP2A Phosphatase in Prostate Cancer Cells.
Prostatic Neoplasms
Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Prostatic Neoplasms
Urology-Important Advances in Clinical Medicine: Prostatic Acid Phosphatase Is Not a Screening Test for Early Prostatic Cancer.
Prostatic Neoplasms
Use of CT to reduce understaging in prostatic cancer: comparison with conventional staging techniques.
Prostatic Neoplasms
Value of biochemical markers in the management of disseminated prostatic cancer.
Prostatic Neoplasms
Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer.
Prostatic Neoplasms
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.
Prostatic Neoplasms
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
Prostatic Neoplasms
What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker.
Prostatic Neoplasms
XB130 is overexpressed in prostate cancer and involved in cell growth and invasion.
Prostatic Neoplasms
[Acid phosphatase and prostatic cancer. Survey of present assay methods]
Prostatic Neoplasms
[Acid phosphatase of prostatic origin and its value in the diagnosis of cancer of the prostate.]
Prostatic Neoplasms
[Aldolase, acid phosphatase and prostatic phosphatase in the blood of patients with prostatic cancer]
Prostatic Neoplasms
[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer].
Prostatic Neoplasms
[Cancer of the prostate: the markers other than prostatic acid phosphatase]
Prostatic Neoplasms
[Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]
Prostatic Neoplasms
[Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer]
Prostatic Neoplasms
[Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]
Prostatic Neoplasms
[Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma]
Prostatic Neoplasms
[Clinical evaluation of serum basic fetoprotein for prostatic cancer--comparative study with PAP, gamma-Sm and PSA]
Prostatic Neoplasms
[Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer]
Prostatic Neoplasms
[Clinical significance of acid phosphatase in the blood serum in prostatic cancer.]
Prostatic Neoplasms
[Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]
Prostatic Neoplasms
[Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]
Prostatic Neoplasms
[Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)]
Prostatic Neoplasms
[Current assessment of radioimmunological determination (RIA) of prostate acid phosphatase in the diagnosis of prostatic cancer]
Prostatic Neoplasms
[Current status and problems of a screening for prostatic cancer in the health facilities in Fukuoka Prefecture]
Prostatic Neoplasms
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]
Prostatic Neoplasms
[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy]
Prostatic Neoplasms
[Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase]
Prostatic Neoplasms
[Diagnostic significance of immunologically determined serum acid phosphatase in prostatic cancer]
Prostatic Neoplasms
[Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma]
Prostatic Neoplasms
[Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]
Prostatic Neoplasms
[Enzyme study in cancer of the prostate. Action of ionized calcium on acid phosphatase.]
Prostatic Neoplasms
[Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)]
Prostatic Neoplasms
[Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis]
Prostatic Neoplasms
[Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy]
Prostatic Neoplasms
[Enzymological study of prostatic cancer. VI. Serum acid phosphatase level and prognosis of patients with prostatic carcinoma (author's transl)]
Prostatic Neoplasms
[Evaluation of immunosuppressive acid protein in genitourinary malignant diseases]
Prostatic Neoplasms
[Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method]
Prostatic Neoplasms
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
Prostatic Neoplasms
[Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer]
Prostatic Neoplasms
[Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase]
Prostatic Neoplasms
[Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer]
Prostatic Neoplasms
[Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group]
Prostatic Neoplasms
[Prognosis of prostate cancer with elevated prostatic acid phosphatase]
Prostatic Neoplasms
[Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases]
Prostatic Neoplasms
[Prostate-specific antigen, acid phosphatases and rectal exploration in the diagnosis of prostatic cancer]
Prostatic Neoplasms
[Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma]
Prostatic Neoplasms
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]
Prostatic Neoplasms
[Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay]
Prostatic Neoplasms
[Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients]
Prostatic Neoplasms
[Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]
Prostatic Neoplasms
[Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB]
Prostatic Neoplasms
[Purification of prostatic acid phosphatase and prostate specific antigen from human seminal plasma]
Prostatic Neoplasms
[Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer]
Prostatic Neoplasms
[Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer]
Prostatic Neoplasms
[Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract]
Prostatic Neoplasms
[Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt]
Prostatic Neoplasms
[Significance of prostatic specific antigen in the mass screening for prostate cancer]
Prostatic Neoplasms
[Significance of tumor markers in the treatment of urological malignancies]
Prostatic Neoplasms
[Significance of various examination methods in the management of prostatic cancer]
Prostatic Neoplasms
[Studies on acid phosphatase in prostatic cancer. I. Acid phosphatase isoenzymes of various tissue extracts (author's transl)]
Prostatic Neoplasms
[Studies on acid phosphatase in prostatic cancer. II. Investigation of acid phosphatase isoenzymes by ion-exchange column chromatography in serum and bone marrow of the patient with prostatic cancer (author's transl)]
Prostatic Neoplasms
[Studies on acid phosphatase in prostatic cancer. III. Production of specific antibody against human prostatic acid phosphatase (author's transl)]
Prostatic Neoplasms
[Studies on acid phosphatase in prostatic cancer. IV. Immunochemical assay of prostatic acid phosphatase (author's transl)]
Prostatic Neoplasms
[Studies on human prostatic carcinoma cell lines: evaluation of acid phosphatase productivity and effects of sex hormones on the cells]
Prostatic Neoplasms
[The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]
Prostatic Neoplasms
[The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer]
Prostatic Neoplasms
[The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]
Prostatic Neoplasms
[Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate]
Prostatic Neoplasms
[Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate]
Prostatic Neoplasms
[VALUE OF THE DETERMINATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER. APROPOS OF 100 CASES.]
Prostatitis
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Prostatitis
Creatine phosphokinase relative to acid phosphatase, lactate dehydrogenase, zinc and fructose in human semen with special reference to chronic prostatitis.
Prostatitis
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Prostatitis
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Prostatitis
Granulomatous prostatitis and poorly differentiated prostate carcinoma. Their distinction with the use of immunohistochemical methods.
Prostatitis
Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.
Prostatitis
Paradoxical increase of sperm motility and seminal carnitine associated with moderate leukocytospermia in infertile patients.
Prostatitis
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Prostatitis
Proteolytic enzymes and acid phosphatase in the prostatic fluid in chronic prostatitis.
Prostatitis
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
Prostatitis
[The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer]
Prostatitis
[The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]
Protein Deficiency
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Protein-Energy Malnutrition
Metabolism of lysosomal enzymes in the protein-deficient weanling rat.
Proteinuria
Associations between polymorphic variety and disease susceptibility in two New Guinea populations.
Proteinuria
Changes in lysosome populations in the rat kidney cortex induced by passive Heymann glomerulonephritis.
Proteinuria
[A study of urine acid phosphatase in students with proteinuria and patients with renal diseases (author's transl)]
Proteinuria
[Experimental studies on the ketogenic effect of high doses of proteins in dairy cows]
Proteinuria
[Study of the enzymatic activity of the blood leukocytes in experimental nephrotoxic nephritis in rats]
Pseudohypoparathyroidism
Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
Psoriasis
Lack of association between psoriasis vulgaris and red cell acid phosphatase polymorphism.
Psoriasis
[Acid phosphatase distribution in the epidermis in psoriasis (an electron microscopy-histochemical study)]
Psoriasis
[Activity of beta-glucuronidase and acid phosphatase in fractions of granulocytes isolated from PMNL in peripheral blood of patients with psoriasis]
Psoriasis
[Comparative enzyme histochemical studies using four different slide making methods. II. Demonstration of acid phosphatase and non-specific esterase in psoriasis and the farmer's skin]
Pulmonary Disease, Chronic Obstructive
Activity of ?1-antitrypsin and some lysosomal enzymes in the blood serum of patients with chronic obstructive pulmonary disease after smoking cessation.
Purpura, Thrombocytopenic, Idiopathic
The activity of serum acid phosphatase in bone marrow aspirates predicts response to steroids/splenectomy in acute/chronic immune thrombocytopenic purpura.
Pyelonephritis
Bacterial antigen and acid phosphatase in macrophages in experimental pyelonephritis.
Pyelonephritis
[Renal acid phosphatase activities in experimental and human chronic pyelonephritis (author's transl)]
Radiation Pneumonitis
Enzyme histochemical observations of diffuse pulmonary fibrosis of rats experimentally induced by ionizing irradiation.
Rectal Neoplasms
Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Relative Energy Deficiency in Sport
Biomolecule from Trigonella stellata from Saudi Flora to Suppress Osteoporosis via Osteostromal Regulations.
Relative Energy Deficiency in Sport
OCY454 Osteocytes as an in Vitro Cell Model for Bone Remodeling Under Mechanical Loading.
Relative Energy Deficiency in Sport
Phelligridin D-loaded oral nanotube titanium implant enhances osseointegration and prevents osteolysis in rat mandible.
Relative Energy Deficiency in Sport
Processing and Sectioning Undecalcified Murine Bone Specimens.
Relative Energy Deficiency in Sport
Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
Renal Insufficiency
Acid phosphatase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity of peritoneal neutrophils in patients with terminal renal failure treated by intermittent peritoneal dialysis.
Renal Insufficiency
Activity of some lysosomal enzymes in peritoneal lymphocytes from patients with terminal renal failure treated by intermittent peritoneal dialysis.
Renal Insufficiency
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Renal Insufficiency
Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
Renal Insufficiency
[Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. IV. Cytochemical studies of acid phosphatase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity]
Renal Insufficiency
[Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]
Renal Insufficiency, Chronic
Effects of Yishenjiangzhuo granules on immunity and bone metabolism in patients with stage 3-4 chronic kidney disease.
Renal Insufficiency, Chronic
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
Renal Insufficiency, Chronic
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Renal Insufficiency, Chronic
[Effects of Yishen Jiangzhuo Granule on the bone metabolism of patients with stage 3-4 chronic kidney disease and its correlation with the immune indices].
Retinal Detachment
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Retinal Dystrophies
Acid phosphatase localization in normal and dystrophic retinal pigment epithelium.
Retinitis Pigmentosa
The distribution of extra-cellular acid phosphatase in the retinas of retinitis pigmentosa rats.
Retinoblastoma
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
Retroviridae Infections
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Rhabdomyolysis
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Rhabdomyosarcoma
Acid phosphatase response in murine rhabdomyosarcoma for various tumour volumes and after different doses of neutron irradiation, alone or combined with exogenous ATP.
Rheumatic Diseases
Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNF? therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular bone score.
Rheumatic Diseases
[Cyclic nucleotides and enzymes of the synovial fluid in various rheumatic diseases]
Rheumatic Diseases
[Study of blood acid phosphatase levels in patients with rheumatism (several perspectives in the clinical study of lysosomal permeability)]
Rheumatic Fever
[Zinc and enzymes in the synovial fluid and blood in various types of rheumatism]
Rheumatoid Nodule
A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule.
Rhinitis, Allergic
The histological and histochemical effects of ketotifen in allergic rhinitis.
Riboflavin Deficiency
Dietary riboflavin deficiency decreases immunity and antioxidant capacity, and changes tight junction proteins and related signaling molecules mRNA expression in the gills of young grass carp (Ctenopharyngodon idella).
Riboflavin Deficiency
Intestinal immune function, antioxidant status and tight junction proteins mRNA expression in young grass carp (Ctenopharyngodon idella) fed riboflavin deficient diet.
Riboflavin Deficiency
[Influence of riboflavin deficiency on the activity of acid phosphatase in maternal and fetal organs of rats]
Rickets
Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.
Rickets
[Acid phosphatase and alpha-glycerolphosphate dehydrogenase activity of the lymphocytes in rickets in children (a cytochemical study)]
Root Resorption
Cellular events at the onset of physiological root resorption in rabbit deciduous teeth.
Root Resorption
Dynamic Evaluation of Orthodontically-Induced Tooth Movement, Root Resorption, and Alveolar Bone Remodeling in Rats by in Vivo Micro-Computed Tomography.
Root Resorption
Effect of appliance reactivation after decay of initial activation on osteoclasts, tooth movement, and root resorption.
Root Resorption
Effects of calcitonin on orthodontic tooth movement and associated root resorption in rats.
Root Resorption
Effects of continuous force application for extrusive tipping movement on periapical root resorption in the rat mandibular first molar.
Root Resorption
Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement.
Root Resorption
Expressions of RANKL/RANK and M-CSF/c-fms in root resorption lacunae in rat molar by heavy orthodontic force.
Root Resorption
Histological and histochemical quantification of root resorption incident to the application of intrusive force to rat molars.
Root Resorption
Histomorphometric and biochemical study of osteoclasts at orthodontic compression sites in the rat during indomethacin inhibition.
Root Resorption
Inhibitory effects of IL-12 on experimental tooth movement and root resorption in mice.
Root Resorption
Non-clast cells start orthodontic root resorption in the periphery of hyalinized zones.
Root Resorption
Orthodontically induced root and alveolar bone resorption: inhibitory effect of systemic doxycycline administration in rats.
Root Resorption
Periodontal regeneration of transplanted rat molars after cryopreservation.
Root Resorption
Proinflammatory mediators related to orthodontically induced periapical root resorption in rat mandibular molars.
Root Resorption
Root resorption on torqued human premolars shown by tartrate-resistant acid phosphatase histochemistry and transmission electron microscopy.
Root Resorption
Tissue responses resulting from tooth movement surgically assisted by corticotomy and corticision in rats.
Sacroiliitis
Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis.
Sarcoidosis
Acid phosphatase (EC 3.1.3.2) activity in alveolar macrophages from patients with active sarcoidosis.
Sarcoidosis
Diminished activity of tartrate resistant acid phosphatase in alveolar macrophages from patients with active sarcoidosis.
Sarcoidosis
Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease.
Sarcoidosis
Polymorphism of acid hydrolases in human epitheliod cells indicates cellular origin and defined differentiation stages.
Sarcoidosis
Tartrate-resistant acid phosphatase 5a in sarcoidosis: further evidence for a novel macrophage biomarker in chronic inflammation.
Sarcoidosis
[Acid phosphatase and beta-glucuronidase activities of lymphocytes in patients with sarcoidosis (author's transl)]
Sarcoidosis
[Functional and morphological characterization of alveolar macrophages from patients with pulmonary sarcoidosis]
Sarcoidosis
[Serum enzyme tests in the diagnosis and follow-up of the evolution of sarcoidosis]
Sarcoidosis, Pulmonary
Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Sarcoma
Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption.
Sarcoma
The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions.
Sarcoma
[Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during the process of growth and exposure to anticoagulants (an enzyme cytochemical analysis)]
Sarcoma, Myeloid
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Sarcoma, Synovial
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Schistosomiasis mansoni
An isoenzyme marker possibly associated with the susceptibility of Biomphalaria glabrata populations to Schistosoma mansoni.
Scoliosis
Association of glycosaminoglycan depletion and degradative enzyme activity in scoliosis.
Scoliosis
[Association between tartrate-resistant acid phosphatase 5 gene polymorphism and adolescent idiopathic scoliosis].
Severe Dengue
Characterization of serum acid phosphatase associated with dengue hemorrhagic fever.
Sexually Transmitted Diseases
[In vivo neutralization of physiological cervicovaginal acidity by sperm nitrogen bases]
Shock, Septic
Production of toxic shock syndrome toxin 1 by Staphylococcus aureus under aerobic and anaerobic conditions and the effect of magnesium ion limitation.
Sickle Cell Trait
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Sjogren's Syndrome
Circulating prostatic acid phosphatase-immunoglobulin complexes in Sjogren's syndrome.
Spinal Cord Compression
Hormone stimulation and chemotherapy in advanced prostate cancer: preliminary results of a prospective controlled clinical trial.
Spinal Cord Injuries
Lysosomal activity in experimental spinal cord trauma: an ultrastructural cytochemical evaluation.
Spinal Cord Injuries
[Electro-acupuncture effects on experimental spinal cord injury of the cat as evaluated by acid phosphatase detection]
Spondylarthritis
In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Spondylitis, Ankylosing
Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process.
Starvation
A major root-associated acid phosphatase in Arabidopsis, AtPAP10, is regulated by both local and systemic signals under phosphate starvation.
Starvation
A type 5 acid phosphatase gene from Arabidopsis thaliana is induced by phosphate starvation and by some other types of phosphate mobilising/oxidative stress conditions.
Starvation
Activity alterations of metabolic enzymes in the anterior pituitary of female rats during acute and chronic starvation, as well as after refeeding.
Starvation
Arabidopsis PHL2 and PHR1 Act Redundantly as the Key Components of the Central Regulatory System Controlling Transcriptional Responses to Phosphate Starvation.
Starvation
Biochemical and molecular characterization of AtPAP26, a vacuolar purple acid phosphatase up-regulated in phosphate-deprived Arabidopsis suspension cells and seedlings.
Starvation
Characterization of low phosphorus insensitive mutants reveals a crosstalk between low phosphorus-induced determinate root development and the activation of genes involved in the adaptation of Arabidopsis to phosphorus deficiency.
Starvation
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana.
Starvation
Corrigendum to "Identification and characterization of an Arabidopsis phosphate starvation induced secreted acid phosphatase as a vegetative storage protein" [Plant Sci. 277 (2018) 278-284].
Starvation
Cytochemical investigation of the digestive gland of two strombidae species (Strombus gigas and Strombus pugilis) in relation to the nutrition.
Starvation
Differential increase in activity of acid phosphatase induced by phosphate starvation in Tetrahymena.
Starvation
Effect of starvation and 6-methylprednisolone (Medrol) on the acid phosphatase of rat liver and muscle.
Starvation
Examination of the endosomal and lysosomal pathways in Dictyostelium discoideum myosin I mutants.
Starvation
Feeding hungry plants: The role of purple acid phosphatases in phosphate nutrition
Starvation
Function of hybrid human-yeast cyclin-dependent kinases in Saccharomyces cerevisiae.
Starvation
Genome-wide characterization of the phosphate starvation response in Schizosaccharomyces pombe.
Starvation
Glycogen and glycogen-hydrolysing lysosomal enzyme activity in mouse liver: effects of fasting, adrenoceptor antagonism and insulin-induced hypoglycaemia.
Starvation
GmPAP12 Is Required for Nodule Development and Nitrogen Fixation Under Phosphorus Starvation in Soybean.
Starvation
High level of zinc triggers phosphorus starvation by inhibiting root-to-shoot translocation and preferential distribution of phosphorus in rice plants.
Starvation
High-level expression of endogenous acid phosphatase inhibits growth and vectorial secretion in Saccharomyces cerevisiae.
Starvation
Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.
Starvation
Identification of rice purple acid phosphatases related to phosphate starvation signalling.
Starvation
Lysosomal hydrolase secretion by Tetrahymena: a comparison of several intralysosomal enzymes with the isoenzymes released into the medium.
Starvation
Mathematical model of cell growth and phosphatase biosynthesis in Saccharomyces carlsbergensis under phosphate limitation.
Starvation
Metabolic and compositional changes in Escherichia coli cells starved in seawater.
Starvation
Metabolic priorities during starvation: enzyme sparing in liver and white muscle of Atlantic cod, Gadus morhua L.
Starvation
On the mitochondria, ribonucleic acid, acid phosphatase and polysaccharide of liver cells of a fish (Oryzias latipes) during starvation. II. On acid phosphatase.
Starvation
On the mitochondria, ribonucleic acid, acid phosphatase and polysaccharide of liver cells of a fish (Oryzias latipes) during starvation. III. On polysaccharide.
Starvation
On the mitochondria, ribonucleic acid, acid phosphatase and polysaccharide of liver cells of a fish (Oryzias latipes) during starvation. I. On the mitochondria and ribonucleic acid.
Starvation
Overexpression of OsPAP10a, A Root-Associated Acid Phosphatase, Increased Extracellular Organic Phosphorus Utilization in Rice.
Starvation
Pho5p and newly identified nucleotide pyrophosphatases/ phosphodiesterases regulate extracellular nucleotide phosphate metabolism in Saccharomyces cerevisiae.
Starvation
Phosphate Starvation Inducible Metabolism in Lycopersicon esculentum: I. Excretion of Acid Phosphatase by Tomato Plants and Suspension-Cultured Cells.
Starvation
Phosphate Starvation Inducible Metabolism in Lycopersicon esculentum: II. Characterization of the Phosphate Starvation Inducible-Excreted Acid Phosphatase.
Starvation
PRD, an Arabidopsis AINTEGUMENTA-like gene, is involved in root architectural changes in response to phosphate starvation.
Starvation
Regulation of two phosphatases and a cyclic phosphodiesterase of Salmonella typhimurium.
Starvation
RNA polymerase II CTD phospho-sites Ser5 and Ser7 govern phosphate homeostasis in fission yeast.
Starvation
Serum acid phosphatase response to starvation and cortisone administration in rats.
Starvation
Strigolactone regulates anthocyanin accumulation, acid phosphatases production and plant growth under low phosphate condition in Arabidopsis.
Starvation
The Arabidopsis gene hypersensitive to phosphate starvation 3 encodes ethylene overproduction 1.
Starvation
The Dual-targeted Purple Acid Phosphatase Isozyme AtPAP26 is Essential for Efficient Acclimation of Arabidopsis thaliana to Nutritional Phosphate Deprivation.
Starvation
TORC1 and TORC2 converge to regulate the SAGA co-activator in response to nutrient availability.
Starvation
Use of the p-nitrophenyl phosphate method for the demonstration of acid phosphatase during starvation and cell autolysis in the planarian Polycelis tenuis Iijima.
Starvation
[Genetical effect of different rye chromosomes on the acid phosphatase (Acph) secretion of common wheat roots under phosphorus starvation conditions]
Starvation
[Interrelationship between metabolic and genetic regulation of alkaline and acid phosphatases in E. coli cells]
Status Epilepticus
Enzyme histochemistry of the rat hippocampus during experimental status epilepticus.
Steatitis
Fish oil-induced yellow fat disease in rats. II. Enzyme histochemistry of adipose tissue.
Stomach Neoplasms
Activity of some lysosomal enzymes in neutrophils from peripheral blood of patients with digestive tract cancer at different clinical stages of the disease. A cytochemical study.
Stomach Neoplasms
Clinical significance of tartrate-resistant acid phosphatase type-5 expression in human gastric cancer.
Stomach Neoplasms
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Stomach Neoplasms
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.
Stomach Neoplasms
Lysosomal enzymes in peripheral blood lymphocytes of patients with gastric cancer.
Stomach Neoplasms
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer.
Stomach Neoplasms
Ultrastructural cytochemical study of enzymes expressed by signet ring cells in gastric cancer.
Stomach Neoplasms
Ultrastructural cytochemistry of human gastric cancer: electron microscopic observations of five organellae marker enzymes.
Stomach Neoplasms
[Histochemical study of acid phosphatase in tumor cells of stomach cancer]
Stomach Neoplasms
[Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach]
Stomach Neoplasms
[The phagocytic activity and the alkaline and acid phosphatase indices of the neutrophilic leukocytes in patients with stomach cancer treated with 5-fluorouracil and zymosan]
Stomach Ulcer
[Lipid peroxidation, the enzyme antioxidative system and acid phosphatase content of the gastric mucosa in stomach ulcer]
Synovitis
Associations of symptomatic knee OA with histopathologic features in subchondral bone.
Synovitis
Cruciate ligament degeneration and stifle joint synovitis in 56 dogs with intact cranial cruciate ligaments: Correlation of histological findings and numbers and phenotypes of inflammatory cells with age, body weight and breed.
Synovitis
IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel Fc?RIIB-deficient rheumatoid arthritis mouse model.
Synovitis
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
Teratoma
Free amino Acid pools and enzymes in teratonia and habituated tobaceo tissue cultures.
Teratozoospermia
Hypothyroidism has an adverse effect on human spermatogenesis: a prospective, controlled study.
Testicular Neoplasms
Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men.
Testicular Neoplasms
[Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract]
Thrombocytopenia
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Thrombocytopenia
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
Thrombocytosis
Uteroferrin and recombinant bovine GM-CSF modulate the myelosuppressive effects of 5-fluorouracil in young female pigs (Sus scrofa).
Thromboembolism
[Megakaryocytopoiesis in patients with acute infectious destruction of the lungs]
Thrombosis
Treatment with recombinant human macrophage colony-stimulating factor resorbs blood clot and restores osteoclastogenesis in heterotopic bone induced by partially purified native bone morphogenetic protein in osteopetrotic (op/op) mice.
Thyroid Neoplasms
An ultrastructural and cytoenzymological study on the folliculo-papillary thyroid carcinoma.
Thyroid Neoplasms
Lipid-rich residual bodies in the human thyroid gland: ultrastructural, histochemical, and morphometric study.
Thyrotoxicosis
A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice.
Thyrotoxicosis
[Acid phosphatase of leukocytes in patients with diffuse toxic goiter in evaluating the stage of the disease]
Tonsillitis
Enzymatic study of tonsil tissue alkaline and acid phosphatase in children with recurrent tonsillitis and tonsil hypertrophy.
Tooth Mobility
Development of Thymol microsponges loaded In situ gel for the treatment of Periodontitis.
Tourette Syndrome
Linkage to Tourette syndrome is excluded for red-cell acid phosphatase (ACP1) and flanking markers on chromosome 2pter-2p23.
Toxoplasmosis
[Cytochemical activity of cells of the lymphocytic-macrophageal system in patients with chronic acquired toxoplasmosis]
Tremor
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
Tricuspid Valve Insufficiency
Predictors of osteoclast activity in patients with sickle cell disease.
Tuberculosis
A comparative study on the activation of J-774 macrophage-like cells by gamma-interferon, 1,25-dihydroxyvitamin D3 and lipopeptide RP-56142: ability to kill intracellularly multiplying Mycobacterium tuberculosis and Mycobacterium avium.
Tuberculosis
HLA-DR2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels in pulmonary tuberculosis.
Tuberculosis
Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues.
Tuberculosis
Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases.
Tuberculosis
Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways.
Tuberculosis
[Alteration in activities of NAD-glycohydrolase, acid and alkaline phosphatases in blood cells tuberculosis]
Tuberculosis
[Histochemical study of alkaline and acid phosphatase in prolonged therapy of tuberculosis]
Tuberculosis
[SapM-induced fusion blocking of autophagosome-lysosome is depended on interaction with Rab7].
Tuberculosis
[Secretory acid phosphatase of Mycobacterium tuberculosis inhibits the autophagy of murine macrophages].
Tuberculosis, Osteoarticular
Mycobacterium tuberculosis infection increases the number of osteoclasts and inhibits osteoclast apoptosis by regulating TNF-?-mediated osteoclast autophagy.
Tuberculosis, Pulmonary
Enzyme levels in bronchoalveolar lavage fluid and serum of active pulmonary tuberculosis patients.
Tuberculosis, Pulmonary
HLA-DR2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels in pulmonary tuberculosis.
Tuberculosis, Pulmonary
[Acid phosphatase and beta-glucuronidase activities of T and B lymphocytes in patients with pulmonary tuberculosis (author's transl)]
Tuberculosis, Pulmonary
[Alteration in activities of NAD-glycohydrolase, acid and alkaline phosphatases in blood cells tuberculosis]
Tuberculosis, Pulmonary
[Lymphocyte enzymes, activity of lipid peroxidation processes and the antioxidant protection of patients with tuberculosis of the lungs]
Ureteral Neoplasms
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
Urinary Bladder Neoplasms
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Urinary Bladder Neoplasms
Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
Urinary Bladder Neoplasms
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
Urinary Bladder Neoplasms
[Enzymological study of bladder tumor. I. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activities and LDH isoenzymes: the relations with stage and histological grade]
Urologic Diseases
[Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]
Urologic Diseases
[Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]
Urologic Neoplasms
[Urological neoplasms and enzyme. IV. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, and total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with dimethylnitrosamine]
Urologic Neoplasms
[Urological neoplasms and enzymes. V. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with lead acetate]
Uterine Cervical Neoplasms
Antitumor activity and DNA-binding investigations of isoeuxanthone and its piperidinyl derivative.
Uterine Cervical Neoplasms
Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
Uterine Cervical Neoplasms
[Lysosomal enzymes in the neoplastic pathology of the uterine cervix. Study of acid phosphatase in the diagnostic test of vaginal secretions in patients with pre-invasive and invasive cancer of the uterine cervix. I. Methods and preliminary experiences]
Uveitis
[The role of lysosomal enzymes in adjuvant-induced uveitis in rabbits (author's transl)]
Vaccinia
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Varicocele
Fructose, prostatic acid phosphatase and zinc levels in the seminal plasma of varicoceles.
Varicocele
Markers of accessory sex glands function in men with varicocele, relationship with seminal parameters.
Varicocele
Seminal biochemistry and sperm characteristics in infertile men with bacteria in ejaculate.
Varicose Veins
Lysosomal enzymes and superoxide production in polymorphonuclear leukocytes of patients with primary varicose veins.
Vascular Calcification
Biochemical markers of vascular calcification in elderly hemodialysis patients.
Vascular Calcification
The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Vasculitis
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
Virus Diseases
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG.
Virus Diseases
CORTISONE ON IN VITRO VIRAL INFECTION. II. EFFECT ON DISTRIBUTION OF CYTOPATHIC EFFECT AND ACID PHOSPHATASE ARRANGEMENT IN HUMAN CELLS INFECTED WITH POLIOVIRUS.
Virus Diseases
Cytochemical demonstration of acid phosphatase in peripheral blood cells in Rauscher virus infection.
Virus Diseases
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Virus Diseases
Influence of 2,4,6-triamino-pyrimidyl-5-azobenzene on the activities of acid phosphatase, alkaline phosphatase and lactate dehydrogenase in cell cultures infected with herpes simplex virus type 1.
Virus Diseases
Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper.
Virus Diseases
Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid.
Virus Diseases
PP2A Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication by Deactivating irf3 and Limiting Type I Interferon Production.
Virus Diseases
Rapid Formation of Peptide/Lipid Coaggregates by the Amyloidogenic Seminal Peptide PAP248-286.
Virus Diseases
The semen enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.
Vitamin B 6 Deficiency
Intravenous Vitamin B6 Increases Resistance to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Randomized Controlled Trial.
Vitamin D Deficiency
Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency.
Vitamin E Deficiency
Vitamin E deficiency depressed fish growth, disease resistance, and the immunity and structural integrity of immune organs in grass carp (Ctenopharyngodon idella): Referring to NF-?B, TOR and Nrf2 signaling.
Waldenstrom Macroglobulinemia
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
Whooping Cough
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Whooping Cough
Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.
Zenker Diverticulum
Morphology of the cricopharyngeal muscle in Zenker and control specimens.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
12.49
Ac-(pT)AILER
synthetic phosphorylated oligopeptide, pH 4, 37°C
16.57
Ac-(pT)IALGK
synthetic phosphorylated oligopeptide, pH 4, 37°C
13.88
Ac-RK(pS)AGKPKN
synthetic phosphorylated oligopeptide, pH 4, 37°C
12.56
KR(pT)IRR
synthetic phosphorylated oligopeptide, pH 4, 37°C
11.89
RRA(pT)VA
synthetic phosphorylated oligopeptide, pH 4, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH RANGE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TEMPERATURE RANGE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable).
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
AtTLP18.3 proteins are crystallized by the hanging drop vapor diffusion method at 23°C. X-ray crystallography reveal the folding of AtTLP18.3 as a three-layer sandwich with 3 alpha-helices in the upper layer, 4 beta-sheets in the middle layer, and 2 alpha-helices in the lower layer, which resembles a Rossmann fold
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
Northern blot analysis reveal AtTLP18.3 with a diurnally fluctuating expression pattern in wild-type plants. The transcripts show 2 high expression peaks, at 8 and 16 h after lights are 14 turned on
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Wu, H.Y.; Liu, M.S.; Lin, T.P.; Cheng, Y.S.
Structural and functional assays of AtTLP18.3 identify its novel acid phosphatase activity in thylakoid lumen
Plant Physiol.
157
1015-1025
2011
Arabidopsis thaliana (Q9ZVL6)
brenda
EXTERNAL LINKS (specific for EC-Number 3.1.3.2)
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
About BRENDA
Social media
Help
Survey
Download
Contribution
Legal
Curated at
Member of
